Page last updated: 2024-10-28

guaifenesin and Disease Models, Animal

guaifenesin has been researched along with Disease Models, Animal in 398 studies

Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" azedarach fruit extract (MAE) using high-performance liquid chromatography (HPLC) and explored the therapeutic effects of MAE on pulmonary inflammation and mucus hypersecretion using a murine model of ovalbumin (OVA) exposed asthma."8.84Melia azedarach L. reduces pulmonary inflammation and mucus hypersecretion on a murine model of ovalbumin exposed asthma. ( Kim, T; Kim, WI; Lee, IS; Lee, SJ; Pak, SW; Shin, IS; Yang, YG, 2024)
"We demonstrated that intranasal adenosine administration effectively decreased inflammation and mucus production in a mouse model of viral ARS."8.31Topical Adenosine Inhibits Inflammation and Mucus Production in Viral Acute Rhinosinusitis. ( Ganama, M; Hua, X; Tilley, S; Varga, SM; Waldstein, KA, 2023)
" In this study, we explored the suppressive effects of SAC on allergic airway inflammation induced in an ovalbumin (OVA)-induced asthma mouse model."7.91S-Allyl cysteine reduces eosinophilic airway inflammation and mucus overproduction on ovalbumin-induced allergic asthma model. ( Kim, JC; Kim, JS; Kim, SH; Ko, JW; Kwon, HJ; Lee, IC; Shin, IS; Shin, NR, 2019)
"The purpose of this study is to explore the influence of ozone repeated short exposures on airway/lung inflammation, airway hyperresponsiveness (AHR) and airway hypersecretion in ovalbumin (OVA) sensitized/challenged asthmatic mouse model."7.88Effects of ozone repeated short exposures on the airway/lung inflammation, airway hyperresponsiveness and mucus production in a mouse model of ovalbumin-induced asthma. ( Bao, A; Bao, W; Fei, X; Zhang, M; Zhang, X; Zhang, Y; Zhou, X, 2018)
" This study aimed to evaluate the preventive activity of IMP in an ovalbumin (OVA)-induced murine model of asthma and to investigate its possible molecular mechanisms."7.85Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma. ( Kwon, HJ; Moon, OS; Park, HS; Seo, CS; Son, HY; Song, JW; Wijerathne, CUB; Won, YS, 2017)
" In the current study, an ovalbumin (OVA)‑induced allergic asthma model was used to investigate the immune‑modulating effects of pidotimod on airway eosinophilia, mucus metaplasia and inflammatory factor expression compared with dexamethasone (positive control)."7.85Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma. ( Fu, AK; Fu, LQ; Hu, SL; Li, WF; Li, YL; Wang, YY; Wu, YP, 2017)
" After oral administration of indomethacin (5 mg/kg) for 5 consecutive days, gastric ulcerated animals were divided into control group and five other groups: three groups that recieved respectively 125, 250 and 500 mg/kg of plant extract, the fourth group received Maalox (50 mg/kg) and the fifth group, Misoprostol (100 μg/kg), respectively, for 5 days."7.85Anti-Helicobacter pylori and antiulcerogenic activity of Aframomum pruinosum seeds on indomethacin-induced gastric ulcer in rats. ( Eyoum Bille, B; Kouitcheu Mabeku, LB; Nanfack Nana, B; Nguepi, E; Tchuenteu Tchuenguem, R, 2017)
"Repeated inhalation of sevoflurane (SVF) can benefit asthmatic patients by bronchodilation."7.81Repeated inhalation of sevoflurane inhibits airway inflammation in an OVA-induced mouse model of allergic airway inflammation. ( Ding, PS; Fang, L; He, F; Liu, RY; Shen, QY; Wu, HM, 2015)
"We have reported that triptolide inhibited pulmonary inflammation in patients with steroid-resistant asthma."7.81Triptolide suppresses airway goblet cell hyperplasia and Muc5ac expression via NF-κB in a murine model of asthma. ( Chen, M; Huang, L; Jiang, S; Liang, R; Lin, X; Lv, Z; Shi, J; Zhang, W, 2015)
"We used ovalbumin (OVA)-based mouse models of asthma and primary CD4(+) T cells."7.81PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function. ( Al-Ghareeb, K; Al-Khami, AA; Boulares, AH; El-Bahrawy, AH; Ghonim, MA; Ibba, SV; Lammi, MR; Mansy, MS; Naura, AS; Ochoa, A; Pyakurel, K; Rady, HF; Ramsay, A; Rodriguez, P; Wang, J, 2015)
"To explore the impact of ozone on the airway hyperresponsinveness (AHR), airway inflammation and mucus production in an allergic asthma mouse model."7.81[Effects of ozone oxidative stress on the airway hyperresponsiveness and mucus production in mice with acute allergic airway inflammation]. ( Aihua, B; Feng, L; Xin, Z; Yuqing, C; Zhang, M, 2015)
"The flavonoid naringenin has been shown to attenuate airway inflammation and airway hyper‑reactivity in acute murine models of asthma."7.80Naringenin inhibits allergen‑induced airway remodeling in a murine model of asthma. ( Gu, W; Mao, S; Shi, Y; Tan, Y, 2014)
"We investigated the suitability of dendritic polyglycerol sulfates (dPGS), conjugated with a hydrophilic version of the indocyanine green label with 6 sulfonate groups (6S-ICG) to monitor sites of inflammation using an experimental mouse model of allergic asthma."7.79Dendritic polyglycerolsulfate near infrared fluorescent (NIRF) dye conjugate for non-invasively monitoring of inflammation in an allergic asthma mouse model. ( Alves, F; Biffi, S; Bosnjak, B; Dal Monego, S; Dullin, C; Epstein, MM; Garrovo, C; Licha, K; Welker, P, 2013)
"Montelukast, a leukotriene receptor antagonist, is used commercially as a maintenance treatment for asthma and to relieve allergic symptoms."7.79Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma. ( Jeon, WY; Lee, MY; Shin, HK; Shin, IS, 2013)
"Verapamil is a useful drug with therapeutic targeting on GCH and a potential way to limit mucous production and improve bronchial inflammation."7.78Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals. ( Ghafarzadegan, K; Hadi, R; Khakzad, MR; Meshkat, M; Mirsadraee, M; Mohammadpour, A; Saghari, M, 2012)
" Female BALB/c mice sensitized and challenged with ovalbumin developed airway inflammation."7.78Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB. ( Cheng, C; Goh, FY; Guan, S; Leung, BP; Sethi, G; Shanmugam, MK; Upton, N; Wong, WS, 2012)
"Evidence suggests that nebulized lidocaine is beneficial in asthma therapy, but to what extent and the mechanisms underlying this effect remain poorly understood."7.78Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma. ( Anjos-Valotta, EA; Arantes, AC; Cordeiro, RS; Cotias, AC; Couto, GC; Ferreira, TP; Jurgilas, PB; Martins, MA; Olsen, PC; Pão, CR; Pires, AL; Serra, MF; Silva, PM, 2012)
"Altered arginine metabolism, the uncoupling of nitric oxide synthase (NOS) by asymmetric dimethyl-arginine (ADMA), increased oxo-nitrosative stress, and cellular injury were reported in airway epithelial cells in asthma."7.77Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma. ( Agrawal, A; Ahmad, T; Aich, J; Ghosh, B; Mabalirajan, U; Makhija, L; Sharma, A, 2011)
"(R)- and (S)-Enantiomers of albuterol likely exert differential effects in patients with asthma."7.73Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model. ( Banerjee, ER; Chi, EY; Henderson, WR, 2005)
"Previous studies have investigated the short-term effect of capsaicin on edema formation and goblet-cell secretion in the trachea."7.72Spontaneous remission of edema and regranulation of goblet cells in rat tracheae after capsaicin-induced acute inflammation. ( Guo, JJ; Huang, HT; Wang, DS, 2003)
"The chronically isoproterenol-treated rat has been proposed as an animal model for cystic fibrosis."7.67The chronically isoproterenol-treated rat in the study of cystic fibrosis: X-ray microanalysis of the submandibular gland. ( Müller, RM; Roomans, GM, 1984)
"Ursolic acid (UA) has activities in immune regulation and anti-inflammatory."5.62Ursolic Acid Alleviates Mucus Secretion and Tissue Remodeling in Rat Model of Allergic Rhinitis After PM2.5 Exposure. ( Deng, C; Dong, W; Duan, Y; Guo, Z; Han, Z; Sun, N; Wang, H; Zhang, R; Zhao, Q; Zhuang, G, 2021)
"The incidence of chronic obstructive pulmonary disease (COPD) has substantially increased in recent decade."5.42Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling. ( Ahn, KS; Hong, JM; Jeon, CM; Kim, JC; Kim, JS; Kwon, OK; Lee, IC; Oh, SR; Park, JW; Shin, IS; Shin, NR, 2015)
"Chronic mucosal inflammation is the hallmark of important and common airway diseases, such as allergic rhinitis (AR) and asthma."5.42Lipoxin B₄ promotes the resolution of allergic inflammation in the upper and lower airways of mice. ( Haworth, O; Karra, L; Levi-Schaffer, F; Levy, BD; Priluck, R, 2015)
"Melatonin was administered by intraperitoneal injection once per day at doses of 10 and 15 mg/kg from days 21 to 23 after the initial OVA sensitization."5.40Melatonin reduces airway inflammation in ovalbumin-induced asthma. ( Ahn, KS; Jeon, CM; Kim, JC; Kim, JS; Kwon, OK; Oh, SR; Park, JW; Shin, IS; Shin, NR, 2014)
"Acute bronchiolitis was induced by inhalation of nickel chloride aerosols for 5 days in Wistar rats according to the method described by Kyono et al."5.31Inflammatory responses and mucus secretion in rats with acute bronchiolitis induced by nickel chloride. ( Ishihara, Y; Kawashima, H; Kyono, H; Miyasaka, M; Serita, F; Toya, T, 2002)
"Ovalbumin (OVA) and BaP co-exposure were used to establish the aggravated asthma model."4.84Qufeng Xuanbi Formula inhibited benzo[a]pyrene-induced aggravated asthma airway mucus secretion by AhR/ROS/ERK pathway. ( Hu, J; Liu, CY; Liu, L; Shi, XL; Sun, XH; Tang, LL; Wang, BH; Wang, Y; Yang, Y; Yu, KY; Zhang, Q; Zhang, XN, 2024)
" azedarach fruit extract (MAE) using high-performance liquid chromatography (HPLC) and explored the therapeutic effects of MAE on pulmonary inflammation and mucus hypersecretion using a murine model of ovalbumin (OVA) exposed asthma."4.84Melia azedarach L. reduces pulmonary inflammation and mucus hypersecretion on a murine model of ovalbumin exposed asthma. ( Kim, T; Kim, WI; Lee, IS; Lee, SJ; Pak, SW; Shin, IS; Yang, YG, 2024)
"We demonstrated that intranasal adenosine administration effectively decreased inflammation and mucus production in a mouse model of viral ARS."4.31Topical Adenosine Inhibits Inflammation and Mucus Production in Viral Acute Rhinosinusitis. ( Ganama, M; Hua, X; Tilley, S; Varga, SM; Waldstein, KA, 2023)
"We established ovalbumin (OVA) induced asthmatic murine model and orally administrated Iristectorigenin A at concentration of 5 and 10 mg/kg and dexamethasone as a positive control substance."4.12Iristectorigenin A exerts novel protective properties against airway inflammation and mucus hypersecretion in OVA-induced asthmatic mice: Iristectorigenin A ameliorates asthma phenotype. ( Abduwaki, M; Cui, J; Dong, JC; Luo, Q; Lv, Y; Nabijan, M; Nurahmat, M; Qin, J; Tang, W; Teng, F; Wang, S; Wei, Y; Wuniqiemu, T; Zhou, Y; Zhu, X, 2022)
" An ovalbumin (OVA)-induced mouse asthma model was established and the effect of acupuncture on airway hyperresponsiveness (AHR), mucus hypersecretion and inflammation was assessed."4.02TMT-based quantitative proteomics reveals suppression of SLC3A2 and ATP1A3 expression contributes to the inhibitory role of acupuncture on airway inflammation in an OVA-induced mouse asthma model. ( Cui, J; Dong, J; Dong, M; Qin, J; Tang, W; Teng, F; Wang, S; Wang, W; Wei, Y; Wuniqiemu, T; Zhu, X, 2021)
"Compared with IL 33 group, the inflammatory cell infiltration around the trachea and blood vessels of the lung tissue in the IL 33+ Iloprost group were reduced; goblet cell hyperplasia was observed in airway mucosa of IL 33 group, and the mucus secretion increased; the percentage of EOS and ILC2s in the BALF and lung single cell suspensions in IL 33+ Iloprost group were statistically lower than that of IL 33 group (p < 0."3.96Iloprost inhibits acute allergic nasal inflammation by GATA3 -ILC2 pathway in mice. ( Jiang, X; Li, L; Liu, H; Liu, J; Liu, K; Yang, C; Zhang, X, 2020)
" In this study, we explored the suppressive effects of SAC on allergic airway inflammation induced in an ovalbumin (OVA)-induced asthma mouse model."3.91S-Allyl cysteine reduces eosinophilic airway inflammation and mucus overproduction on ovalbumin-induced allergic asthma model. ( Kim, JC; Kim, JS; Kim, SH; Ko, JW; Kwon, HJ; Lee, IC; Shin, IS; Shin, NR, 2019)
"The purpose of this study is to explore the influence of ozone repeated short exposures on airway/lung inflammation, airway hyperresponsiveness (AHR) and airway hypersecretion in ovalbumin (OVA) sensitized/challenged asthmatic mouse model."3.88Effects of ozone repeated short exposures on the airway/lung inflammation, airway hyperresponsiveness and mucus production in a mouse model of ovalbumin-induced asthma. ( Bao, A; Bao, W; Fei, X; Zhang, M; Zhang, X; Zhang, Y; Zhou, X, 2018)
"NK may be an effective alternative therapeutic option in patients with CRSwNP and comorbid asthma by causing fibrin degradation."3.85Nattokinase, profibrinolytic enzyme, effectively shrinks the nasal polyp tissue and decreases viscosity of mucus. ( Fujieda, S; Imoto, Y; Ishizuka, T; Kato, Y; Narita, N; Sakashita, M; Takabayashi, T; Tokunaga, T; Yoshida, K, 2017)
" This study aimed to evaluate the preventive activity of IMP in an ovalbumin (OVA)-induced murine model of asthma and to investigate its possible molecular mechanisms."3.85Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma. ( Kwon, HJ; Moon, OS; Park, HS; Seo, CS; Son, HY; Song, JW; Wijerathne, CUB; Won, YS, 2017)
" This study evaluates whether intranasally delivered gas-filled microbubble (MB)-associated ovalbumin (OVA), used as a model allergen, can serve as a therapeutic treatment in a mouse model of established allergic asthma."3.85Therapeutic intranasal instillation of allergen-loaded microbubbles suppresses experimental allergic asthma in mice. ( Bioley, G; Corthésy, B, 2017)
" In the current study, an ovalbumin (OVA)‑induced allergic asthma model was used to investigate the immune‑modulating effects of pidotimod on airway eosinophilia, mucus metaplasia and inflammatory factor expression compared with dexamethasone (positive control)."3.85Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma. ( Fu, AK; Fu, LQ; Hu, SL; Li, WF; Li, YL; Wang, YY; Wu, YP, 2017)
" After oral administration of indomethacin (5 mg/kg) for 5 consecutive days, gastric ulcerated animals were divided into control group and five other groups: three groups that recieved respectively 125, 250 and 500 mg/kg of plant extract, the fourth group received Maalox (50 mg/kg) and the fifth group, Misoprostol (100 μg/kg), respectively, for 5 days."3.85Anti-Helicobacter pylori and antiulcerogenic activity of Aframomum pruinosum seeds on indomethacin-induced gastric ulcer in rats. ( Eyoum Bille, B; Kouitcheu Mabeku, LB; Nanfack Nana, B; Nguepi, E; Tchuenteu Tchuenguem, R, 2017)
" In addition, to investigate the effects of CuONPs on asthma development, we used a murine model of ovalbumin (OVA)-induced asthma."3.83Copper oxide nanoparticles aggravate airway inflammation and mucus production in asthmatic mice via MAPK signaling. ( Ahn, KS; Jeon, CM; Kim, JC; Ko, JW; Kwon, OK; Lee, IC; Oh, SR; Park, JW; Shin, IS; Shin, NR, 2016)
" This study aimed to determine the possible effects and underlying mechanisms of Suhuang on chronic ovalbumin (OVA)-induced airway hyperresponsiveness (AHR), inflammation, and remodeling in mice."3.83Suhuang antitussive capsule at lower doses attenuates airway hyperresponsiveness, inflammation, and remodeling in a murine model of chronic asthma. ( Che, LQ; Chen, ZH; Lai, TW; Li, W; Shen, HH; Wang, HS; Wu, YF; Xiao, H; Ying, SM; Zhang, C; Zhang, LH, 2016)
"Repeated inhalation of sevoflurane (SVF) can benefit asthmatic patients by bronchodilation."3.81Repeated inhalation of sevoflurane inhibits airway inflammation in an OVA-induced mouse model of allergic airway inflammation. ( Ding, PS; Fang, L; He, F; Liu, RY; Shen, QY; Wu, HM, 2015)
"We have reported that triptolide inhibited pulmonary inflammation in patients with steroid-resistant asthma."3.81Triptolide suppresses airway goblet cell hyperplasia and Muc5ac expression via NF-κB in a murine model of asthma. ( Chen, M; Huang, L; Jiang, S; Liang, R; Lin, X; Lv, Z; Shi, J; Zhang, W, 2015)
"We used ovalbumin (OVA)-based mouse models of asthma and primary CD4(+) T cells."3.81PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function. ( Al-Ghareeb, K; Al-Khami, AA; Boulares, AH; El-Bahrawy, AH; Ghonim, MA; Ibba, SV; Lammi, MR; Mansy, MS; Naura, AS; Ochoa, A; Pyakurel, K; Rady, HF; Ramsay, A; Rodriguez, P; Wang, J, 2015)
"To explore the impact of ozone on the airway hyperresponsinveness (AHR), airway inflammation and mucus production in an allergic asthma mouse model."3.81[Effects of ozone oxidative stress on the airway hyperresponsiveness and mucus production in mice with acute allergic airway inflammation]. ( Aihua, B; Feng, L; Xin, Z; Yuqing, C; Zhang, M, 2015)
"The flavonoid naringenin has been shown to attenuate airway inflammation and airway hyper‑reactivity in acute murine models of asthma."3.80Naringenin inhibits allergen‑induced airway remodeling in a murine model of asthma. ( Gu, W; Mao, S; Shi, Y; Tan, Y, 2014)
" In this study, we investigated the protective effects of SG extract on allergic asthma in an ovalbumin (OVA)-induced asthma murine model and lipopolysaccharide (LPS)-stimulated RAW264."3.80Siegesbeckia glabrescens attenuates allergic airway inflammation in LPS-stimulated RAW 264.7 cells and OVA induced asthma murine model. ( Ahn, KS; Hong, JM; Jeon, CM; Kim, HS; Kwon, OK; Myung, PK; Oh, SR; Shin, IS; Shin, NR, 2014)
"We investigated the suitability of dendritic polyglycerol sulfates (dPGS), conjugated with a hydrophilic version of the indocyanine green label with 6 sulfonate groups (6S-ICG) to monitor sites of inflammation using an experimental mouse model of allergic asthma."3.79Dendritic polyglycerolsulfate near infrared fluorescent (NIRF) dye conjugate for non-invasively monitoring of inflammation in an allergic asthma mouse model. ( Alves, F; Biffi, S; Bosnjak, B; Dal Monego, S; Dullin, C; Epstein, MM; Garrovo, C; Licha, K; Welker, P, 2013)
"In the OVA-exposed mice for 6 wks inflammatory cells infiltration, levels of inflammatory cytokines and chemokines, goblet cell metaplasia, collagen deposition and AHR were significantly decreased by treatment with AR inhibitor, fidarestat."3.79Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice. ( Aguilera-Aguirre, L; Boldogh, I; Boulares, HA; Calhoun, WJ; Naura, AS; Ramana, KV; Srivastava, SK; Yadav, UC, 2013)
"Montelukast, a leukotriene receptor antagonist, is used commercially as a maintenance treatment for asthma and to relieve allergic symptoms."3.79Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma. ( Jeon, WY; Lee, MY; Shin, HK; Shin, IS, 2013)
"Verapamil is a useful drug with therapeutic targeting on GCH and a potential way to limit mucous production and improve bronchial inflammation."3.78Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals. ( Ghafarzadegan, K; Hadi, R; Khakzad, MR; Meshkat, M; Mirsadraee, M; Mohammadpour, A; Saghari, M, 2012)
" Female BALB/c mice sensitized and challenged with ovalbumin developed airway inflammation."3.78Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB. ( Cheng, C; Goh, FY; Guan, S; Leung, BP; Sethi, G; Shanmugam, MK; Upton, N; Wong, WS, 2012)
"The preventive and healing properties of Croton urucurana bark methanol extract (CUE) were evaluated in experimental models of acute (ethanol and indomethacin) and chronic (acetic acid) gastric ulcers."3.78Antiulcerogenic effect of Croton urucurana Baillon bark. ( Aparecida Pinto, L; de Cássia Freitas, K; Faloni de Andrade, S; Leite Kassuya, CA; Nazari Formagio, AS; Wolff Cordeiro, K, 2012)
"Evidence suggests that nebulized lidocaine is beneficial in asthma therapy, but to what extent and the mechanisms underlying this effect remain poorly understood."3.78Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma. ( Anjos-Valotta, EA; Arantes, AC; Cordeiro, RS; Cotias, AC; Couto, GC; Ferreira, TP; Jurgilas, PB; Martins, MA; Olsen, PC; Pão, CR; Pires, AL; Serra, MF; Silva, PM, 2012)
" They were subjected to the absolute ethanol- and indomethacin-induced gastric ulcer, and pyloric ligation assays after 30 min."3.78Antiulcer activity of the chloroform extract of Bauhinia purpurea leaf. ( Hamid, HA; Hisam, EE; Mohtaruddin, N; Othman, F; Rofiee, MS; Zakaria, ZA, 2012)
"Altered arginine metabolism, the uncoupling of nitric oxide synthase (NOS) by asymmetric dimethyl-arginine (ADMA), increased oxo-nitrosative stress, and cellular injury were reported in airway epithelial cells in asthma."3.77Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma. ( Agrawal, A; Ahmad, T; Aich, J; Ghosh, B; Mabalirajan, U; Makhija, L; Sharma, A, 2011)
" The acetic acid-induced gastric ulcer model and Western Blot assay (COX-2 and EGF) were also used to evaluate the OEH healing capacity."3.77Gastroprotective and ulcer healing effects of essential oil from Hyptis spicigera Lam. (Lamiaceae). ( de Almeida, AC; de-Faria, FM; Dunder, RJ; Hiruma-Lima, CA; Luiz-Ferreira, A; Manzo, LP; Pellizzon, CH; Rehen, CS; Rozza, AL; Salvador, MJ; Socca, EA; Souza-Brito, AR; Takayama, C; Valim-Araújo, Dde A, 2011)
"The effect of PET was investigated in ovalbumin (OVA) immunized BALB/c mice given intranasally together with antigen challenge in the murine model of allergic airway disease (asthma) with the analysis of the inflammatory and immune parameters in the lung."3.76Petasites extract Ze 339 (PET) inhibits allergen-induced Th2 responses, airway inflammation and airway hyperreactivity in mice. ( Brattström, A; Maillet, I; Moser, R; Ryffel, B; Schapowal, A; Schnyder, B, 2010)
"ITE obtained from leaves by supercritical carbon dioxide extraction was investigated in ovalbumin (OVA) immunised BALB/c mice given intranasally together with antigen challenge in the murine model of allergic airway disease (asthma) with the analysis of the inflammatory and immune parameters in the lung."3.76The plant extract Isatis tinctoria L. extract (ITE) inhibits allergen-induced airway inflammation and hyperreactivity in mice. ( Brattström, A; Kamal, MA; Maillet, I; Moser, R; Ryffel, B; Schapowal, A, 2010)
" Pretreatment with Cyclea peltata extract provided significant protection against the peptic ulceration caused by ethanol administered individually, or in combination with indomethacin."3.75Gastric antisecretory and antiulcer activities of Cyclea peltata (Lam.) Hook. f. & Thoms. in rats. ( Anuja, GI; Latha, PG; Pradeep, S; Rajasekharan, S; Shine, VJ; Shyamal, S; Sini, S; Suja, SR, 2009)
") inhibited the number of coughs induced by capsaicin aerosol (P<0."3.74Novel triple neurokinin receptor antagonist CS-003 inhibits respiratory disease models in guinea pigs. ( Kuraya, T; Morimoto, K; Nosaka, E; Takahashi, S; Tsuchida, H; Yamashita, M, 2008)
" In order to investigate the pharmacological effects of kefir, we used a mouse asthma model, in which airway inflammation and airway remodeling was produced by ovalbumin sensitization and challenge."3.74Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model. ( Ahn, KS; Kim, MJ; Kim, MK; Kwon, OK; Lee, HK; Lee, IY; Lee, MY; Oh, SR, 2007)
" The extract at 400 mg/kg body weight, once daily, orally has a significant effect in cold restraint (CRU, 2 h cold restraint stress), aspirin (ASA, 150 mg/kg body weight, orally), alcohol (AL, 1 ml/200 gm of absolute alcohol) and pyloric ligation (PL, 4h ligation) induced gastric ulcer models as it showed protection index of 71."3.73Allophylus serratus: a plant with potential anti-ulcerogenic activity. ( Dharmani, P; Maurya, R; Mishra, PK; Palit, G; Singh Chauhan, V, 2005)
"(R)- and (S)-Enantiomers of albuterol likely exert differential effects in patients with asthma."3.73Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model. ( Banerjee, ER; Chi, EY; Henderson, WR, 2005)
"Twenty-four BALB/c mice were randomly divided into 3 equal groups: asthma group [ovalbumin (OVA) and aluminum hydroxide were injected intraperitoneally on day 0 and day 14 so as to establish mouse asthma model and aerosol inhalation of OVA PBS was conducted for 30 min on the days 21, 22, and 24], asthma + dexamethasone group (OVA and aluminum hydroxide were injected intraperitoneally on days 0 and 14, aerosol inhalation of OVA PBS was conducted for 30 min on the days 21, 22, and 24, and dexamethasone was injected intraperitoneally 1 hour before the aerosol inhalation), and control group (aerosol inhalation of PBS was conducted instead)."3.73[Effects of glucocorticoid on airway mucus secretion in asthma: experiment with asthmatic mouse model]. ( Liu, JB; Xing, LH; Xu, YJ; Zhang, HL; Zhang, ZX, 2006)
"Previous studies have investigated the short-term effect of capsaicin on edema formation and goblet-cell secretion in the trachea."3.72Spontaneous remission of edema and regranulation of goblet cells in rat tracheae after capsaicin-induced acute inflammation. ( Guo, JJ; Huang, HT; Wang, DS, 2003)
" To clarify the effects of DE on the exacerbation of asthma, guinea pigs were exposed 12 h daily to 3 mg/m(3) DE or air for 8 wk with or without sensitization to ovalbumin (OVA)."3.71Exposure to diesel exhaust exacerbates allergen-induced airway responses in guinea pigs. ( Hashimoto, K; Hirano, K; Ishii, Y; Kimura, T; Masuyama, K; Morishima, Y; Nomura, A; Sagai, M; Sakamoto, T; Sekizawa, K; Takano, H; Uchida, Y, 2001)
"To evaluate the effects of teprenone on acute gastritis, its inhibitory effects on gastric mucosal damage were compared to that of gefarnate in taurocholate/hydrochloric acid-induced acute gastric mucosal lesions in rats."3.70[Protective effects of teprenone and gefarnate against taurocholate/hydrochloric acid-induced acute gastric mucosal lesions in rats]. ( Katoh, Y; Kawashima, H; Tanaka, M, 1998)
"The ovalbumin-sensitized guinea pig is commonly used as a small animal model of allergic asthma."3.69Effect of dexamethasone on antigen-induced high molecular weight glycoconjugate secretion in allergic guinea pigs. ( Boulet, L; Chan, CC; Plant, M; Pon, DJ; Rodger, IW; Savoie, C; van Staden, CJ; Zwikker, M, 1995)
"The chronically isoproterenol-treated rat has been proposed as an animal model for cystic fibrosis."3.67The chronically isoproterenol-treated rat in the study of cystic fibrosis: X-ray microanalysis of the submandibular gland. ( Müller, RM; Roomans, GM, 1984)
"Chronic treatment of rats with reserpine, isoproterenol, or a combination of these two agents has been suggested as a means to produce an experimental animal model for the chronic exocrinopathy cystic fibrosis."3.67Changes in glycoconjugates in rat submandibular gland after chronic treatment with reserpine and isoproterenol. ( Maltarello, MC; Müller, RM; Roomans, GM; Versura, P, 1988)
"In three models of cholelithiasis (dihydrocholesterol-fed rabbits, cholesterol-cholic acid-fed mice, and Lincomycin-treated guinea pigs), the quantity and chemical composition of gallbladder epithelial mucin have been studied using (1) a spectrum of histochemical glycoprotein stains, and (2) biochemical extraction, purification and analysis of the carbohydrate components of epithelial mucin."3.66Hypersecretion of mucus glycoprotein by the gallbladder epithelium in experimental cholelithiasis. ( Lee, SP, 1981)
"Human patients with active ulcerative colitis have this layer penetrable to bacteria and beads the size of bacteria."2.49Mucus and the goblet cell. ( Hansson, GC; Johansson, ME, 2013)
"Current therapeutics for ulcerative colitis (UC) have limitations."1.91Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of γδT17 cells. ( Huang, J; Liu, Z; Ma, J; Tang, X; Wang, F; Wang, Y; Yang, X; Zhang, J, 2023)
"IL-13 develops bronchial asthma by elevating bronchial hyperresponsiveness and enables production of immunoglobulin M (IgM) and IgE."1.72High throughput virtual screening strategy to develop a potential treatment for bronchial asthma by targeting interleukin 13 cytokine signaling. ( Jing, J; Ma, Q; Tong, H, 2022)
"Ursolic acid (UA) has activities in immune regulation and anti-inflammatory."1.62Ursolic Acid Alleviates Mucus Secretion and Tissue Remodeling in Rat Model of Allergic Rhinitis After PM2.5 Exposure. ( Deng, C; Dong, W; Duan, Y; Guo, Z; Han, Z; Sun, N; Wang, H; Zhang, R; Zhao, Q; Zhuang, G, 2021)
"Tectochrysin treatment reduced the level of IgE in plasma, the percentage of eosinophils in total white blood cells in peripheral blood, the total number of cells in BAL fluid, and eosinophil peroxidase activity in lung tissues."1.62Tectochrysin ameliorates murine allergic airway inflammation by suppressing Th2 response and oxidative stress. ( Fang, L; He, Z; Jiang, X; Wu, F; Xu, Z; Yan, Y; Yu, D; Yuan, X; Zhang, T; Zhou, S, 2021)
"Pretreatment with diminazene aceturate, a small molecule with ability to inhibit acid detection through blockade of the acid-sensing ion channel (ASIC) at the doses provided, did not prevent acid-induced pathologic mucus or transport defects but did mitigate airway obstruction."1.56Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways. ( Atanasova, KR; Bravo, L; Collins, EN; Dadural, JS; Eken, E; Guevara, MV; Kuan, SP; Liao, YSJ; Reznikov, LR; Schurmann, V; Sponchiado, M; Vogt, K, 2020)
"Dithiothreitol and P3001 were directly compared with NAC in vitro and both exhibited superior reducing activities."1.51An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases. ( Boucher, RC; Delion, MF; Donaldson, SH; Ehre, C; Esther, CR; Fontana, NC; Grubb, BR; Hill, DB; Hothem, LN; Kato, T; Livraghi-Butrico, A; Markovetz, MR; Morrison, CB; Rushton, ZL; Thelin, WR; Villalon, D; Wang, B, 2019)
"Chronic obstructive pulmonary disease (COPD) is a chronic, progressive and lethal lung disease with few treatments."1.48Limax extract ameliorates cigarette smoke-induced chronic obstructive pulmonary disease in mice. ( Guan, R; Li, D; Liang, X; Long, Z; Lu, W; Wang, J; Wang, Z; Xie, J; Xu, J; Yang, Q; Zhao, L, 2018)
"Phloretin pretreatment dramatically suppressed the mucins secretion, inflammatory cell infiltration and inflammatory cytokine release in mouse lungs induced by CS, and it also suppressed CSE-induced expression of MUC5AC and IL-1β in NCI-H292 bronchial epithelial cells."1.48Phloretin attenuates mucus hypersecretion and airway inflammation induced by cigarette smoke. ( Chen, L; Hao, N; Shen, Y; Wang, H; Wang, T; Wen, F; Wu, Y; Yang, T; Yuan, Z, 2018)
"Chronic colitis was induced in C57BL/6 mice by administration of dextran sulfate sodium (DSS) for 27 days."1.48Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model. ( Cheng, L; Yang, J; Zhao, J; Zhao, R; Zhu, L, 2018)
"TAS2R agonists attenuated features of airway remodeling including smooth muscle mass, extracellular matrix deposition and pro-fibrotic signaling, and also prevented mucus accumulation and development of AHR in mice."1.46Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice. ( Deshpande, DA; Knight, MJ; Nayak, AP; Oliver, B; Pan, S; Sharma, P; Tang, F; Wang, N; Yi, R, 2017)
"Sprague-Dawley rats were made chronic obstructive pulmonary disease models via tobacco smoke exposure for 12 weeks and the rats were treated with 10 ml/kg hydrogen-rich saline intraperitoneally during the last 4 weeks."1.46Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats. ( Geng, W; Jiang, C; Li, C; Liu, Y; Liu, Z; Qin, S; Si, Y; Zhang, X; Zhang, Y; Zhao, S, 2017)
"The incidence of chronic obstructive pulmonary disease (COPD) has substantially increased in recent decade."1.42Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling. ( Ahn, KS; Hong, JM; Jeon, CM; Kim, JC; Kim, JS; Kwon, OK; Lee, IC; Oh, SR; Park, JW; Shin, IS; Shin, NR, 2015)
"Chronic mucosal inflammation is the hallmark of important and common airway diseases, such as allergic rhinitis (AR) and asthma."1.42Lipoxin B₄ promotes the resolution of allergic inflammation in the upper and lower airways of mice. ( Haworth, O; Karra, L; Levi-Schaffer, F; Levy, BD; Priluck, R, 2015)
"We used a murine model of respiratory allergy to the mite Blomia tropicalis (Bt) and evaluated certain parameters known to be altered in this model."1.42The anti-allergic activity of Cymbopogon citratus is mediated via inhibition of nuclear factor kappa B (Nf-Κb) activation. ( Alcântara-Neves, NM; Alves de Souza, S; da Silva Velozo, E; Ferreira Silva, HB; Figueiredo, CA; Meneses Souza, FL; Pires de Oliveira, A; Pontes-de-Carvalho, LC; Rios, R; Santos Alves, W; Santos Costa, R; Santos Serafim Machado, M; Sarmento Silva, TM; Silva, ML; Vilany Queiroz Carneiro, N, 2015)
"Pretreatment with carvedilol attenuated LPO elevation, mucus content and sulfhydryl group inhibitions."1.42Carvedilol attenuates inflammatory biomarkers and oxidative stress in a rat model of ulcerative colitis. ( Abuohashish, HM; Ahmed, MM; Al-Hosaini, KA; Al-Rejaie, SS; Fatani, AJ; Parmar, MY, 2015)
"(CJT) on the development of COPD using a Cigarette smoke (CS)-induced murine model and cigarette smoke condensate (CSC)-stimulated H292 cells, human pulmonary mucoepidermoid cell line."1.42Callicarpa japonica Thunb. attenuates cigarette smoke-induced neutrophil inflammation and mucus secretion. ( Ahn, KS; Hee Kim, J; Kwon, OK; Lee, HJ; Lee, HS; Lee, J; Lee, JW; Oh, SR; Park, JW; Park, SY; Shin, NR; Zhang, ZY, 2015)
"Mucoobstructive lung diseases have highlighted the importance of a proper description of the normal mucus clearance system."1.42On the Pathogenesis of Acute Exacerbations of Mucoobstructive Lung Diseases. ( Boucher, RC, 2015)
"Chlamydia infections are common causes of respiratory disease, particularly pneumonia in neonates, and are linked to permanent reductions in pulmonary function and the induction of asthma."1.40Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease. ( Collison, AM; Essilfie, AT; Foster, PS; Hansbro, PM; Hatchwell, LM; Horvat, JC; Kim, RY; Mattes, J; Nguyen, DH; Starkey, MR; Yagita, H, 2014)
"Melatonin was administered by intraperitoneal injection once per day at doses of 10 and 15 mg/kg from days 21 to 23 after the initial OVA sensitization."1.40Melatonin reduces airway inflammation in ovalbumin-induced asthma. ( Ahn, KS; Jeon, CM; Kim, JC; Kim, JS; Kwon, OK; Oh, SR; Park, JW; Shin, IS; Shin, NR, 2014)
"Mycobacterium avium subsp."1.39Divergent immune responses to Mycobacterium avium subsp. paratuberculosis infection correlate with kinome responses at the site of intestinal infection. ( Griebel, P; Kusalik, A; Määttänen, P; Napper, S; Potter, A; Scruten, E; Trost, B, 2013)
" At the same dosing levels, no significant differences in FA were observed in mice pretreated with strains with similar adhesive abilities but different antagonistic activities."1.39Alleviating effects of Lactobacillus strains on pathogenic Vibrio parahaemolyticus-induced intestinal fluid accumulation in the mouse model. ( Fang, WM; Gao, L; Gu, RX; Jiao, XA; Jin, CJ; Qian, JY; Yang, ZQ, 2013)
" Colon-targeted, intraluminal delivery of 5-HT(4)R agonists might be used to promote motility and alleviate visceral pain, while restricting systemic bioavailability and resulting adverse side effects."1.38Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. ( Balemba, OB; Brooks, EM; Galligan, JJ; Greenwood-Van Meerveld, B; Hoffman, JM; Johnson, AC; MacEachern, SJ; Mawe, GM; Moses, PL; Sharkey, KA; Swain, GM; Tyler, K; Zhao, H, 2012)
"Pre-treatment with arbutin or omeprazole protected the gastric mucosa as seen by reduction in ulcer area and mucosal content, reduced or absence of edema, inflammation and leucocytes infiltration on both models."1.38Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin. ( Abdelwahab, SI; Abdulla, MA; Ali, HM; Hadi, AH; Salga, MS; Taha, MM, 2012)
" The current study compared three rat models induced by cigarette smoke (CS) exposure alone or combined with pre- or post-treatment with lipopolysaccharide (LPS)."1.38Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease. ( Li, PB; Luo, YL; Nie, YC; Shen, JG; Su, WW; Wu, H; Zhang, CC, 2012)
"Inflammation was induced by sensitization and chronic exposure of 16 C57BL/6 mice to Aspergillus fumigatus."1.38In vivo determination of mouse olfactory mucus cation concentrations in normal and inflammatory states. ( Conley, DB; Epstein, VA; Kern, RC; Liu, K; Richter, CP; Robinson, AM; Selvaraj, S, 2012)
"Inflammation was assessed by the total and differential cell counts and IL-4 and IL-5 levels in bronchoalveolar lavage (BAL) fluid."1.38The AGC kinase inhibitor H89 attenuates airway inflammation in mouse models of asthma. ( Daubeuf, F; Frossard, N; Nemska, S; Reber, LL, 2012)
"The most striking difference in the pulmonary inflammation induced in A(2B) receptor knockout (A(2B)KO) and wild-type mice was the lack of allergen-induced IL-4 release in the airways of A(2B)KO animals, in line with a significant reduction in IL-4 protein and mRNA levels in lung tissue."1.36Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. ( Biaggioni, I; Blackburn, MR; Feoktistov, I; Goldstein, AE; Goleniewska, K; Mitchell, D; Morschl, E; Newcomb, DC; Novitskiy, SV; Peebles, RS; Polosukhin, VV; Ryzhov, S; Yin, H; Zaynagetdinov, R; Zhou, Y, 2010)
" Because we have previously described that arginase affects NOx content and interferes with the activation of NF-kappaB in lung epithelial cells, the goal of this study was to investigate the impact of arginase inhibition on the bioavailability of NO and the implications for NF-kappaB activation and inflammation in a mouse model of allergic airway disease."1.35Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. ( Ckless, K; Irvin, CG; Janssen-Heininger, YM; Kasahara, D; Lampert, A; Lundblad, LK; Norton, R; Poynter, ME; Reiss, J; van der Vliet, A, 2008)
"In both asthma and COPD mouse models, pendrin was up-regulated at the apical side of airway epithelial cells in association with mucus overproduction."1.35Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. ( Aizawa, H; Arima, K; Fukuda, T; Green, ED; Hasegawa, M; Hayashi, H; Hoshino, T; Inoue, H; Inoue, M; Izuhara, K; Kanaji, S; Kubo, H; Matsushita, H; Nagai, H; Nakao, I; Nakayama, K; Ohta, S; Okinami, S; Sagara, H; Shiraki, A; Sugiyama, K; Suzuki, K; Tanaka, H; Toda, S; Watanabe, M; Yamaya, M; Yuyama, N, 2008)
"Airway eosinophilia was observed during both responses."1.33Effect of disodium cromoglycate on airway mucus secretion during antigen-induced late asthmatic responses in a murine model of asthma. ( Arakawa, H; Koyama, H; Mayuzumi, H; Mizuno, T; Mochizuki, H; Morikawa, A; Nishimura, H; Ohki, Y; Tokuyama, K, 2005)
"Human bronchial asthma is characterized by airway hyperresponsiveness (AHR), eosinophilic airway inflammation, mucus hypersecretion and high serum level of IgE."1.33Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness. ( Ishikawa, Y; Nakanishi, K; Yoshimoto, T, 2006)
"This strategy resulted in a pulmonary eosinophilia equivalent to that observed in OVA-treated wild-type animals."1.32A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. ( Ansay, TL; Biechelle, TL; Borchers, MT; Colbert, DC; Cormier, SA; Crosby, JR; Hines, EM; Justice, JP; Lee, JJ; Lee, NA; McGarry, MP; O'Neill, KR; Ochkur, SI; Shen, HH; Wang, H, 2003)
" It has not been determined whether rib cage compression combined with endotracheal suctioning improves oxygenation, ventilation, and mucus clearance."1.32Effects of expiratory rib cage compression combined with endotracheal suctioning on gas exchange in mechanically ventilated rabbits with induced atelectasis. ( Mizutani, T; Toyooka, H; Unoki, T, 2004)
"Acute bronchiolitis was induced by inhalation of nickel chloride aerosols for 5 days in Wistar rats according to the method described by Kyono et al."1.31Inflammatory responses and mucus secretion in rats with acute bronchiolitis induced by nickel chloride. ( Ishihara, Y; Kawashima, H; Kyono, H; Miyasaka, M; Serita, F; Toya, T, 2002)
"Pretreatment with glycine significantly protected animals against stress-, indomethacin- and necrotizing agents induced gastric lesions."1.30Studies on the antisecretory, gastric anti-ulcer and cytoprotective properties of glycine. ( Al Moutaery, AR; Tariq, M, 1997)
"A streptomycin-treated mouse model was used to compare the intestinal colonizing capacity of E."1.28Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. ( Burris, JA; O'Brien, AD; Wadolkowski, EA, 1990)
" Thus a stimulation of the mucociliary transport rate by the other major pharmacodynamic mechanisms, secretagogue activity and stimulation of pulmonary surfactant, has to be considered."1.27Pharmacodynamic mechanism and therapeutic activity of ambroxol in animal experiments. ( Disse, BG; Ziegler, HW, 1987)

Research

Studies (398)

TimeframeStudies, this research(%)All Research%
pre-199031 (7.79)18.7374
1990's24 (6.03)18.2507
2000's92 (23.12)29.6817
2010's196 (49.25)24.3611
2020's55 (13.82)2.80

Authors

AuthorsStudies
Kuang, Y1
Li, B1
Fan, J1
Qiao, X1
Ye, M1
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W6
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Ma, Q1
Tong, H2
Jing, J1
Lim, JO1
Lee, SJ2
Kim, WI2
Pak, SW2
Moon, C1
Shin, IS10
Heo, JD1
Ko, JW3
Kim, JC5
Du, X1
Yang, Y3
Yang, M1
Yuan, L1
Wang, L4
Wu, M6
Zhou, K1
Xiang, Y2
Qu, X2
Liu, H4
Qin, X2
Liu, C5
Yu, W1
Moninger, TO2
Thurman, AL1
Xie, Y2
Jain, A1
Zarei, K1
Powers, LS1
Pezzulo, AA3
Stoltz, DA5
Welsh, MJ4
Wu, D2
Jiang, W1
Liu, L4
Li, F2
Ma, X1
Pan, L1
Ousingsawat, J1
Centeio, R1
Cabrita, I2
Talbi, K1
Zimmer, O1
Graf, M1
Göpferich, A1
Schreiber, R2
Kunzelmann, K2
Singanayagam, A1
Footitt, J1
Marczynski, M1
Radicioni, G1
Cross, MT1
Finney, LJ1
Trujillo-Torralbo, MB1
Calderazzo, M1
Zhu, J2
Aniscenko, J2
Clarke, TB1
Molyneaux, PL1
Bartlett, NW2
Moffatt, MF1
Cookson, WO1
Wedzicha, J1
Evans, CM3
Boucher, RC11
Kesimer, M1
Lieleg, O1
Mallia, P1
Johnston, SL2
Fang, J1
Zhang, Z2
Cheng, Y1
Yang, H2
Zhang, H4
Xue, Z1
Lu, S2
Dong, Y1
Song, C1
Zhang, X7
Zhou, Y4
Mann, TS1
Larcombe, AN1
Wang, KCW1
Shamsuddin, D1
Landwehr, KR1
Noble, PB1
Henry, PJ1
Wuniqiemu, T2
Teng, F2
Qin, J2
Lv, Y1
Nabijan, M1
Luo, Q1
Cui, J2
Tang, W2
Zhu, X3
Wang, S4
Abduwaki, M1
Nurahmat, M1
Wei, Y2
Dong, JC1
Wu, Z1
Liu, X3
Huang, S2
Li, T1
Pang, J1
Zhao, J3
Chen, L3
Zhang, B1
Wang, J3
Han, D1
Eddie, AM1
Chen, KW1
Schenkel, LB1
Swinger, KK1
Molina, JR1
Kunii, K1
Raybuck, AL1
Keilhack, H1
Gibson-Corley, KN1
Niepel, M1
Peebles, RS2
Boothby, MR1
Cho, SH1
Zhi, W1
Jiang, S2
Xu, Z2
An, Y1
Chen, J1
Li, Y8
Liu, Y6
Lu, X1
Tan, ZX1
Wang, WJ1
Zhan, P1
Wang, Y6
Fu, L1
Gao, L2
Zhao, H3
Wang, H6
Xu, DX1
Waldstein, KA1
Ganama, M1
Varga, SM1
Tilley, S1
Hua, X1
Ma, J2
Zhang, J2
Huang, J1
Yang, X4
Liu, Z4
Wang, F1
Tang, X1
Fang, YX1
Liu, YQ1
Hu, YM1
Yang, YY1
Zhang, DJ1
Jiang, CH1
Wang, JH1
Wang, Q2
Xu, K1
Cai, X1
Wang, C2
Cao, Y1
Xiao, J1
Briata, P1
Mastracci, L1
Zapparoli, E1
Caputo, L1
Ferracci, E1
Silvestri, A1
Garuti, A1
Hamadou, MH1
Inga, A1
Marcaccini, E1
Grillo, F1
Bucci, G1
Puri, PL1
Beznoussenko, G1
Mironov, A1
Chiacchiera, F1
Gherzi, R1
Homolak, J1
De Busscher, J1
Zambrano-Lucio, M1
Joja, M1
Virag, D1
Babic Perhoc, A1
Knezovic, A1
Osmanovic Barilar, J1
Salkovic-Petrisic, M1
Hou, Y1
Zheng, S1
Zou, F1
Wang, D2
Da, H1
Fan, X2
Liu, J2
He, J1
Li, H3
Sun, X1
Wang, BH1
Tang, LL1
Sun, XH1
Zhang, Q1
Liu, CY1
Zhang, XN1
Yu, KY1
Hu, J3
Shi, XL1
Lee, IS1
Yang, YG1
Kim, T1
Benedetto, R1
Wang, Z2
Yao, N1
Fu, X1
Wei, L1
Ding, M1
Pang, Y1
Liu, D1
Ren, Y1
Guo, M1
Aviello, G1
Singh, AK1
O'Neill, S1
Conroy, E1
Gallagher, W1
D'Agostino, G1
Walker, AW1
Bourke, B1
Scholz, D1
Knaus, UG1
Qian, Q1
Shi, L1
Gao, X2
Ma, Y2
Yang, J3
Qian, J1
Koumangoye, R1
Omer, S1
Kabeer, MH1
Delpire, E1
Koch, S1
Knipfer, L1
Kölle, J1
Mirzakhani, H1
Graser, A1
Zimmermann, T1
Kiefer, A1
Melichar, VO1
Rascher, W1
Papadopoulos, NG1
Rieker, RJ1
Raby, BA1
Weiss, ST1
Wirtz, S1
Finotto, S1
Garić, D1
De Sanctis, JB1
Dumut, DC1
Shah, J1
Peña, MJ1
Youssef, M1
Petrof, BJ1
Kopriva, F1
Hanrahan, JW1
Hajduch, M1
Radzioch, D1
Balázs, A1
Mall, MA8
Liu, W1
Mao, B1
Jiang, H2
Yang, T2
Zeng, Z1
Shen, Y3
Wan, C1
Wu, Y4
Dong, J2
Wen, F3
Xue, X1
Gao, C1
Wang, T3
Li, L2
Tong, X1
Xu, J3
Jiang, X2
Liu, K2
Yang, C1
Pieper, M1
Schulz-Hildebrandt, H1
Hüttmann, G1
König, P1
Schroeder, HA1
Newby, J1
Schaefer, A1
Subramani, B1
Tubbs, A1
Gregory Forest, M1
Miao, E1
Lai, SK2
Liao, YSJ1
Kuan, SP1
Guevara, MV1
Collins, EN1
Atanasova, KR1
Dadural, JS1
Vogt, K1
Schurmann, V1
Bravo, L1
Eken, E1
Sponchiado, M1
Reznikov, LR1
Cavalcanti, RFP1
Gadelha, FAAF1
de Jesus, TG1
Cavalcante-Silva, LHA1
Paiva Ferreira, LKD1
Paiva Ferreira, LAM1
Vieira, GC1
Piuvezam, MR1
Xue, K1
Ruan, L1
Fu, Z2
Tian, D2
Zou, W2
Sun, N1
Deng, C1
Zhao, Q1
Han, Z1
Guo, Z1
Dong, W1
Duan, Y1
Zhuang, G1
Zhang, R1
Yan, P1
Su, Y1
Shang, C1
Zhou, X3
An, W2
Yu, C2
Jeon, YJ1
Gil, CH1
Won, J1
Jo, A1
Kim, HJ1
Choi, W2
Yang, AX2
Sieve, A1
Kuo, SH1
Mudalagiriyappa, S1
Vieson, M1
Maddox, CW2
Nanjappa, SG1
Lau, GW2
Pavan, E2
Damazo, AS2
Arunachalam, K2
Almeida, POA1
Oliveira, DM1
Venturini, CL1
Figueiredo, FF1
Cruz, TCDD1
Silva, JVD1
Martins, DTO2
Yang, D1
Xu, D1
Yuan, Z2
Dong, M1
Wang, W1
Oliveira, RG1
Antonielli, LF1
Miyajima, F1
Duckworth, CA1
Lima, JCDS1
Morgan, LE1
Jaramillo, AM1
Shenoy, SK1
Raclawska, D1
Emezienna, NA1
Richardson, VL1
Hara, N1
Harder, AQ1
NeeDell, JC1
Hennessy, CE1
El-Batal, HM1
Magin, CM1
Grove Villalon, DE1
Duncan, G1
Hanes, JS1
Suk, JS1
Thornton, DJ2
Holguin, F1
Janssen, WJ1
Thelin, WR2
Huang, W1
Liang, S1
Wu, H2
Zhou, Z2
Liu, A1
Cai, S1
Johnathan, M1
Muhamad, SA1
Gan, SH1
Stanslas, J1
Mohd Fuad, WE1
Hussain, FA1
Wan Ahmad, WAN1
Nurul, AA1
Brown, R1
Small, DM2
Doherty, DF2
Holsinger, L2
Booth, R2
Williams, R1
Ingram, RJ1
Elborn, JS2
Taggart, CC2
Weldon, S2
Erickson-DiRenzo, E1
Easwaran, M1
Martinez, JD1
Dewan, K1
Sung, CK1
Fang, L3
Yan, Y1
He, Z1
Zhou, S1
Wu, F1
Yuan, X3
Zhang, T1
Yu, D1
Jiang, M1
Fang, Y1
Huang, H1
Wei, Z1
Sung, HK1
Qiang, L1
Ruan, J1
Chen, Q1
Jiang, D1
Whitsett, JA2
Ai, X2
Que, J1
Xie, J2
Sun, H2
Wei, Q1
Nong, G1
Yu, L1
Zhao, D1
Nian, Y1
Li, C2
Lai, T1
Jing, D1
Yang, S1
Li, Z2
Zhao, Y2
Zhou, L2
Chen, H1
Shen, J1
Ying, S1
Chen, Z2
Wu, X1
Shen, H1
Al-Shaibi, AA1
Abdel-Motal, UM1
Hubrack, SZ1
Bullock, AN1
Al-Marri, AA1
Agrebi, N1
Al-Subaiey, AA1
Ibrahim, NA1
Charles, AK1
Elawad, M1
Uhlig, HH1
Lo, B1
Choudhary, I1
Vo, T1
Paudel, K1
Yadav, R1
Mao, Y1
Patial, S2
Saini, Y2
Cloots, E1
Debeuf, N1
Deswarte, K2
Fayazpour, F1
Vanheerswynghels, M1
De Wolf, C1
Van De Velde, E1
Hammad, H2
Lambrecht, BN2
Eyckerman, S1
Janssens, S1
Takabayashi, T1
Imoto, Y1
Sakashita, M1
Kato, Y1
Tokunaga, T1
Yoshida, K1
Narita, N1
Ishizuka, T1
Fujieda, S1
Sugita, K1
Steer, CA1
Martinez-Gonzalez, I1
Altunbulakli, C1
Morita, H1
Castro-Giner, F1
Kubo, T1
Wawrzyniak, P1
Rückert, B1
Sudo, K1
Nakae, S1
Matsumoto, K1
O'Mahony, L1
Akdis, M1
Takei, F2
Akdis, CA1
Xu, B1
Fang, S1
Zhang, Y9
Sharma, P1
Yi, R1
Nayak, AP1
Wang, N1
Tang, F1
Knight, MJ1
Pan, S1
Oliver, B1
Deshpande, DA1
Ehlers, A1
Xie, W1
Agapov, E1
Brown, S1
Steinberg, D1
Tidwell, R1
Sajol, G1
Schutz, R1
Weaver, R1
Yu, H1
Castro, M1
Bacharier, LB1
Wang, X7
Holtzman, MJ1
Haspel, JA1
Huang, R1
Yao, R1
Yang, A1
Glymenaki, M1
Singh, G1
Brass, A1
Warhurst, G1
McBain, AJ1
Else, KJ1
Cruickshank, SM1
Wijerathne, CUB1
Seo, CS2
Song, JW1
Park, HS1
Moon, OS1
Won, YS1
Kwon, HJ2
Son, HY1
Lewis, BW1
Sultana, R1
Sharma, R1
Noël, A1
Langohr, I1
Penn, AL1
Corthésy, B1
Bioley, G1
Fu, LQ1
Li, YL1
Fu, AK1
Wu, YP1
Wang, YY2
Hu, SL1
Li, WF1
Geng, W1
Jiang, C2
Zhao, S1
Qin, S2
Si, Y1
Zafar, MA1
Hamaguchi, S1
Zangari, T1
Cammer, M1
Weiser, JN1
Liang, X1
Guan, R1
Zhao, L2
Li, D1
Long, Z1
Yang, Q1
Lu, W1
Iturra, PA1
Rojas, DA1
Pérez, FJ1
Méndez, A1
Ponce, CA1
Bonilla, P1
Bustamante, R1
Rodríguez, H1
Beltrán, CJ1
Vargas, SL1
Hao, N1
Birket, SE2
Davis, JM1
Fernandez, CM1
Tuggle, KL1
Oden, AM1
Chu, KK2
Tearney, GJ2
Fanucchi, MV1
Sorscher, EJ1
Rowe, SM2
Zhou, JS1
Xu, XC1
Li, ZY1
Chen, HP1
Ying, SM2
Shen, HH4
Chen, ZH2
Bao, W1
Zhang, M2
Bao, A1
Fei, X1
Lin, Z1
Chen, T1
Shang, M1
Tang, Z1
Shi, M1
Ren, P1
Qu, H1
Lin, J2
Li, X2
Huang, Y1
Yu, X1
Ding, F1
Liu, B1
Li, Q1
Dai, J1
Luo, Z1
Seibel, J1
Kryshen, K1
Pongrácz, JE1
Lehner, MD1
Ermund, A2
Meiss, LN1
Dolan, B1
Bähr, A1
Klymiuk, N1
Hansson, GC4
Zhao, R1
Cheng, L1
Zhu, L1
Pu, Q1
Sun, Y2
Huang, T1
Lin, P1
Zhou, C1
Singh, BB1
Zhao, C1
Crosby, J1
Lv, T1
Bai, D1
Monia, BP1
Guo, S1
Patel, DF1
Peiró, T1
Shoemark, A1
Akthar, S1
Walker, SA1
Grabiec, AM1
Jackson, PL1
Hussell, T1
Gaggar, A1
Xu, X1
Trevor, JL1
Li, J1
Steele, C1
Tavernier, G1
Blalock, JE1
Niven, RM1
Gregory, LG1
Simpson, A1
Lloyd, CM2
Snelgrove, RJ1
Fernández-Blanco, JA1
Fakih, D1
Arike, L1
Rodríguez-Piñeiro, AM1
Martínez-Abad, B1
Skansebo, E1
Jackson, S1
Root, J1
Singh, D1
McCrae, C1
Åstrand, A1
Ehre, C1
Rushton, ZL1
Wang, B1
Hothem, LN1
Morrison, CB1
Fontana, NC1
Markovetz, MR1
Delion, MF1
Kato, T1
Villalon, D1
Esther, CR1
Hill, DB1
Grubb, BR6
Livraghi-Butrico, A3
Donaldson, SH1
Waltenburg, MA1
Choe, S1
Steiner, M1
Radwan, A1
Stern, AW1
Fredrickson, RL1
Gungl, A1
Biasin, V1
Wilhelm, J1
Olschewski, A1
Kwapiszewska, G1
Marsh, LM1
Ring, C1
Klopfleisch, R1
Dahlke, K1
Basic, M1
Bleich, A1
Blaut, M1
Rosa, MPG1
Jose, MMF1
Ahmed, I1
Roy, BC1
Raach, RT1
Owens, SM1
Xia, L2
Anant, S1
Sampath, V1
Umar, S1
Ostedgaard, L1
Abou Alaiwa, MH1
Lu, L1
Fischer, AJ2
Barrios, J1
Kho, AT1
Aven, L1
Mitchel, JA1
Park, JA1
Randell, SH4
Miller, LA1
Tantisira, KG1
Shin, NR6
Kim, JS4
Lee, IC3
Kim, SH2
Brown, RR1
Abladey, A1
Zhou-Suckow, Z2
Delaney, RJ1
Kerrigan, L1
Dougan, CM1
Borensztajn, KS1
Scott, CJ1
López-Campos, G1
Li Bassi, G1
Comaru, T1
Martí, D1
Xiol, EA1
Chiurazzi, C1
Travierso, C1
Carbonara, M1
Ranzani, OT1
Amaro, R1
Frigola, G1
Fuster, C1
Saco, MA1
Zanella, A1
De Rosa, F1
Rigol, M1
Fernandez, L1
Luque, N1
Ramirez, J1
Blasi, F1
Suen, J1
Fraser, J1
Torres, A1
Piersanti, RL1
Zimpel, R1
Molinari, PCC1
Dickson, MJ1
Ma, Z1
Jeong, KC1
Santos, JEP1
Sheldon, IM1
Bromfield, JJ1
Park, HA1
Kwon, OK9
Ryu, HW1
Min, JH1
Park, MW1
Park, MH1
Paik, JH1
Choi, S1
Paryanto, I1
Yuniato, P1
Oh, SR9
Ahn, KS7
Lee, JW2
Fernandez-Petty, CM1
Hughes, GW1
Bowers, HL1
Watson, JD1
Rosen, BH1
Townsend, SM1
Santos, C1
Ridley, CE1
Leung, HM1
Mazur, M1
Garcia, BA1
Evans, TIA1
Libby, EF1
Hathorne, H1
Hanes, J2
Clancy, JP1
Engelhardt, JF1
Swords, WE1
Wiesmann, WP1
Baker, SM1
Reddehase, MJ1
Persson, EK1
Verstraete, K1
Heyndrickx, I1
Gevaert, E1
Aegerter, H1
Percier, JM1
Verschueren, KHG1
Dansercoer, A1
Gras, D1
Chanez, P2
Bachert, C1
Gonçalves, A1
Van Gorp, H1
De Haard, H1
Blanchetot, C1
Saunders, M1
Savvides, SN1
Zhang, W5
Preska Steinberg, A1
Wang, ZG1
Ismagilov, RF1
Shi, J2
Cheng, Z1
Cerqueira, JV1
Meira, CS1
Santos, ES1
de Aragão França, LS1
Vasconcelos, JF1
Nonaka, CKV1
de Melo, TL1
Dos Santos Filho, JM1
Moreira, DRM1
Soares, MBP1
Chuang, LS1
Morrison, J1
Hsu, NY1
Labrias, PR1
Nayar, S1
Chen, E1
Villaverde, N1
Facey, JA1
Boschetti, G1
Giri, M1
Castillo-Martin, M1
Thin, TH1
Sharma, Y1
Chu, J1
Cho, JH1
Biffi, S1
Dal Monego, S1
Dullin, C1
Garrovo, C1
Bosnjak, B2
Licha, K1
Welker, P1
Epstein, MM2
Alves, F1
Yadav, UC1
Naura, AS3
Aguilera-Aguirre, L1
Boldogh, I1
Boulares, HA1
Calhoun, WJ1
Ramana, KV1
Srivastava, SK1
Lee, MY5
Jeon, WY2
Lim, HS1
Kim, JH4
Ha, H1
Graeber, SY2
Schatterny, J3
Hirtz, S2
Wei, M1
Xie, X1
Chu, X1
Guan, M1
Toumi, R1
Abdelouhab, K1
Rafa, H1
Soufli, I1
Raissi-Kerboua, D1
Djeraba, Z1
Touil-Boukoffa, C1
Wrzosek, L1
Miquel, S1
Noordine, ML1
Bouet, S1
Joncquel Chevalier-Curt, M1
Robert, V1
Philippe, C1
Bridonneau, C1
Cherbuy, C1
Robbe-Masselot, C1
Langella, P1
Thomas, M1
Määttänen, P1
Trost, B1
Scruten, E1
Potter, A1
Kusalik, A1
Griebel, P1
Napper, S1
Boyoglu-Barnum, S1
Gaston, KA1
Todd, SO1
Boyoglu, C1
Chirkova, T1
Barnum, TR1
Jorquera, P1
Haynes, LM1
Tripp, RA1
Moore, ML1
Anderson, LJ1
Starkey, MR1
Nguyen, DH1
Essilfie, AT1
Kim, RY1
Hatchwell, LM1
Collison, AM1
Yagita, H1
Foster, PS2
Horvat, JC1
Mattes, J1
Hansbro, PM2
Tilp, C1
Tomsic, C1
Dekan, G1
Pieper, MP1
Erb, KJ1
Shin, HK2
de Boer, JD1
van den Boogaard, FE1
Hoogendijk, AJ2
de Beer, R2
van der Zee, JS2
Roelofs, JJ2
van 't Veer, C1
de Vos, AF2
van der Poll, T2
Saravia, J3
You, D2
Thevenot, P1
Lee, GI1
Shrestha, B1
Lomnicki, S1
Cormier, SA5
Johansson, ME2
Loonen, LM1
Stolte, EH1
Jaklofsky, MT1
Meijerink, M1
Dekker, J1
van Baarlen, P1
Wells, JM1
Kober, OI1
Ahl, D1
Pin, C1
Holm, L1
Carding, SR1
Juge, N1
Shi, Y1
Tan, Y1
Mao, S1
Gu, W1
Gehrig, S1
Duerr, J2
Weitnauer, M1
Wagner, CJ1
Belaaouaj, A1
Dalpke, AH1
Schultz, C1
Levendoski, EE1
Leydon, C1
Thibeault, SL1
Winkler, C1
Bahlmann, O1
Viereck, J1
Knudsen, L1
Wedekind, D1
Hoymann, HG1
Madsen, J1
Thum, T2
Hohlfeld, JM1
Ochs, M1
Staab, EB1
Sanderson, SD1
Wells, SM1
Poole, JA1
Fishman, JE1
Levy, G1
Alli, V1
Zheng, X1
Mole, DJ1
Deitch, EA1
Jeon, CM4
Hong, JM2
Kim, HS1
Myung, PK1
Zhong, B1
Sun, Q1
Lan, X1
Tian, J1
He, Q1
Hou, W1
Gao, N2
Hoegger, MJ1
McMenimen, JD1
Ostedgaard, LS2
Tucker, AJ1
Awadalla, MA1
Michalski, AS1
Hoffman, EA1
Zabner, J2
Silva, RA1
Almeida, FM1
Olivo, CR1
Saraiva-Romanholo, BM1
Martins, MA3
Carvalho, CR1
Park, JW4
Toledo-Piza, AR1
Maria, DA1
Shen, QY2
Wu, HM2
He, F1
Ding, PS1
Liu, RY2
Nau, F1
Miller, J1
Ahlert, T1
Yu, B1
Happel, KI1
Nichols, CD1
Pinheiro Silva, L1
Damacena de Angelis, C1
Bonamin, F2
Kushima, H2
José Mininel, F1
Campaner Dos Santos, L1
Karina Delella, F1
Luis Felisbino, S1
Vilegas, W3
Regina Machado da Rocha, L1
Aparecido Dos Santos Ramos, M1
Maria Bauab, T1
Toma, W3
Akiko Hiruma-Lima, C1
Karra, L1
Haworth, O1
Priluck, R1
Levy, BD1
Levi-Schaffer, F1
Chen, M2
Lv, Z1
Huang, L1
Lin, X1
Liang, R1
Yao, H1
Niu, X1
Mu, Q1
Hardy, CL2
King, SJ1
Mifsud, NA1
Hedger, MP1
Phillips, DJ2
Mackay, F1
de Kretser, DM2
Wilson, JW1
Rolland, JM2
O'Hehir, RE2
Weir, D1
Busse, P1
Yang, N1
Emala, C1
Li, XM1
Andemariam, B1
Adami, AJ1
Singh, A1
McNamara, JT1
Secor, ER1
Guernsey, LA1
Thrall, RS2
Santos Serafim Machado, M1
Ferreira Silva, HB1
Rios, R1
Pires de Oliveira, A1
Vilany Queiroz Carneiro, N1
Santos Costa, R1
Santos Alves, W1
Meneses Souza, FL1
da Silva Velozo, E1
Alves de Souza, S1
Sarmento Silva, TM1
Silva, ML1
Pontes-de-Carvalho, LC1
Alcântara-Neves, NM1
Figueiredo, CA1
Fatani, AJ1
Al-Hosaini, KA1
Ahmed, MM2
Abuohashish, HM2
Parmar, MY1
Al-Rejaie, SS2
Jaligama, S1
Yadav, N1
Lomnicki, SM1
Dugas, TR1
Sanjo, H1
Tokumaru, S1
Akira, S1
Taki, S1
Ghonim, MA1
Pyakurel, K1
Ibba, SV1
Al-Khami, AA1
Rodriguez, P1
Rady, HF1
El-Bahrawy, AH1
Lammi, MR1
Mansy, MS1
Al-Ghareeb, K1
Ramsay, A1
Ochoa, A1
Boulares, AH2
Xie, T1
Luo, G1
Li, G3
Aihua, B1
Yuqing, C1
Feng, L1
Xin, Z1
Park, SY1
Lee, HS1
Hee Kim, J1
Lee, HJ2
Lee, J2
Zhang, ZY1
Zhu, T2
Wu, XL1
Xiao, M1
Ni, ZH1
Tang, JH1
Chen, G1
Lai, YM1
Chen, QG1
Yang, W1
Luo, XM1
Wang, XB1
Son, Y1
Bae, MJ1
Lee, SS1
Park, SH1
Lee, SI1
Lee, CG1
Kim, SD1
Jo, WS1
Verbrugghe, E1
Van Parys, A1
Leyman, B1
Boyen, F1
Arnouts, S1
Lundberg, U1
Ducatelle, R1
Van den Broeck, W1
Yekta, MA1
Cox, E1
Haesebrouck, F1
Pasmans, F1
Ribeiro, AR1
Diniz, PB1
Pinheiro, MS1
Albuquerque-Júnior, RL1
Thomazzi, SM1
Manni, ML1
Mandalapu, S1
McHugh, KJ1
Elloso, MM1
Dudas, PL1
Alcorn, JF1
Zhang, C1
Zhang, LH1
Wu, YF1
Lai, TW1
Wang, HS1
Xiao, H1
Che, LQ1
Zakaria, ZA3
Balan, T1
Azemi, AK1
Omar, MH1
Mohtarrudin, N1
Ahmad, Z1
Abdullah, MN1
Desa, MN1
Teh, LK2
Salleh, MZ2
Lee, CC1
Lee, YL1
Wang, CN1
Tsai, HC1
Chiu, CL1
Liu, LF1
Lin, HY1
Wu, R1
Jia, J1
Ding, Y1
Shang, P1
Liu, T1
Hui, G1
Wang, M1
Zhu, Z1
Wen, A1
da Cunha, AA1
Nuñez, NK1
de Souza, RG1
Moraes Vargas, MH1
Silveira, JS1
Antunes, GL1
Durante, Lda S1
Porto, BN1
Marczak, ES1
Jones, MH1
Pitrez, PM1
McCann, JR1
Mason, SN1
Auten, RL1
St Geme, JW1
Seed, PC1
Bergstrom, K1
Fu, J1
Wu, Q1
Song, J1
McDaniel, JM1
McGee, S1
Chen, W1
Braun, J1
Bayes, HK1
Ritchie, ND1
Ward, C1
Corris, PA1
Brodlie, M1
Evans, TJ1
Wang, RX1
Shen, JL1
Liu, DS1
Li, CM1
Miyasaka, T1
Okuyama-Dobashi, K1
Masuda, C1
Iwami, S1
Sato, M1
Mizoguchi, H1
Kawano, T1
Ohkawara, Y2
Sakurada, S1
Takayanagi, M2
Ohno, I2
de Lacerda Neto, LJ1
Ramos, AG1
Santos Sales, V1
de Souza, SD1
Dos Santos, AT1
de Oliveira, LR1
Kerntopf, MR1
de Albuquerque, TR1
Coutinho, HD1
Quintans-Júnior, LJ2
Wanderley, AG1
de Menezes, IR1
Yokota, M1
Tamachi, T1
Yokoyama, Y1
Maezawa, Y1
Takatori, H1
Suto, A1
Suzuki, K2
Hirose, K1
Takeda, K1
Nakajima, H1
Ueha, R1
Ueha, S1
Kondo, K1
Nito, T1
Fujimaki, Y1
Nishijima, H1
Tsunoda, K1
Shand, FH1
Matsushima, K1
Yamasoba, T1
Dai, X1
Niu, B1
Wu, J1
Xiong, A1
Zhong, N2
Kouitcheu Mabeku, LB1
Nanfack Nana, B1
Eyoum Bille, B1
Tchuenteu Tchuenguem, R1
Nguepi, E1
Luo, D1
Tsuchida, H1
Takahashi, S1
Nosaka, E1
Kuraya, T1
Yamashita, M1
Morimoto, K1
Ckless, K1
Lampert, A1
Reiss, J1
Kasahara, D1
Poynter, ME2
Irvin, CG1
Lundblad, LK1
Norton, R1
van der Vliet, A1
Janssen-Heininger, YM1
Landgraf, RG1
Jancar, S1
Lee, M1
Kim, S1
Lee, HK4
Ahn, K2
Tumes, DJ1
Connolly, A1
Dent, LA1
Shine, VJ1
Latha, PG1
Shyamal, S1
Suja, SR1
Anuja, GI1
Sini, S1
Pradeep, S1
Rajasekharan, S1
Song, DJ1
Min, MG1
Miller, M1
Cho, JY1
Broide, DH1
Zaynagetdinov, R1
Ryzhov, S1
Goldstein, AE1
Yin, H1
Novitskiy, SV1
Goleniewska, K1
Polosukhin, VV1
Newcomb, DC1
Mitchell, D1
Morschl, E1
Blackburn, MR1
Biaggioni, I1
Feoktistov, I1
Park, SW1
Verhaeghe, C1
Nguyenvu, LT1
Barbeau, R1
Eisley, CJ1
Nakagami, Y1
Huang, X1
Woodruff, PG1
Fahy, JV2
Erle, DJ1
Hida, K1
Shukair, S1
Figueiredo, A1
Cone, R1
Hope, TJ1
Hattori, R4
Shimizu, S4
Majima, Y4
Shimizu, T6
Brattström, A2
Schapowal, A2
Maillet, I2
Schnyder, B1
Ryffel, B2
Moser, R2
Arawwawala, LD1
Thabrew, MI1
Arambewela, LS1
Rodrigues, Pde A1
de Morais, SM1
de Souza, CM1
Silva, AR1
de Andrade, GM1
Silva, MG1
Albuquerque, RL1
Rao, VS1
Santos, FA1
Kamal, MA1
Meyerholz, DK2
Castro, GA1
Carvalho, JE1
Tinti, SV1
Possenti, A1
Sgarbieri, VC1
Gulbins, E1
Prakash, UN1
Srinivasan, K1
Larsen, ST1
Matsubara, S1
McConville, G1
Poulsen, SS1
Gelfand, EW1
Dif, F1
Wu, YZ1
Burgel, PR1
Ollero, M1
Leduc, D1
Aarbiou, J1
Borot, F1
Garcia-Verdugo, I1
Martin, C1
Chignard, M1
Israel-Biet, D1
Kita, Y1
Scholte, BJ1
Touqui, L1
Ramachandran, S1
Rogan, MP1
Davis, GJ1
Hanfland, RA1
Wohlford-Lenane, C1
Dohrn, CL1
Bartlett, JA1
Nelson, GA1
Chang, EH1
Taft, PJ1
Ludwig, PS1
Estin, M1
Hornick, EE1
Launspach, JL1
Samuel, M1
Rokhlina, T1
Karp, PH1
Uc, A1
Starner, TD1
Horswill, AR1
Brogden, KA1
Prather, RS1
Richter, SS1
Shilyansky, J1
McCray, PB1
Nishimoto, Y1
Hisatsune, A1
Katsuki, H1
Miyata, T1
Yokomizo, K1
Isohama, Y1
Yao, Y1
Xia, D1
Zhou, J1
Santin, JR2
Lemos, M2
Klein Júnior, LC2
Niero, R1
de Andrade, SF1
Ahmad, T1
Mabalirajan, U1
Sharma, A1
Aich, J1
Makhija, L1
Ghosh, B1
Agrawal, A2
Umegaki, E1
Yoda, Y1
Tokioka, S1
Murano, M1
Higuchi, K1
Lee, NH1
Lee, JA1
Jung, DY1
Almeida-Reis, R1
Toledo, AC1
Reis, FG1
Marques, RH1
Prado, CM1
Dolhnikoff, M1
Leick-Maldonado, EA1
Tibério, IF1
Hardaker, EL1
Freeman, MS1
Dale, N1
Bahra, P1
Raza, F1
Banner, KH1
Poll, C1
Sun, S1
Kitano, M1
Ishinaga, H1
Takeuchi, K1
Mebratu, YA1
Schwalm, K1
Smith, KR1
Schuyler, M1
Tesfaigzi, Y1
van Echteld, CJ1
Beckmann, N1
Takayama, C2
de-Faria, FM1
de Almeida, AC1
Valim-Araújo, Dde A1
Rehen, CS1
Dunder, RJ1
Socca, EA1
Manzo, LP1
Rozza, AL1
Salvador, MJ1
Pellizzon, CH2
Hiruma-Lima, CA3
Luiz-Ferreira, A2
Souza-Brito, AR2
Sehra, S1
Yao, W1
Nguyen, ET1
Ahyi, AN1
Tuana, FM1
Ahlfeld, SK1
Snider, P1
Tepper, RS1
Petrache, I1
Conway, SJ1
Kaplan, MH1
Pierucci-Alves, F1
Akoyev, V1
Stewart, JC1
Wang, LH1
Janardhan, KS1
Schultz, BD1
Cola, M1
Barbastefano, V1
Farias-Silva, E1
Calvo, TR2
de Almeida, AB3
Henderson, WR6
Oslund, RC1
Bollinger, JG1
Ye, X1
Tien, YT2
Xue, J1
Gelb, MH1
Jaiswal, SK1
Rao, CV1
Sharma, B1
Mishra, P1
Das, S1
Dubey, MK1
Cheng, C2
Ho, WE1
Goh, FY2
Guan, SP1
Kong, LR1
Lai, WQ1
Leung, BP4
Wong, WS4
Mukherjee, S1
Lindell, DM1
Berlin, AA1
Morris, SB1
Shanley, TP1
Hershenson, MB1
Lukacs, NW3
Freitas, FF1
Fernandes, HB1
Piauilino, CA1
Pereira, SS1
Carvalho, KI1
Chaves, MH1
Soares, PM1
Miura, LM1
Leite, JR1
Oliveira, RC1
Oliveira, FA1
Abdul Hisam, EE1
Rofiee, MS2
Norhafizah, M1
Somchit, MN1
Paula de Oliveira, A1
Couto, AG1
Meyre da Silva Bittencourt, C1
Filho, VC1
Faloni de Andrade, S2
Mitchell, VL1
Van Winkle, LS1
Gershwin, LJ1
Khakzad, MR1
Mirsadraee, M1
Mohammadpour, A1
Ghafarzadegan, K1
Hadi, R1
Saghari, M1
Meshkat, M1
Hoffman, JM1
Tyler, K1
MacEachern, SJ1
Balemba, OB1
Johnson, AC1
Brooks, EM1
Swain, GM1
Moses, PL1
Galligan, JJ1
Sharkey, KA1
Greenwood-Van Meerveld, B1
Mawe, GM1
Hariprasath, L1
Raman, J1
Nanjian, R1
Upton, N1
Guan, S1
Shanmugam, MK1
Sethi, G1
Taha, MM1
Salga, MS1
Ali, HM1
Abdulla, MA1
Abdelwahab, SI1
Hadi, AH1
Kelly, EJ2
Wilkinson, KJ1
Geiser, M1
O'Neal, WK3
Klem, ER1
Dang, H1
Wolfgang, MC1
Halim, TY1
Krauss, RH1
Sun, AC1
Obidike, IC1
Aboh, MI1
Salawu, OA1
Sycuro, LK1
Wyckoff, TJ1
Biboy, J1
Born, P1
Pincus, Z1
Vollmer, W1
Salama, NR1
Thorburn, AN1
Gibson, PG1
Behrendt, AK1
Meyer-Bahlburg, A1
Hansen, G2
Oehlers, SH1
Flores, MV1
Hall, CJ1
Crosier, KE1
Crosier, PS1
Wang, DX1
Huang, NW1
Bo, H1
Deng, W1
Deng, J1
Nie, YC1
Li, PB1
Luo, YL1
Zhang, CC1
Shen, JG1
Su, WW1
Oliveira, IS1
da Silva, FV1
Viana, AF1
dos Santos, MR1
Martins, Mdo C1
Nunes, PH1
Oliveira, Fde A1
Oliveira, Rde C1
Zhang, L3
Li, K1
Bing Ma, L1
Gong, SB1
Wang, GY1
Ji, XY1
Xu, L1
Liu, SK1
Chen, P1
Ouyang, RY1
Xiang, XD1
Wolff Cordeiro, K1
Aparecida Pinto, L1
Nazari Formagio, AS1
Leite Kassuya, CA1
de Cássia Freitas, K1
Osaki, T1
Matsuki, T1
Asahara, T1
Zaman, C1
Hanawa, T1
Yonezawa, H1
Kurata, S1
Woo, TD1
Nomoto, K1
Kamiya, S1
Serra, MF1
Anjos-Valotta, EA1
Olsen, PC1
Couto, GC1
Jurgilas, PB1
Cotias, AC1
Pão, CR1
Ferreira, TP1
Arantes, AC1
Pires, AL1
Cordeiro, RS1
Silva, PM1
Selvaraj, S1
Robinson, AM1
Epstein, VA1
Conley, DB1
Kern, RC1
Richter, CP1
Anagnostopoulou, P1
Riederer, B1
Michel, S1
Binia, A1
Agrawal, R1
Kalitzki, K1
Xiao, F1
Hartmann, D1
Kabesch, M1
Soleimani, M1
Seidler, U1
Kreda, SM1
Davis, CW2
Rose, MC2
Hisam, EE1
Mohtaruddin, N1
Hamid, HA1
Othman, F1
Aleisa, AM1
Alkhamees, O1
de Morais Lima, GR1
de Albuquerque Montenegro, C1
de Sousa Falcão, H1
de Jesus, NZ1
Cabral, AG1
Gomes, IF1
Agra, Mde F2
Tavares, JF1
Batista, LM3
Falcão, Hde S1
Maia, GL1
Moraes, TM1
Hiruma Lima, CA1
Ferreira, AL1
Souza Brito, AR2
Barbosa Filho, JM1
Hasnain, SZ1
Tauro, S1
Das, I1
Chen, AC1
Jeffery, PL1
McDonald, V1
Florin, TH1
McGuckin, MA1
Reber, LL1
Daubeuf, F1
Nemska, S1
Frossard, N1
Yang, ZQ1
Jin, CJ1
Fang, WM1
Gu, RX1
Qian, JY1
Jiao, XA1
Daan de Boer, J1
Schouten, M1
Hommes, TJ1
de Boer, OJ1
Stroo, I1
Veer, CV1
Chi, EY5
Teo, JL1
Nguyen, C1
Kahn, M1
Ye, YN1
So, HL1
Liu, ES1
Shin, VY1
Cho, CH1
Ochkur, SI1
McGarry, MP1
Crosby, JR1
Hines, EM1
Borchers, MT1
Biechelle, TL1
O'Neill, KR1
Ansay, TL1
Colbert, DC1
Justice, JP1
Lee, NA1
Lee, JJ1
Miller, AL1
Strieter, RM1
Gruber, AD2
Ho, SB1
Guo, JJ1
Wang, DS1
Huang, HT1
Gabazza, EC1
Mashima, Y1
Singer, M1
Martin, LD1
Vargaftig, BB2
Park, J1
Adler, KB1
de Pietro Magri, L1
Kelly-Welch, AE1
Melo, ME1
Smith, E1
Ford, AQ1
Haudenschild, C1
Noben-Trauth, N1
Keegan, AD1
Mall, M1
Harkema, JR1
Deaton, CM1
Marlin, DJ1
Smith, NC1
Smith, KC1
Newton, RJ1
Gower, SM1
Cade, SM1
Roberts, CA1
Harris, PA1
Schroter, RC1
Kelly, FJ1
Duan, W2
Chan, JH1
Wong, CH1
Fink, JB1
Unoki, T1
Mizutani, T1
Toyooka, H1
Scherf, W1
Burdach, S1
Castagliuolo, I1
Galeazzi, F1
Ferrari, S1
Elli, M1
Brun, P1
Cavaggioni, A1
Tormen, D1
Sturniolo, GC1
Morelli, L1
Palù, G1
Aguinaldo Datiles, AM1
Vlahos, CJ1
Liu, JB2
Zhang, ZX2
Xu, YJ2
Xing, LH2
Zhang, HL2
Zhang, GS1
Dharmani, P1
Mishra, PK1
Maurya, R1
Singh Chauhan, V1
Palit, G1
Tariq, M2
Al Moutaery, A1
Robichaud, A2
Tuck, SA1
Kargman, S1
Tam, J1
Wong, E1
Abramovitz, M1
Mortimer, JR2
Mortimer, J1
Burston, HE1
Masson, P1
Hirota, J1
Slipetz, D2
Kennedy, B1
O'Neill, G1
Xanthoudakis, S1
Banerjee, ER1
Ohki, Y2
Tokuyama, K2
Mayuzumi, H2
Sato, A1
Koyama, H2
Takizawa, T1
Arakawa, H2
Mochizuki, H2
Morikawa, A2
Medoff, BD1
Tager, AM1
Jackobek, R1
Means, TK1
Luster, AD1
Phaybouth, V1
Wang, SZ1
Hutt, JA1
McDonald, JD1
Harrod, KS1
Barrett, EG1
Rogers, TD1
Diggs, PC1
Ostrowski, LE1
Nishimura, H1
Mizuno, T1
Encinas, JA1
Janssen, EM1
Weiner, DB1
Calarota, SA1
Nieto, D1
Moll, T1
Carlo, DJ1
Moss, RB1
De Lisle, RC2
Roach, EA1
Norkina, O1
Cohn, L2
Voynow, JA1
Gendler, SJ1
Köhl, J1
Baelder, R1
Lewkowich, IP1
Pandey, MK1
Hawlisch, H1
Best, J1
Herman, NS1
Sproles, AA1
Zwirner, J1
Gerard, C1
Sfyroera, G1
Lambris, JD1
Wills-Karp, M1
Ishikawa, Y1
Yoshimoto, T1
Nakanishi, K1
Park, BY1
Joung, H1
Kim, DY1
Lee, S1
Long, AJ1
Sypek, JP1
Askew, R1
Fish, SC1
Mason, LE1
Williams, CM1
Goldman, SJ1
Muz, MH1
Deveci, F1
Bulut, Y1
Ilhan, N1
Yekeler, H1
Turgut, T1
Hamelin, ME1
Prince, GA1
Gomez, AM1
Kinkead, R1
Boivin, G1
Venkataraman, C1
Justen, K1
Galbreath, E1
Na, S1
O'Connor, AE1
Yao, J1
Sebire, K1
Anderson, GP1
Kodavanti, UP1
Schladweiler, MC1
Ledbetter, AD1
Ortuno, RV1
Suffia, M1
Evansky, P1
Richards, JH1
Jaskot, RH1
Thomas, R1
Karoly, E1
Huang, YC1
Costa, DL1
Gilmour, PS1
Pinkerton, KE1
Mitchell, H1
Fulkerson, PC1
Fischetti, CA1
McBride, ML1
Hassman, LM1
Hogan, SP1
Rothenberg, ME1
Livraghi, A1
Choi, SM1
Shin, JH1
Kang, KK1
Ahn, BO1
Yoo, M1
Chapman, RW1
Minnicozzi, M1
Celly, CS1
Phillips, JE1
Kung, TT1
Hipkin, RW1
Rindgen, D1
Deno, G1
Bond, R1
Gonsiorek, W1
Billah, MM1
Fine, JS1
Hey, JA1
Paveglio, SA1
Allard, J1
Mayette, J1
Whittaker, LA1
Juncadella, I1
Anguita, J1
Swaisgood, CM1
Aronica, MA1
Swaidani, S1
Plow, EF1
Roach, E1
Jansson, K1
McCusker, CT1
Shan, J1
Kinyanjui, MW1
Villeneuve, A1
Michael, H1
Fixman, ED1
Smit, J1
Lindell, D1
Schaller, M1
Kim, MJ1
Kim, MK1
Lee, IY1
Ohwada, K1
Watanabe, K1
Okuyama, K1
Sugaya, T1
Lang, IM1
Haworth, ST1
Medda, BK1
Roerig, DL1
Forster, HV1
Shaker, R1
Ko, HM1
Kang, NI1
Kim, YS1
Lee, YM1
Jin, ZW1
Jung, YJ1
Im, SY1
Shin, YH1
Cho, BH1
Sugimoto, K1
Ogawa, A1
Mizoguchi, E1
Shimomura, Y1
Andoh, A1
Bhan, AK1
Blumberg, RS1
Xavier, RJ1
Mizoguchi, A1
Walton, RP1
Edwards, MR1
Caramori, G1
Glanville, N1
Choy, KJ1
Jourdan, P1
Burnet, J1
Tuthill, TJ1
Pedrick, MS1
Hurle, MJ1
Plumpton, C1
Sharp, NA1
Bussell, JN1
Swallow, DM1
Schwarze, J1
Guy, B1
Almond, JW1
Jeffery, PK1
Papi, A1
Killington, RA1
Rowlands, DJ1
Blair, ED1
Clarke, NJ1
Therien, AG1
Bernier, V1
Weicker, S1
Tawa, P1
Falgueyret, JP1
Mathieu, MC1
Honsberger, J1
Pomerleau, V1
Stocco, R1
Dufresne, L1
Houshyar, H1
Lafleur, J1
Ramachandran, C1
O'Neill, GP1
Tan, CM1
Hans, CP1
Zerfaoui, M1
Oumouna, M1
Yokota, J1
Takuma, D1
Hamada, A1
Onogawa, M1
Yoshioka, S1
Kusunose, M1
Miyamura, M1
Kyotani, S1
Nishioka, Y1
Adriaens, E1
Bytheway, H1
De Wever, B1
Eschrich, D1
Guest, R1
Hansen, E1
Vanparys, P1
Schoeters, G1
Warren, N1
Weltens, R1
Whittingham, A1
Remon, JP1
Nakao, I1
Kanaji, S1
Ohta, S1
Matsushita, H1
Arima, K1
Yuyama, N1
Yamaya, M1
Nakayama, K1
Kubo, H1
Watanabe, M1
Sagara, H1
Sugiyama, K1
Tanaka, H1
Toda, S1
Hayashi, H1
Inoue, H1
Hoshino, T1
Shiraki, A1
Inoue, M1
Aizawa, H1
Okinami, S1
Nagai, H1
Hasegawa, M1
Fukuda, T1
Green, ED1
Izuhara, K1
Müller, RM2
Roomans, GM2
Wanner, A1
Abraham, WM2
Pfeiffer, CJ1
Lee, SP1
Reid, L6
Bhaskar, K2
Coles, S2
Jones, R2
Savoie, C1
Plant, M1
Zwikker, M1
van Staden, CJ2
Boulet, L2
Chan, CC1
Rodger, IW2
Pon, DJ2
Vignola, AM1
Campbell, AM1
Fournier, M1
Godard, P1
Alarcón de la Lastra, C1
Martín, MJ1
La Casa, C1
Motilva, V1
Korpás, J1
Widdicombe, JG2
Vrabec, M1
Barthalmus, GT1
Hardin, LK1
Thompson, D1
Ahmed, A1
Cortes, A1
Sielczak, M1
Hallmon, J1
Zeeh, JM1
Procaccino, F1
Hoffmann, P1
Aukerman, SL1
McRoberts, JA1
Soltani, S1
Pierce, GF1
Lakshmanan, J1
Lacey, D1
Eysselein, VE1
Hotchkiss, CE1
Merritt, AM1
Lewis, DB1
Albert, RK1
Lamm, WJ1
Chiang, GK1
Jones, F1
Eriksen, P1
Jonas, M1
Bulbena, O1
Culat, J1
Bravo, ML1
Al Moutaery, AR1
Norlander, T1
Larsen, P1
Westrin, KM1
Hultenby, K1
Carlsöö, B2
Stierna, P2
Rege, RV1
Prystowsky, JB1
King, M1
Cohen, JC1
Morrow, SL1
Cork, RJ1
Delcarpio, JB1
Larson, JE1
Wills, PJ1
Pritchard, K1
Cole, PJ1
Sifontes Rodríguez, S1
Infante Bourzac, JF1
Marrero Chang, O1
Fariñas Medina, M1
Muñoz Carnago, E1
López Hernández, Y1
Katoh, Y1
Tanaka, M1
Kawashima, H2
Homer, RJ1
Niu, N1
Bottomly, K1
Maliszewski, CR1
Lu, J1
Poole, KM1
Dietsch, GN1
Trifilieff, A1
El-Hashim, A1
Bertrand, C1
Gracioso, JD1
de Paula, AC1
Brasil, DD1
Muller, AH1
Brito, AR1
Nakanishi, A1
Morita, S1
Iwashita, H1
Sagiya, Y1
Ashida, Y1
Shirafuji, H1
Fujisawa, Y1
Nishimura, O1
Fujino, M1
Patrzykat, A1
Mendoza, V1
Iwama, GK1
Hancock, RE1
Russo, M1
Nahori, MA1
Lefort, J1
Gomes, E1
de Castro Keller, A1
Rodriguez, D1
Ribeiro, OG1
Adriouch, S1
Gallois, V1
de Faria, AM1
Shimotoyodome, A1
Meguro, S1
Hase, T1
Tokimitsu, I1
Sakata, T1
Wu, CA1
Puddington, L1
Whiteley, HE1
Yiamouyiannis, CA1
Schramm, CM1
Mohammadu, F1
Tarran, R1
Parsons, D1
Picher, M1
Hirsh, AJ1
Hashimoto, K1
Ishii, Y1
Uchida, Y1
Kimura, T1
Masuyama, K1
Morishima, Y1
Hirano, K1
Nomura, A1
Sakamoto, T1
Takano, H1
Sagai, M1
Sekizawa, K1
Chadburn, JL1
Ishihara, Y1
Kyono, H1
Serita, F1
Toya, T1
Miyasaka, M1
Englert, E1
Harman, CG1
Freston, JW1
Straight, RC1
Wales, EE1
Reid, LM2
Snouwaert, JN1
Brigman, KK1
Latour, AM1
Malouf, NN1
Smithies, O1
Koller, BH1
Kumlien, J1
Barbeau, J1
Deslauriers, N1
Wadolkowski, EA1
Burris, JA1
O'Brien, AD1
Tanaka, K1
Okamoto, Y1
Nagaya, Y1
Nishimura, F1
Takeoka, A1
Hanada, S1
Kohno, S1
Kawai, M1
Myers, SI1
Haley-Russell, D1
Parks, L1
Husband, K1
Versura, P1
Maltarello, MC1
Bhaskar, KR1
Drazen, JM1
O'Sullivan, DD1
Scanlon, PM1
Disse, BG1
Ziegler, HW1
Vol'fson, NI1
Berendt, RF1
Zaidi, SH1
Kilburn, KH2
Rylander, R3
Chakrin, LW2
Saunders, LZ1
Dalhamn, T1
Wardell, JR1
Payne, BJ1
Green, GM1
Mawdesley-Thomas, LE1
Healey, P1
Barry, DH1

Clinical Trials (15)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Immunostimulation With Polyvalent Mechanical Bacterial Lysate on Changes in the Concentration of iNKT Cells in Children With Allergic Rhinitis.[NCT04802616]Phase 380 participants (Actual)Interventional2021-03-22Completed
The Effect Of Polivalent Mechanical Bacterial Lysate On The Clinical Course Of Grass Pollen-Induced Allergic Rhinitis In Children[NCT04270552]Phase 376 participants (Actual)Interventional2018-04-22Completed
The Effect of Polyvalent Mechanical Bacterial Lysate on the Reduction of Nasal Staphylococcus Aureus Carriage in Children With Pollen Allergic Rhinitis[NCT04637425]Phase 370 participants (Actual)Interventional2018-04-22Completed
Identifying the Role of Pulses in a Healthful Diet: Metabolomic Signatures of Dietary Pulses and Their Benefits on Cardiometabolic Risk Factors[NCT04887584]20 participants (Actual)Interventional2022-05-01Completed
Alteration of Intestinal Microflora and Efficacy and Safety of Fecal Microbiota Transplantation for Severe Acute Pancreatitis[NCT03015467]Phase 1/Phase 280 participants (Anticipated)Interventional2016-12-31Recruiting
Symptom Based Performance of Airway Clearance Therapy After Starting Highly Effective CFTR Modulator Therapy for Cystic Fibrosis[NCT05392855]30 participants (Anticipated)Interventional2023-09-05Recruiting
Assessing Target Engagement of Terazosin in Healthy Adults[NCT04551040]Phase 118 participants (Anticipated)Interventional2021-03-26Active, not recruiting
A Pilot Placebo-controlled Randomized Double-blind Trial of Melatonin in Outpatients With COVID-19 Infection[NCT04784754]Phase 20 participants (Actual)Interventional2021-04-01Withdrawn (stopped due to lack of subject enrollment)
A Pilot Placebo-controlled Randomized Double-blind Trial of Melatonin in Outpatients With COVID-19 Infection[NCT04474483]Phase 28 participants (Actual)Interventional2020-11-06Terminated (stopped due to difficult recruitment and complete first visit in person during thne hight of tne pandemic and later not enough subjects)
Phase Ib/II Clinical Trial of Topical Verapamil Hydrochloride for Chronic Rhinosinusitis With Nasal Polyps[NCT03102190]Phase 16 participants (Actual)Interventional2017-06-05Terminated (stopped due to Phase II funding not available)
Randomized Double Blind Placebo Controlled Trial of Verapamil in Chronic Rhinosinusitis[NCT02454608]29 participants (Actual)Interventional2015-05-31Terminated (stopped due to Evidence that the dose is insufficient.)
A Phase 2 Study of the Safety and Efficacy of BIO-11006 in the Treatment of Recurrent Osteosarcoma and Ewing's Sarcoma in Patients With Lung Metastases[NCT04183062]Phase 210 participants (Anticipated)Interventional2019-10-04Active, not recruiting
Comparison of Airway Remodeling Mediators Following Experimental Human Rhinovirus Infection in Subjects With Mild to Moderate Asthma and Healthy, Non-asthmatic Control Subjects[NCT05775952]24 participants (Anticipated)Observational2011-09-01Recruiting
Efficacy of Nebulised 5% Hypertonic Saline in Children With Chronic Suppurative Lung Disease[NCT04765033]Phase 446 participants (Actual)Interventional2021-02-04Completed
Effect of Exposure to Allergens and Air Pollution on Lung Function and Immunity[NCT01792232]18 participants (Actual)Interventional2011-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With Dose Limiting Toxicity

Dose Limiting Toxicity will be defined as a development of 2nd or 3rd degree heart block as measured by an EKG. (Phase Ib primary outcome) (NCT03102190)
Timeframe: 1-8 weeks

InterventionParticipants (Count of Participants)
Phase Ib0

Diastolic Blood Pressure

(NCT02454608)
Timeframe: Mean change between baseline and week 8 measurements

InterventionmmHg (Mean)
Treatment-0.6
Control1

Heart Rate

(NCT02454608)
Timeframe: Mean change between baseline and week 8 measurements.

Interventionbeats per minute (Mean)
Treatment-1.4
Control4

Objective Sinonasal Symptoms on Lund-Kennedy Score(LKS)

Minimum Score: 0 Maximum Score: 12 Higher value represents worse outcome. (NCT02454608)
Timeframe: baseline to week 8

Interventionunits on a scale (Least Squares Mean)
Treatment-1.3
Control-0.25

Objective Sinonasal Symptoms on Lund-McKay Score(LMS)

Minimum Score: 0 Maximum Score: 24 Higher value represents worse outcome. (NCT02454608)
Timeframe: Week 8

Interventionunits on a scale (Mean)
Treatment12.5
Control17.7

Subjective Sinonasal Symptoms on 10cm Visual Analogue Scale(VAS)

Minimum Score: 0 Maximum Score: 100 A higher score indicates a worse outcome. (NCT02454608)
Timeframe: baseline to week 8

Interventionunits on a scale (Least Squares Mean)
Treatment-44.03
Control-6.07

Subjective Sinonasal Symptoms on Sinonasal Outcomes Test-22(SNOT-22)

Minimum Score: 0 Maximum Score: 110 A higher score indicates a worse outcome (NCT02454608)
Timeframe: baseline to week 8

Interventionunits on a scale (Least Squares Mean)
Treatment-27.3
Control0.4

Systolic Blood Pressure

(NCT02454608)
Timeframe: Mean change between baseline and week 8 measurements

InterventionmmHg (Mean)
Treatment-4.5
Control-6.6

Subjective Sinonasal Symptoms on 10cm Visual Analogue Scale(VAS)

Minimum Score: 0 Maximum Score: 100 A higher score indicates a worse outcome. (NCT02454608)
Timeframe: baseline to week 56

Interventionunits on a scale (Mean)
Medicine Completers, baselineMedicine Completers, week 56Surgical Completers, baselineSurgical Completers, week 12
Open Label64.335.090.016.7

Subjective Sinonasal Symptoms on Sinonasal Outcomes Test-22(SNOT-22)

Minimum Score: 0 Maximum Score: 110 A higher score indicates a worse outcome (NCT02454608)
Timeframe: baseline to week 56

Interventionunits on a scale (Mean)
Medicine Completers, baselineMedicine Completers, week 56Surgical Completers, baselineSurgical Completers, week 12
Open Label31.824.1472.008.00

Reviews

23 reviews available for guaifenesin and Disease Models, Animal

ArticleYear
Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathway.
    Pediatric pulmonology, 2019, Volume: 54 Suppl 3

    Topics: Airway Obstruction; Animals; Child; Child, Preschool; Cystic Fibrosis; Disease Models, Animal; Human

2019
Mucociliary Transport in Healthy and Cystic Fibrosis Pig Airways.
    Annals of the American Thoracic Society, 2018, Volume: 15, Issue:Suppl 3

    Topics: Animals; Animals, Newborn; Cystic Fibrosis; Disease Models, Animal; Mucociliary Clearance; Mucus; Re

2018
Adverse immunological imprinting by cytomegalovirus sensitizing for allergic airway disease.
    Medical microbiology and immunology, 2019, Volume: 208, Issue:3-4

    Topics: Animals; Asthma; Cell Differentiation; Cytokines; Cytomegalovirus Infections; Dendritic Cells; Disea

2019
Mucus and the goblet cell.
    Digestive diseases (Basel, Switzerland), 2013, Volume: 31, Issue:3-4

    Topics: Animals; Colitis, Ulcerative; Disease Models, Animal; Goblet Cells; Humans; Mucins; Mucus

2013
Vocal fold epithelial barrier in health and injury: a research review.
    Journal of speech, language, and hearing research : JSLHR, 2014, Volume: 57, Issue:5

    Topics: Air Pollutants; Animals; Aquaporins; Cell Membrane; Disease Models, Animal; Humans; Intercellular Ju

2014
Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models.
    Journal of aerosol medicine and pulmonary drug delivery, 2008, Volume: 21, Issue:1

    Topics: Animals; Cilia; Disease Models, Animal; Mice; Mucociliary Clearance; Mucus; Respiratory Mechanics; R

2008
A view on imaging in drug research and development for respiratory diseases.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:2

    Topics: Animals; Clinical Trials as Topic; Diagnostic Imaging; Disease Models, Animal; Drug Delivery Systems

2011
CFTR, mucins, and mucus obstruction in cystic fibrosis.
    Cold Spring Harbor perspectives in medicine, 2012, Sep-01, Volume: 2, Issue:9

    Topics: Airway Obstruction; Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; D

2012
Regulation of mucin genes in chronic inflammatory airway diseases.
    American journal of respiratory cell and molecular biology, 2006, Volume: 34, Issue:6

    Topics: Animals; Asthma; Cystic Fibrosis; Cytokines; Disease Models, Animal; Gene Expression Regulation; Hum

2006
The roles of mucus-associated bacteria in inflammatory bowel disease.
    Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:9

    Topics: Adult; Animals; Disease Models, Animal; Helicobacter; Humans; Inflammatory Bowel Diseases; Mucus

2006
Cystic fibrosis and other respiratory diseases of impaired mucus clearance.
    Toxicologic pathology, 2007, Volume: 35, Issue:1

    Topics: Animals; Cilia; Cystic Fibrosis; Disease Models, Animal; Female; Gene Silencing; Humans; Male; Mice;

2007
Respiratory syncytial virus-induced pulmonary disease and exacerbation of allergic asthma.
    Contributions to microbiology, 2007, Volume: 14

    Topics: Animals; Asthma; Chemokines; Dendritic Cells; Disease Models, Animal; Humans; Immunity, Innate; Mice

2007
Experimental models of asthma.
    Lung, 1982, Volume: 160, Issue:5

    Topics: Airway Resistance; Animals; Asthma; Bronchi; Bronchial Provocation Tests; Cilia; Disease Models, Ani

1982
Experimental studies on the pathophysiology of peptic ulcer disease.
    Scandinavian journal of gastroenterology. Supplement, 1982, Volume: 72

    Topics: Animals; Disease Models, Animal; Gastric Acid; Gastric Mucosa; Humans; Mucus; Peptic Ulcer; Stomach

1982
Clinical aspects of respiratory mucus.
    Advances in experimental medicine and biology, 1982, Volume: 144

    Topics: Animals; Bronchi; Bronchitis; Calcium; Cilia; Colchicine; Cytochalasin B; Disease Models, Animal; Hu

1982
[Mechanisms of bronchial hyperreactivity. Role of the epithelium].
    Revue des maladies respiratoires, 1994, Volume: 11, Issue:2

    Topics: Animals; Antigens, CD; Asthma; Biopsy; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Capi

1994
Experimental models for studying mucociliary clearance.
    The European respiratory journal, 1998, Volume: 11, Issue:1

    Topics: Animals; Cough; Disease Models, Animal; Elasticity; Humans; Models, Biological; Mucociliary Clearanc

1998
Virulence Enhancement Agents for Haemophilus influenzae type B infection in mice.
    Laboratory animal science, 1999, Volume: 49, Issue:1

    Topics: Animals; Dextrans; Disease Models, Animal; Haemophilus Infections; Haemophilus influenzae type b; He

1999
Remodeling of the airway epithelium in asthma.
    American journal of respiratory and critical care medicine, 2001, Nov-15, Volume: 164, Issue:10 Pt 2

    Topics: Animals; Asthma; Biopsy; Bronchi; Bronchoconstriction; Capillary Permeability; Cell Degranulation; C

2001
Secretory cells.
    Federation proceedings, 1977, Volume: 36, Issue:13

    Topics: Animals; Bronchi; Disease Models, Animal; Epithelium; Glycoproteins; Humans; Mice; Mucus; Nicotiana;

1977
The cell biology of mucus secretion in the lung.
    Monographs in pathology, 1978, Volume: 19

    Topics: Animals; Disease Models, Animal; Epithelial Cells; Glycoproteins; Humans; Lung; Lung Diseases; Mucus

1978
[Morphological and molecular biological aspects of the origin of experimental stomach cancer].
    Voprosy onkologii, 1985, Volume: 31, Issue:6

    Topics: Animals; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; Epithelium; Gastric M

1985
Biological effects of cigarette smoking in the pathogenesis of pulmonary disease.
    Journal of occupational medicine. : official publication of the Industrial Medical Association, 1973, Volume: 15, Issue:3

    Topics: Animals; Bacteriolysis; Bronchi; Cell Movement; Cilia; Disease Models, Animal; Environmental Exposur

1973

Other Studies

375 other studies available for guaifenesin and Disease Models, Animal

ArticleYear
Antitussive and expectorant activities of licorice and its major compounds.
    Bioorganic & medicinal chemistry, 2018, 01-01, Volume: 26, Issue:1

    Topics: Administration, Oral; Ammonia; Animals; Antitussive Agents; Cough; Disease Models, Animal; Dose-Resp

2018
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
High throughput virtual screening strategy to develop a potential treatment for bronchial asthma by targeting interleukin 13 cytokine signaling.
    Allergologia et immunopathologia, 2022, Volume: 50, Issue:6

    Topics: Animals; Asthma; Child; Cytokines; Disease Models, Animal; Epinephrine; Guaifenesin; Humans; Hyperse

2022
Titanium Dioxide Nanoparticles Exacerbate Allergic Airway Inflammation via TXNIP Upregulation in a Mouse Model of Asthma.
    International journal of molecular sciences, 2021, Sep-14, Volume: 22, Issue:18

    Topics: Animals; Apoptosis; Asthma; bcl-2-Associated X Protein; Bronchoalveolar Lavage Fluid; Carrier Protei

2021
ITGB4 deficiency induces mucus hypersecretion by upregulating MUC5AC in RSV-infected airway epithelial cells.
    International journal of biological sciences, 2022, Volume: 18, Issue:1

    Topics: Animals; Disease Models, Animal; Epithelial Cells; Humans; Integrin beta4; Mice; Mucin 5AC; Mucus; R

2022
Cellular and molecular architecture of submucosal glands in wild-type and cystic fibrosis pigs.
    Proceedings of the National Academy of Sciences of the United States of America, 2022, 01-25, Volume: 119, Issue:4

    Topics: Acinar Cells; Animals; Biomarkers; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regula

2022
CTNNAL1 participates in the regulation of mucus overproduction in HDM-induced asthma mouse model through the YAP-ROCK2 pathway.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:5

    Topics: alpha Catenin; Animals; Asthma; Disease Models, Animal; Humans; Interleukin-13; Interleukin-4; Lung;

2022
Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease.
    International journal of molecular sciences, 2022, Jan-19, Volume: 23, Issue:3

    Topics: Animals; Asthma; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Ca

2022
Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease.
    The Journal of clinical investigation, 2022, 04-15, Volume: 132, Issue:8

    Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Humans; Inflammation; Mice; Mucin 5AC; Muci

2022
EPA and DHA differentially coordinate the crosstalk between host and gut microbiota and block DSS-induced colitis in mice by a reinforced colonic mucus barrier.
    Food & function, 2022, Apr-20, Volume: 13, Issue:8

    Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Docosahexaeno

2022
Azithromycin inhibits mucin secretion, mucous metaplasia, airway inflammation, and airways hyperresponsiveness in mice exposed to house dust mite extract.
    American journal of physiology. Lung cellular and molecular physiology, 2022, 05-01, Volume: 322, Issue:5

    Topics: Adenosine Triphosphate; Allergens; Animals; Asthma; Azithromycin; Disease Models, Animal; Inflammati

2022
Iristectorigenin A exerts novel protective properties against airway inflammation and mucus hypersecretion in OVA-induced asthmatic mice: Iristectorigenin A ameliorates asthma phenotype.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 104

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Immunoglobulin E; Immunoglobu

2022
Milk Fat Globule Membrane Attenuates Acute Colitis and Secondary Liver Injury by Improving the Mucus Barrier and Regulating the Gut Microbiota.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Glycolipids;

2022
Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic Response.
    ImmunoHorizons, 2022, 07-11, Volume: 6, Issue:7

    Topics: Allergens; Animals; Asthma; Disease Models, Animal; Immunoglobulin E; Mice; Mucus; Pharmaceutical Pr

2022
Oxysophocarpine inhibits airway inflammation and mucus hypersecretion through JNK/AP-1 pathway in vivo and in vitro.
    Fitoterapia, 2022, Volume: 162

    Topics: Alkaloids; Animals; Antioxidants; Asthma; Cytokines; Disease Models, Animal; Eosine Yellowish-(YS);

2022
Juvenile arsenic exposure aggravates goblet cell hyperplasia and airway mucus secretion in ovalbumin-sensitized mice.
    Environmental pollution (Barking, Essex : 1987), 2022, Dec-15, Volume: 315

    Topics: Animals; Arsenic; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Drinking

2022
Topical Adenosine Inhibits Inflammation and Mucus Production in Viral Acute Rhinosinusitis.
    The Laryngoscope, 2023, Volume: 133, Issue:9

    Topics: Adenosine; Animals; Disease Models, Animal; Inflammation; Mice; Mucins; Mucus; Sinusitis

2023
Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of γδT17 cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 111

    Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Inflammasomes

2023
Shaoyao decoction restores the mucus layer in mice with DSS-induced colitis by regulating Notch signaling pathway.
    Journal of ethnopharmacology, 2023, May-23, Volume: 308

    Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Drugs, Chines

2023
Rosmarinic Acid Restores Colonic Mucus Secretion in Colitis Mice by Regulating Gut Microbiota-Derived Metabolites and the Activation of Inflammasomes.
    Journal of agricultural and food chemistry, 2023, Mar-22, Volume: 71, Issue:11

    Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammasome

2023
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis.
    Nucleic acids research, 2023, 06-09, Volume: 51, Issue:10

    Topics: Animals; Cell Transformation, Neoplastic; Colon; Disease Models, Animal; Humans; Inflammation; Intes

2023
Altered Secretion, Constitution, and Functional Properties of the Gastrointestinal Mucus in a Rat Model of Sporadic Alzheimer's Disease.
    ACS chemical neuroscience, 2023, 08-02, Volume: 14, Issue:15

    Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Goblet Cells; Mucins; Mucus; Rats

2023
Lactobacillus rhamnosus 76 alleviates airway inflammation in ovalbumin-allergic mice and improves mucus secretion by down-regulating STAT6/SPDEF pathway.
    Immunobiology, 2023, Volume: 228, Issue:5

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Hypersensitivity; Inf

2023
Qufeng Xuanbi Formula inhibited benzo[a]pyrene-induced aggravated asthma airway mucus secretion by AhR/ROS/ERK pathway.
    Journal of ethnopharmacology, 2024, Jan-30, Volume: 319, Issue:Pt 1

    Topics: Air Pollutants; Animals; Asthma; Benzo(a)pyrene; Disease Models, Animal; Extracellular Signal-Regula

2024
Melia azedarach L. reduces pulmonary inflammation and mucus hypersecretion on a murine model of ovalbumin exposed asthma.
    Journal of ethnopharmacology, 2024, Feb-10, Volume: 320

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Inflammation; Meli

2024
Niclosamide repurposed for the treatment of inflammatory airway disease.
    JCI insight, 2019, 08-08, Volume: 4, Issue:15

    Topics: Animals; Anoctamins; Anti-Inflammatory Agents; Asthma; Bronchi; Cell Line, Tumor; Cystic Fibrosis; D

2019
Butylphthalide ameliorates airway inflammation and mucus hypersecretion via NF-κB in a murine asthma model.
    International immunopharmacology, 2019, Volume: 76

    Topics: Allergens; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Benzofurans; Bronchoalv

2019
Colitis susceptibility in mice with reactive oxygen species deficiency is mediated by mucus barrier and immune defense defects.
    Mucosal immunology, 2019, Volume: 12, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Colitis; Colon; Cytochrome b Group; Disease Models, Animal; Dysbiosi

2019
A Paclitaxel-Based Mucoadhesive Nanogel with Multivalent Interactions for Cervical Cancer Therapy.
    Small (Weinheim an der Bergstrasse, Germany), 2019, Volume: 15, Issue:47

    Topics: Acrylic Resins; Adhesiveness; Animals; beta-Cyclodextrins; Cell Death; Cell Line, Tumor; Cell Membra

2019
Novel Human NKCC1 Mutations Cause Defects in Goblet Cell Mucus Secretion and Chronic Inflammation.
    Cellular and molecular gastroenterology and hepatology, 2020, Volume: 9, Issue:2

    Topics: Animals; Chronic Disease; Citrobacter rodentium; Colectomy; Colitis; Colon; Disease Models, Animal;

2020
Targeted deletion of NFAT-Interacting-Protein-(NIP) 45 resolves experimental asthma by inhibiting Innate Lymphoid Cells group 2 (ILC2).
    Scientific reports, 2019, 10-30, Volume: 9, Issue:1

    Topics: Animals; Asthma; Carrier Proteins; Child; Child, Preschool; Disease Models, Animal; Female; Humans;

2019
Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction.
    Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020, Volume: 1865, Issue:2

    Topics: Administration, Oral; Animals; Arachidonic Acid; Cell Line; Cystic Fibrosis; Disease Models, Animal;

2020
Systems pharmacology-based study of Tanreqing injection in airway mucus hypersecretion.
    Journal of ethnopharmacology, 2020, Mar-01, Volume: 249

    Topics: Animals; Data Analysis; Disease Models, Animal; Drugs, Chinese Herbal; Ethnopharmacology; Humans; Li

2020
Serotonin receptors 5-HTR2A and 5-HTR2B are involved in cigarette smoke-induced airway inflammation, mucus hypersecretion and airway remodeling in mice.
    International immunopharmacology, 2020, Volume: 81

    Topics: Airway Remodeling; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Injections

2020
Rhubarb-Evoke Mucus Secretion through Aggregation and Degranulation of Mast Cell in the Colon of Rat: In vivo and ex vivo studies.
    Scientific reports, 2019, 12-18, Volume: 9, Issue:1

    Topics: Animals; Cell Aggregation; Cell Degranulation; Colon; Cytokines; Digestive System; Disease Models, A

2019
Iloprost inhibits acute allergic nasal inflammation by GATA3 -ILC2 pathway in mice.
    Respiratory physiology & neurobiology, 2020, Volume: 276

    Topics: Animals; Disease Models, Animal; Female; GATA3 Transcription Factor; Goblet Cells; Hyperplasia; Ilop

2020
Intravital microscopic optical coherence tomography imaging to assess mucus-mobilizing interventions for muco-obstructive lung disease in mice.
    American journal of physiology. Lung cellular and molecular physiology, 2020, 03-01, Volume: 318, Issue:3

    Topics: Animals; Disease Models, Animal; Epithelial Sodium Channels; Humans; Intravital Microscopy; Lung Dis

2020
LPS-binding IgG arrests actively motile Salmonella Typhimurium in gastrointestinal mucus.
    Mucosal immunology, 2020, Volume: 13, Issue:5

    Topics: Animals; Antibodies, Bacterial; Disease Models, Animal; Immunoglobulin Fab Fragments; Immunoglobulin

2020
Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways.
    American journal of physiology. Lung cellular and molecular physiology, 2020, 05-01, Volume: 318, Issue:5

    Topics: Acetic Acid; Acid Sensing Ion Channel Blockers; Acid Sensing Ion Channels; Airway Obstruction; Anima

2020
Warifteine and methylwarifteine inhibited the type 2 immune response on combined allergic rhinitis and asthma syndrome (CARAS) experimental model through NF-кB pathway.
    International immunopharmacology, 2020, Volume: 85

    Topics: Alkaloids; Animals; Anti-Allergic Agents; Asthma; Behavior, Animal; Bronchoalveolar Lavage Fluid; Ci

2020
Panax notoginseng saponin R1 modulates TNF-α/NF-κB signaling and attenuates allergic airway inflammation in asthma.
    International immunopharmacology, 2020, Volume: 88

    Topics: Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Disease Models, Ani

2020
Ursolic Acid Alleviates Mucus Secretion and Tissue Remodeling in Rat Model of Allergic Rhinitis After PM2.5 Exposure.
    American journal of rhinology & allergy, 2021, Volume: 35, Issue:2

    Topics: Animals; Disease Models, Animal; Mucus; Nasal Mucosa; Ovalbumin; Particulate Matter; Rats; Rhinitis,

2021
The establishment of humanized IL-4/IL-4RA mouse model by gene editing and efficacy evaluation.
    Immunobiology, 2020, Volume: 225, Issue:5

    Topics: Allergens; Animals; Antibodies, Monoclonal; Asthma; Bronchoalveolar Lavage Fluid; Cells, Cultured; D

2020
Symbiotic microbiome Staphylococcus aureus from human nasal mucus modulates IL-33-mediated type 2 immune responses in allergic nasal mucosa.
    BMC microbiology, 2020, 10-07, Volume: 20, Issue:1

    Topics: Animals; Corynebacterium; Cytokines; Disease Models, Animal; Enterobacter aerogenes; Epithelial Cell

2020
Pulmonary Mycosis Drives Forkhead Box Protein A2 Degradation and Mucus Hypersecretion through Activation of the Spleen Tyrosine Kinase-Epidermal Growth Factor Receptor-AKT/Extracellular Signal-Regulated Kinase 1/2 Signaling.
    The American journal of pathology, 2021, Volume: 191, Issue:1

    Topics: Animals; Blastomycosis; Cats; Disease Models, Animal; Dogs; ErbB Receptors; Hepatocyte Nuclear Facto

2021
Copaifera malmei Harms leaves infusion attenuates TNBS-ulcerative colitis through modulation of cytokines, oxidative stress and mucus in experimental rats.
    Journal of ethnopharmacology, 2021, Mar-01, Volume: 267

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Colitis, Ulcerative; Colon; Cytokines;

2021
Mitoquinone ameliorates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice.
    International immunopharmacology, 2021, Volume: 90

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Inflammation Med

2021
TMT-based quantitative proteomics reveals suppression of SLC3A2 and ATP1A3 expression contributes to the inhibitory role of acupuncture on airway inflammation in an OVA-induced mouse asthma model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 134

    Topics: Acupuncture Therapy; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Anima

2021
Dilodendron bipinnatum Radlk. extract alleviates ulcerative colitis induced by TNBS in rats by reducing inflammatory cell infiltration, TNF-α and IL-1β concentrations, IL-17 and COX-2 expressions, supporting mucus production and promotes an antioxidant ef
    Journal of ethnopharmacology, 2021, Apr-06, Volume: 269

    Topics: Animals; Antioxidants; Brazil; Caco-2 Cells; Cell Survival; Colitis, Ulcerative; Cyclooxygenase 2; D

2021
Disulfide disruption reverses mucus dysfunction in allergic airway disease.
    Nature communications, 2021, 01-11, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Animals; Asthma; Disease Models, Animal; Disulfides; Expectorants; Female; Glycop

2021
Long non-coding RNA TUG1 promotes airway remodeling and mucus production in asthmatic mice through the microRNA-181b/HMGB1 axis.
    International immunopharmacology, 2021, Volume: 94

    Topics: Airway Remodeling; Allergens; Animals; Asthma; Cells, Cultured; Disease Models, Animal; Female; HMGB

2021
Lignosus rhinocerotis Cooke Ryvarden ameliorates airway inflammation, mucus hypersecretion and airway hyperresponsiveness in a murine model of asthma.
    PloS one, 2021, Volume: 16, Issue:3

    Topics: Animals; Asthma; Disease Models, Animal; Mice; Mucus; Polyporaceae; Th2 Cells

2021
Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult
    Mediators of inflammation, 2021, Volume: 2021

    Topics: Animals; Cathepsins; Cystic Fibrosis; Disease Models, Animal; Epithelial Sodium Channels; Inflammati

2021
Mainstream Cigarette Smoke Impacts the Mouse Vocal Fold Epithelium and Mucus Barrier.
    The Laryngoscope, 2021, Volume: 131, Issue:11

    Topics: Adult; Animals; Cigarette Smoking; Disease Models, Animal; Epithelium; Female; Humans; Laryngeal Muc

2021
Tectochrysin ameliorates murine allergic airway inflammation by suppressing Th2 response and oxidative stress.
    European journal of pharmacology, 2021, Jul-05, Volume: 902

    Topics: Allergens; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Basophil

2021
VEGF receptor 2 (KDR) protects airways from mucus metaplasia through a Sox9-dependent pathway.
    Developmental cell, 2021, 06-07, Volume: 56, Issue:11

    Topics: Airway Obstruction; Animals; Cell Transdifferentiation; Disease Models, Animal; Gene Expression Regu

2021
sRAGE Inhibits the Mucus Hypersecretion in a Mouse Model with Neutrophilic Asthma.
    Immunological investigations, 2022, Volume: 51, Issue:5

    Topics: Animals; Asthma; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Glyco

2022
Casein-fed mice showed faster recovery from DSS-induced colitis than chicken-protein-fed mice.
    Food & function, 2021, Jul-05, Volume: 12, Issue:13

    Topics: Animals; Bacteria; Body Weight; Caseins; Chickens; Colitis; Colon; Dextran Sulfate; Disease Models,

2021
Epithelium-derived IL17A Promotes Cigarette Smoke-induced Inflammation and Mucus Hyperproduction.
    American journal of respiratory cell and molecular biology, 2021, Volume: 65, Issue:6

    Topics: Animals; Cell Line; Cigarette Smoking; Disease Models, Animal; Humans; Inflammation; Interleukin-17;

2021
Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease.
    Cellular and molecular gastroenterology and hepatology, 2021, Volume: 12, Issue:5

    Topics: Amino Acid Sequence; Animals; Biomarkers; Disease Models, Animal; Disease Susceptibility; Endoplasmi

2021
Postnatal Ozone Exposure Disrupts Alveolar Development, Exaggerates Mucoinflammatory Responses, and Suppresses Bacterial Clearance in Developing
    Journal of immunology (Baltimore, Md. : 1950), 2021, 08-15, Volume: 207, Issue:4

    Topics: Animals; Bacteria; Cystic Fibrosis; Disease Models, Animal; Epithelial Sodium Channels; Inflammation

2021
IRE1β does not affect mucus secretion during allergic asthma development in a house dust mite murine model.
    Allergy, 2021, Volume: 76, Issue:11

    Topics: Allergens; Animals; Asthma; Disease Models, Animal; Humans; Mice; Mucus; Pyroglyphidae

2021
Nattokinase, profibrinolytic enzyme, effectively shrinks the nasal polyp tissue and decreases viscosity of mucus.
    Allergology international : official journal of the Japanese Society of Allergology, 2017, Volume: 66, Issue:4

    Topics: Adult; Aged; Animals; Asthma; Chronic Disease; Disease Models, Animal; Eosinophils; Female; Fibrin;

2017
Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients.
    The Journal of allergy and clinical immunology, 2018, Volume: 141, Issue:1

    Topics: Animals; Asthma; Disease Models, Animal; Epithelial Cells; Humans; Immunity, Innate; Interleukin-13;

2018
Anti‑inflammatory effects of dihydromyricetin in a mouse model of asthma.
    Molecular medicine reports, 2017, Volume: 15, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models,

2017
Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice.
    Scientific reports, 2017, 04-11, Volume: 7

    Topics: Airway Remodeling; Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Flu

2017
BMAL1 links the circadian clock to viral airway pathology and asthma phenotypes.
    Mucosal immunology, 2018, Volume: 11, Issue:1

    Topics: Airway Remodeling; Airway Resistance; Animals; ARNTL Transcription Factors; Asthma; Bronchiolitis, V

2018
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Lung, 2017, Volume: 195, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid

2017
Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation.
    Inflammatory bowel diseases, 2017, Volume: 23, Issue:6

    Topics: Animals; Bacteria; Colitis; Colon; Disease Models, Animal; DNA, Bacterial; Dysbiosis; Feces; Gastroi

2017
Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma.
    International immunopharmacology, 2017, Volume: 49

    Topics: Allergens; Animals; Anti-Inflammatory Agents; Asthma; Cytokines; Disease Models, Animal; Female; Fur

2017
Early Postnatal Secondhand Smoke Exposure Disrupts Bacterial Clearance and Abolishes Immune Responses in Muco-Obstructive Lung Disease.
    Journal of immunology (Baltimore, Md. : 1950), 2017, 08-01, Volume: 199, Issue:3

    Topics: Animals; Animals, Newborn; Bacterial Infections; Bacterial Load; Cell Movement; Cystic Fibrosis; Dis

2017
Therapeutic intranasal instillation of allergen-loaded microbubbles suppresses experimental allergic asthma in mice.
    Biomaterials, 2017, Volume: 142

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Allergens; Animals; Antibody Formation; Asthma;

2017
Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma.
    Molecular medicine reports, 2017, Volume: 16, Issue:4

    Topics: Animals; Arginase; Asthma; Bronchoalveolar Lavage Fluid; Cell Differentiation; Disease Models, Anima

2017
Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.
    Experimental biology and medicine (Maywood, N.J.), 2017, Volume: 242, Issue:15

    Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Bronchoalveolar Lavage Fluid; Cytokines; Disea

2017
Capsule Type and Amount Affect Shedding and Transmission of
    mBio, 2017, 08-22, Volume: 8, Issue:4

    Topics: Animals; Animals, Newborn; Bacterial Capsules; Bacterial Shedding; Disease Models, Animal; Host-Path

2017
Limax extract ameliorates cigarette smoke-induced chronic obstructive pulmonary disease in mice.
    International immunopharmacology, 2018, Volume: 54

    Topics: Animals; Cigarette Smoking; Complex Mixtures; Cytokines; Disease Models, Animal; Gastropoda; Humans;

2018
Progression of Type 2 Helper T Cell-Type Inflammation and Airway Remodeling in a Rodent Model of Naturally Acquired Subclinical Primary Pneumocystis Infection.
    The American journal of pathology, 2018, Volume: 188, Issue:2

    Topics: Animals; Bronchioles; Disease Models, Animal; Disease Progression; Extracellular Matrix; Female; Gen

2018
Phloretin attenuates mucus hypersecretion and airway inflammation induced by cigarette smoke.
    International immunopharmacology, 2018, Volume: 55

    Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cigarette Smoking; Disease Models, Animal; ErbB Recept

2018
Development of an airway mucus defect in the cystic fibrosis rat.
    JCI insight, 2018, 01-11, Volume: 3, Issue:1

    Topics: Animals; Bicarbonates; Biological Transport; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conducta

2018
Endoplasmic reticulum chaperone GRP78 mediates cigarette smoke-induced necroptosis and injury in bronchial epithelium.
    International journal of chronic obstructive pulmonary disease, 2018, Volume: 13

    Topics: Animals; Apoptosis; Bronchi; Cell Line; Cytokines; Disease Models, Animal; Endoplasmic Reticulum Cha

2018
Effects of ozone repeated short exposures on the airway/lung inflammation, airway hyperresponsiveness and mucus production in a mouse model of ovalbumin-induced asthma.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 101

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Disease Models, Animal; Enzyme-Linked Immunosorbent Assa

2018
Bacillus subtilis spore with surface display of paramyosin from Clonorchis sinensis potentializes a promising oral vaccine candidate.
    Parasites & vectors, 2018, 03-07, Volume: 11, Issue:1

    Topics: Administration, Oral; Animals; Antibodies, Helminth; Bacillus subtilis; Bile; Blood Chemical Analysi

2018
LPS Exposure in Early Life Protects Against Mucus Hypersecretion in Ovalbumin-Induced Asthma by Down-Regulation of the IL-13 and JAK-STAT6 Pathways.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 46, Issue:3

    Topics: Administration, Intranasal; Animals; Asthma; Cell Line; Disease Models, Animal; Down-Regulation; Hum

2018
In vivo and in vitro investigation of anti-inflammatory and mucus-regulatory activities of a fixed combination of thyme and primula extracts.
    Pulmonary pharmacology & therapeutics, 2018, Volume: 51

    Topics: Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Epithelial Cells; Humans; Lipo

2018
The mucus bundles responsible for airway cleaning are retained in cystic fibrosis and by cholinergic stimulation.
    The European respiratory journal, 2018, Volume: 52, Issue:2

    Topics: Animals; Cholinergic Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; D

2018
Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018, Volume: 50, Issue:11

    Topics: Animals; Caco-2 Cells; Colitis; Dextran Sulfate; Disease Models, Animal; HT29 Cells; Humans; Intesti

2018
TRPC1 intensifies house dust mite-induced airway remodeling by facilitating epithelial-to-mesenchymal transition and STAT3/NF-κB signaling.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:1

    Topics: Airway Remodeling; Animals; Bronchi; Calcium; Collagen; Disease Models, Animal; Down-Regulation; Epi

2019
Antisense oligonucleotide targeting of mRNAs encoding ENaC subunits α, β, and γ improves cystic fibrosis-like disease in mice.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2019, Volume: 18, Issue:3

    Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Anima

2019
An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.
    Science translational medicine, 2018, 08-22, Volume: 10, Issue:455

    Topics: Airway Remodeling; Airway Resistance; Animals; Asthma; Bronchi; Cell Count; Disease Models, Animal;

2018
Attached stratified mucus separates bacteria from the epithelial cells in COPD lungs.
    JCI insight, 2018, 09-06, Volume: 3, Issue:17

    Topics: Animals; Bacteria; Bronchoalveolar Lavage Fluid; Cystic Fibrosis; Disease Models, Animal; Epithelial

2018
An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
    American journal of respiratory and critical care medicine, 2019, 01-15, Volume: 199, Issue:2

    Topics: Acetylcysteine; Animals; Asthma; Cystic Fibrosis; Disease Models, Animal; Dithiothreitol; Expectoran

2019
FOXA2 depletion leads to mucus hypersecretion in canine airways with respiratory diseases.
    Cellular microbiology, 2019, Volume: 21, Issue:1

    Topics: Animals; Bordetella Infections; Bronchitis; Disease Models, Animal; Dogs; Goblet Cells; Hepatocyte N

2019
Fra2 Overexpression in Mice Leads to Non-allergic Asthma Development in an IL-13 Dependent Manner.
    Frontiers in immunology, 2018, Volume: 9

    Topics: Animals; Antibodies, Blocking; Asthma; Cell Proliferation; Cells, Cultured; Cytokines; Disease Model

2018
Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term intestinal inflammation in gnotobiotic interleukin-10-deficient mice.
    Gut microbes, 2019, Volume: 10, Issue:2

    Topics: Animals; Body Weight; Cecum; Disease Models, Animal; Escherichia coli; Gastrointestinal Microbiome;

2019
Petiveria alliacea Suppresses Airway Inflammation and Allergen-Specific Th2 Responses in Ovalbumin-Sensitized Murine Model of Asthma.
    Chinese journal of integrative medicine, 2018, Volume: 24, Issue:12

    Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Chemokines; Dis

2018
Enteric infection coupled with chronic Notch pathway inhibition alters colonic mucus composition leading to dysbiosis, barrier disruption and colitis.
    PloS one, 2018, Volume: 13, Issue:11

    Topics: Animals; Animals, Outbred Strains; Citrobacter rodentium; Colitis; Colon; Dibenzazepines; Disease Mo

2018
Pulmonary Neuroendocrine Cells Secrete γ-Aminobutyric Acid to Induce Goblet Cell Hyperplasia in Primate Models.
    American journal of respiratory cell and molecular biology, 2019, Volume: 60, Issue:6

    Topics: Acute Lung Injury; Animals; Asthma; Bronchi; Disease Models, Animal; Epithelial Cells; gamma-Aminobu

2019
S-Allyl cysteine reduces eosinophilic airway inflammation and mucus overproduction on ovalbumin-induced allergic asthma model.
    International immunopharmacology, 2019, Volume: 68

    Topics: Allergens; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage

2019
Targeting of cathepsin S reduces cystic fibrosis-like lung disease.
    The European respiratory journal, 2019, Volume: 53, Issue:3

    Topics: Airway Obstruction; Animals; Cathepsins; Cystic Fibrosis; Disease Models, Animal; Epithelial Sodium

2019
Recruitment manoeuvres dislodge mucus towards the distal airways in an experimental model of severe pneumonia.
    British journal of anaesthesia, 2019, Volume: 122, Issue:2

    Topics: Airway Management; Animals; Disease Models, Animal; Female; Intubation, Intratracheal; Mucus; Peak E

2019
A model of clinical endometritis in Holstein heifers using pathogenic Escherichia coli and Trueperella pyogenes.
    Journal of dairy science, 2019, Volume: 102, Issue:3

    Topics: Actinomycetaceae; Actinomycetales Infections; Animals; Body Fluids; Cattle; Cattle Diseases; Disease

2019
Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules.
    International journal of molecular medicine, 2019, Volume: 43, Issue:4

    Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Count; Chemokine CCL2; Disease Models, Animal; Down-Regu

2019
A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.
    JCI insight, 2019, 04-18, Volume: 4, Issue:8

    Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Anima

2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatment.
    Science (New York, N.Y.), 2019, 05-24, Volume: 364, Issue:6442

    Topics: Adaptive Immunity; Adjuvants, Immunologic; Animals; Asthma; Bronchial Hyperreactivity; Crystallizati

2019
Rho-kinase inhibitor attenuates airway mucus hypersecretion and inflammation partly by downregulation of IL-13 and the JNK1/2-AP1 signaling pathway.
    Biochemical and biophysical research communications, 2019, 08-20, Volume: 516, Issue:2

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Down-Regulation; Female; Infl

2019
Food Polyelectrolytes Compress the Colonic Mucus Hydrogel by a Donnan Mechanism.
    Biomacromolecules, 2019, 07-08, Volume: 20, Issue:7

    Topics: Animals; Bacterial Infections; Biofilms; Carboxymethylcellulose Sodium; Colon; Disease Models, Anima

2019
ORMDL3 knockdown in the lungs alleviates airway inflammation and airway remodeling in asthmatic mice via JNK1/2-MMP-9 pathway.
    Biochemical and biophysical research communications, 2019, 08-27, Volume: 516, Issue:3

    Topics: Airway Remodeling; Animals; Asthma; Bronchoalveolar Lavage Fluid; Child; Disease Models, Animal; Fem

2019
Anti-inflammatory activity of SintMed65, an N-acylhydrazone derivative, in a mouse model of allergic airway inflammation.
    International immunopharmacology, 2019, Volume: 75

    Topics: Allergens; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage

2019
Zebrafish modeling of intestinal injury, bacterial exposures and medications defines epithelial
    Disease models & mechanisms, 2019, 08-13, Volume: 12, Issue:8

    Topics: Acids; Animals; Autophagy; Bacterial Proteins; Dextran Sulfate; Dinoprostone; Disease Models, Animal

2019
Dendritic polyglycerolsulfate near infrared fluorescent (NIRF) dye conjugate for non-invasively monitoring of inflammation in an allergic asthma mouse model.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Animals; Asthma; Disease Models, Animal; Female; Fluorescent Dyes; Glycerol; Immunoglobulin G; Infla

2013
Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Airway Remodeling; Aldehyde Reductase; Animals; Asthma; Biomarkers; Chronic Disease; Disease Models,

2013
Pinellia ternata Breitenbach attenuates ovalbumin-induced allergic airway inflammation and mucus secretion in a murine model of asthma.
    Immunopharmacology and immunotoxicology, 2013, Volume: 35, Issue:3

    Topics: Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Disease

2013
Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease.
    American journal of respiratory cell and molecular biology, 2013, Volume: 49, Issue:3

    Topics: Age Factors; Animals; Animals, Newborn; Chemotaxis; Disease Models, Animal; Epithelial Sodium Channe

2013
Dihydroartemisinin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.
    Immunopharmacology and immunotoxicology, 2013, Volume: 35, Issue:3

    Topics: Animals; Anti-Asthmatic Agents; Artemisinins; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disea

2013
Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.
    Immunopharmacology and immunotoxicology, 2013, Volume: 35, Issue:3

    Topics: Animals; Bifidobacterium; Colitis, Ulcerative; Dextran Sulfate; Dietary Supplements; Disease Models,

2013
Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent.
    BMC biology, 2013, May-21, Volume: 11

    Topics: Acetates; Animals; Bacteroides; Bacteroides Infections; Cell Differentiation; Colon; Disease Models,

2013
Divergent immune responses to Mycobacterium avium subsp. paratuberculosis infection correlate with kinome responses at the site of intestinal infection.
    Infection and immunity, 2013, Volume: 81, Issue:8

    Topics: Animals; Cattle; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Host-Pathogen Interact

2013
A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.
    Journal of virology, 2013, Volume: 87, Issue:20

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Viral; Chemoprevention; Disease Models, Animal; Female;

2013
Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.
    Mucosal immunology, 2014, Volume: 7, Issue:3

    Topics: Animals; Animals, Newborn; Antibodies, Neutralizing; Apoptosis; Chlamydia Infections; Chlamydia muri

2014
Tiotropium bromide inhibits relapsing allergic asthma in BALB/c mice.
    Pulmonary pharmacology & therapeutics, 2014, Volume: 27, Issue:1

    Topics: Airway Remodeling; Animals; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Dexamethasone;

2014
Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
    International immunopharmacology, 2013, Volume: 17, Issue:3

    Topics: Acetates; Allergens; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cycloprop

2013
Mast cell-deficient kit mice develop house dust mite-induced lung inflammation despite impaired eosinophil recruitment.
    Journal of innate immunity, 2014, Volume: 6, Issue:2

    Topics: Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemokine CCL11; Disease Models, Animal; E

2014
Early-life exposure to combustion-derived particulate matter causes pulmonary immunosuppression.
    Mucosal immunology, 2014, Volume: 7, Issue:3

    Topics: Adoptive Transfer; Allergens; Animals; Animals, Newborn; Antigens; Asthma; Dendritic Cells; Disease

2014
REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum.
    Mucosal immunology, 2014, Volume: 7, Issue:4

    Topics: Animals; Disease Models, Animal; Gene Expression Profiling; Ileum; Immunity, Innate; Inflammation; I

2014
γδ T-cell-deficient mice show alterations in mucin expression, glycosylation, and goblet cells but maintain an intact mucus layer.
    American journal of physiology. Gastrointestinal and liver physiology, 2014, Apr-01, Volume: 306, Issue:7

    Topics: Animals; Antigens, Surface; Colitis; Dextran Sulfate; Disease Models, Animal; Epidermal Growth Facto

2014
Naringenin inhibits allergen‑induced airway remodeling in a murine model of asthma.
    Molecular medicine reports, 2014, Volume: 9, Issue:4

    Topics: Airway Remodeling; Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Flu

2014
Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
    American journal of respiratory and critical care medicine, 2014, May-01, Volume: 189, Issue:9

    Topics: Airway Obstruction; Animals; Bronchiectasis; Cystic Fibrosis; Disease Models, Animal; Epithelial Sod

2014
Impact of a Met(11)Thr single nucleotide polymorphism of surfactant protein D on allergic airway inflammation in a murine asthma model.
    Experimental lung research, 2014, Volume: 40, Issue:4

    Topics: Animals; Disease Models, Animal; Humans; Lung; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs;

2014
Treatment with the C5a receptor/CD88 antagonist PMX205 reduces inflammation in a murine model of allergic asthma.
    International immunopharmacology, 2014, Volume: 21, Issue:2

    Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models,

2014
The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis.
    Shock (Augusta, Ga.), 2014, Volume: 42, Issue:3

    Topics: Acute Disease; Amylases; Animals; Antioxidants; Disease Models, Animal; Disease Progression; Ileum;

2014
Siegesbeckia glabrescens attenuates allergic airway inflammation in LPS-stimulated RAW 264.7 cells and OVA induced asthma murine model.
    International immunopharmacology, 2014, Volume: 22, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Asteraceae; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cel

2014
Pdcd4 modulates markers of macrophage alternative activation and airway remodeling in antigen-induced pulmonary inflammation.
    Journal of leukocyte biology, 2014, Volume: 96, Issue:6

    Topics: Airway Remodeling; Animals; Apoptosis Regulatory Proteins; Arginase; Asthma; beta-N-Acetylhexosamini

2014
Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.
    Science (New York, N.Y.), 2014, Aug-15, Volume: 345, Issue:6198

    Topics: Animals; Animals, Newborn; Anions; Cilia; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance

2014
Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.
    Science (New York, N.Y.), 2014, Aug-15, Volume: 345, Issue:6198

    Topics: Animals; Animals, Newborn; Anions; Cilia; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance

2014
Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.
    Science (New York, N.Y.), 2014, Aug-15, Volume: 345, Issue:6198

    Topics: Animals; Animals, Newborn; Anions; Cilia; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance

2014
Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.
    Science (New York, N.Y.), 2014, Aug-15, Volume: 345, Issue:6198

    Topics: Animals; Animals, Newborn; Anions; Cilia; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance

2014
Airway remodeling is reversed by aerobic training in a murine model of chronic asthma.
    Scandinavian journal of medicine & science in sports, 2015, Volume: 25, Issue:3

    Topics: Airway Remodeling; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cell Movement; Chemokine

2015
Melatonin reduces airway inflammation in ovalbumin-induced asthma.
    Immunobiology, 2014, Volume: 219, Issue:12

    Topics: Animals; Antibody Formation; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Cytokines; Disease Mod

2014
Melatonin reduces airway inflammation in ovalbumin-induced asthma.
    Immunobiology, 2014, Volume: 219, Issue:12

    Topics: Animals; Antibody Formation; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Cytokines; Disease Mod

2014
Melatonin reduces airway inflammation in ovalbumin-induced asthma.
    Immunobiology, 2014, Volume: 219, Issue:12

    Topics: Animals; Antibody Formation; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Cytokines; Disease Mod

2014
Melatonin reduces airway inflammation in ovalbumin-induced asthma.
    Immunobiology, 2014, Volume: 219, Issue:12

    Topics: Animals; Antibody Formation; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Cytokines; Disease Mod

2014
Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling.
    Journal of pineal research, 2015, Volume: 58, Issue:1

    Topics: Animals; Antioxidants; Cell Line, Tumor; Disease Models, Animal; Extracellular Signal-Regulated MAP

2015
Healing process in mice model of surgical wounds enhanced by Phyllocaulis boraceiensis mucus.
    Advances in skin & wound care, 2014, Volume: 27, Issue:12

    Topics: Animals; Biological Products; Cell Proliferation; Disease Models, Animal; Female; Gastropoda; Mice;

2014
Repeated inhalation of sevoflurane inhibits airway inflammation in an OVA-induced mouse model of allergic airway inflammation.
    Respirology (Carlton, Vic.), 2015, Volume: 20, Issue:2

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Disease Models, Animal; Eosino

2015
Serotonin 5-HT₂ receptor activation prevents allergic asthma in a mouse model.
    American journal of physiology. Lung cellular and molecular physiology, 2015, Jan-15, Volume: 308, Issue:2

    Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactiv

2015
Terminalia catappa L.: a medicinal plant from the Caribbean pharmacopeia with anti-Helicobacter pylori and antiulcer action in experimental rodent models.
    Journal of ethnopharmacology, 2015, Jan-15, Volume: 159

    Topics: Acetic Acid; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Caribbean Region; Disease Models, An

2015
Lipoxin B₄ promotes the resolution of allergic inflammation in the upper and lower airways of mice.
    Mucosal immunology, 2015, Volume: 8, Issue:4

    Topics: Animals; Cell Degranulation; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Eosinophils;

2015
Triptolide suppresses airway goblet cell hyperplasia and Muc5ac expression via NF-κB in a murine model of asthma.
    Molecular immunology, 2015, Volume: 64, Issue:1

    Topics: Airway Remodeling; Animals; Asthma; Blotting, Western; Bronchi; Bronchoalveolar Lavage Fluid; Diseas

2015
Protective effect of δ-amyrone against ethanol-induced gastric ulcer in mice.
    Immunobiology, 2015, Volume: 220, Issue:6

    Topics: Animals; Cytokines; Disease Models, Animal; Ethanol; Gastric Acidity Determination; Gastric Mucosa;

2015
The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology.
    Immunology and cell biology, 2015, Volume: 93, Issue:6

    Topics: Activins; Adult; Animals; Body Weight; Cystic Fibrosis; Disease Models, Animal; Female; Follistatin;

2015
The Flavonoid 7,4'-Dihydroxyflavone Inhibits MUC5AC Gene Expression, Production, and Secretion via Regulation of NF-κB, STAT6, and HDAC2.
    Phytotherapy research : PTR, 2015, Volume: 29, Issue:6

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Disease Models, Animal; Epithelial Cells;

2015
The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.
    Translational research : the journal of laboratory and clinical medicine, 2015, Volume: 166, Issue:3

    Topics: Anemia, Sickle Cell; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytok

2015
The anti-allergic activity of Cymbopogon citratus is mediated via inhibition of nuclear factor kappa B (Nf-Κb) activation.
    BMC complementary and alternative medicine, 2015, Jun-06, Volume: 15

    Topics: Allergens; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage F

2015
Carvedilol attenuates inflammatory biomarkers and oxidative stress in a rat model of ulcerative colitis.
    Drug development research, 2015, Volume: 76, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbazoles; Carvedilol; Colitis, Ulcera

2015
Exposure to Deepwater Horizon Crude Oil Burnoff Particulate Matter Induces Pulmonary Inflammation and Alters Adaptive Immune Response.
    Environmental science & technology, 2015, Jul-21, Volume: 49, Issue:14

    Topics: Adaptive Immunity; Animals; Asthma; Cell Death; Cell Line; Cell Survival; Dinoprost; Disease Models,

2015
Conditional Deletion of TAK1 in T Cells Reveals a Pivotal Role of TCRαβ+ Intraepithelial Lymphocytes in Preventing Lymphopenia-Associated Colitis.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Animals; Antimicrobial Cationic Peptides; Colitis; Cytokines; Disease Models, Animal; Intestinal Muc

2015
SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model.
    Molecular immunology, 2015, Volume: 67, Issue:2 Pt B

    Topics: Acute Disease; Animals; Anthracenes; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Di

2015
PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function.
    Journal of translational medicine, 2015, Jul-14, Volume: 13

    Topics: Adoptive Transfer; Animals; Antigens, CD; Asthma; Bronchial Hyperreactivity; CD4-Positive T-Lymphocy

2015
Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2015, Volume: 45, Issue:12

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Allergens; Animals; Asthma; Case-Control Studies; Cel

2015
[Effects of ozone oxidative stress on the airway hyperresponsiveness and mucus production in mice with acute allergic airway inflammation].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2015, Volume: 38, Issue:3

    Topics: Animals; Asthma; Bronchoalveolar Lavage; Disease Models, Animal; Female; Inflammation; Interleukin-1

2015
Callicarpa japonica Thunb. attenuates cigarette smoke-induced neutrophil inflammation and mucus secretion.
    Journal of ethnopharmacology, 2015, Dec-04, Volume: 175

    Topics: Animals; Bronchoalveolar Lavage Fluid; Callicarpa; Cell Line; Cell Line, Tumor; Disease Models, Anim

2015
Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice.
    International journal of molecular sciences, 2015, Aug-26, Volume: 16, Issue:9

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cyclic AMP-Dependent Protein Kinases; Cytokines; Dise

2015
Copper oxide nanoparticles aggravate airway inflammation and mucus production in asthmatic mice via MAPK signaling.
    Nanotoxicology, 2016, Volume: 10, Issue:4

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Copper; Cytokines; Disease Models, Animal

2016
Resveratrol inhibits mucus overproduction and MUC5AC expression in a murine model of asthma.
    Molecular medicine reports, 2016, Volume: 13, Issue:1

    Topics: Animals; Asthma; Cell Line; Disease Models, Animal; Epithelial Cells; Female; Gene Expression Regula

2016
Continuous Exposure to Low-Dose-Rate Gamma Irradiation Reduces Airway Inflammation in Ovalbumin-Induced Asthma.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Animals; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Choline; Disease Models,

2015
On the Pathogenesis of Acute Exacerbations of Mucoobstructive Lung Diseases.
    Annals of the American Thoracic Society, 2015, Volume: 12 Suppl 2

    Topics: Animals; Disease Models, Animal; Disease Progression; Humans; Lung; Lung Diseases, Obstructive; Mice

2015
Heat-labile enterotoxin of Escherichia coli promotes intestinal colonization of Salmonella enterica.
    Comparative immunology, microbiology and infectious diseases, 2015, Volume: 43

    Topics: Animals; Bacterial Load; Bacterial Toxins; Cell Line; Cell Survival; Diarrhea; Disease Models, Anima

2015
Gastroprotective effects of thymol on acute and chronic ulcers in rats: The role of prostaglandins, ATP-sensitive K(+) channels, and gastric mucus secretion.
    Chemico-biological interactions, 2016, Jan-25, Volume: 244

    Topics: Acetic Acid; Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relation

2016
Molecular Mechanisms of Airway Hyperresponsiveness in a Murine Model of Steroid-Resistant Airway Inflammation.
    Journal of immunology (Baltimore, Md. : 1950), 2016, Feb-01, Volume: 196, Issue:3

    Topics: Adoptive Transfer; Animals; Asthma; Disease Models, Animal; Drug Resistance; Immunoblotting; Interle

2016
Suhuang antitussive capsule at lower doses attenuates airway hyperresponsiveness, inflammation, and remodeling in a murine model of chronic asthma.
    Scientific reports, 2016, Feb-10, Volume: 6

    Topics: Airway Remodeling; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal;

2016
Mechanism(s) of action underlying the gastroprotective effect of ethyl acetate fraction obtained from the crude methanolic leaves extract of Muntingia calabura.
    BMC complementary and alternative medicine, 2016, Feb-24, Volume: 16

    Topics: Animals; Anti-Ulcer Agents; Antioxidants; Dinoprostone; Disease Models, Animal; Gallic Acid; Gastric

2016
Polygonum multiflorum Decreases Airway Allergic Symptoms in a Murine Model of Asthma.
    The American journal of Chinese medicine, 2016, Volume: 44, Issue:1

    Topics: Administration, Oral; Animals; Anti-Asthmatic Agents; Asthma; Cytokines; Disease Models, Animal; Dos

2016
Alpha-boswellic acid protects against ethanol-induced gastric injury in rats: involvement of nuclear factor erythroid-2-related factor 2/heme oxygenase-1 pathway.
    The Journal of pharmacy and pharmacology, 2016, Volume: 68, Issue:4

    Topics: Animals; Anti-Ulcer Agents; Antioxidants; Biomarkers; Cytoprotection; Dinoprostone; Disease Models,

2016
Recombinant human deoxyribonuclease therapy improves airway resistance and reduces DNA extracellular traps in a murine acute asthma model.
    Experimental lung research, 2016, Volume: 42, Issue:2

    Topics: Administration, Intranasal; Airway Obstruction; Airway Resistance; Allergens; Animals; Asthma; Bronc

2016
Early-Life Intranasal Colonization with Nontypeable Haemophilus influenzae Exacerbates Juvenile Airway Disease in Mice.
    Infection and immunity, 2016, Volume: 84, Issue:7

    Topics: Animals; Bacterial Load; Cytokines; Disease Models, Animal; Disease Progression; Female; Haemophilus

2016
Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice.
    Mucosal immunology, 2017, Volume: 10, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Colitis, Ulcerative; Colon; Disease Models, Animal;

2017
IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2016, Volume: 15, Issue:6

    Topics: Animals; Chronic Disease; Cystic Fibrosis; Disease Models, Animal; Interleukin-22; Interleukins; Lun

2016
[The effect and injury to the airways of different sputum aspiration pressure in a rat model of mucus hypersecretion].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2016, Volume: 39, Issue:7

    Topics: Animals; Biopsy, Needle; Disease Models, Animal; Interleukin-1beta; Mucus; Pressure; Random Allocati

2016
The involvement of central nervous system histamine receptors in psychological stress-induced exacerbation of allergic airway inflammation in mice.
    Allergology international : official journal of the Japanese Society of Allergology, 2016, Volume: 65 Suppl

    Topics: Animals; Antigens; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Central Nervous System;

2016
Gastroprotective and ulcer healing effects of hydroethanolic extract of leaves of Caryocar coriaceum: Mechanisms involved in the gastroprotective activity.
    Chemico-biological interactions, 2017, Jan-05, Volume: 261

    Topics: Animals; Antioxidants; Capsaicin; Chromatography, High Pressure Liquid; Chronic Disease; Disease Mod

2017
IκBNS induces Muc5ac expression in epithelial cells and causes airway hyper-responsiveness in murine asthma models.
    Allergy, 2017, Volume: 72, Issue:7

    Topics: Allergens; Animals; Asthma; Blood Cells; Cytokines; Dermatophagoides pteronyssinus; Disease Models,

2017
Laryngeal mucus hypersecretion is exacerbated after smoking cessation and ameliorated by glucocorticoid administration.
    Toxicology letters, 2017, Jan-04, Volume: 265

    Topics: Animals; Cytokines; Disease Models, Animal; Glucocorticoids; Laryngeal Mucosa; Laryngitis; Male; Muc

2017
Lyn kinase represses mucus hypersecretion by regulating IL-13-induced endoplasmic reticulum stress in asthma.
    EBioMedicine, 2017, Volume: 15

    Topics: Animals; Asthma; Biomarkers; Case-Control Studies; Cytokines; Disease Models, Animal; Endoplasmic Re

2017
Anti-Helicobacter pylori and antiulcerogenic activity of Aframomum pruinosum seeds on indomethacin-induced gastric ulcer in rats.
    Pharmaceutical biology, 2017, Volume: 55, Issue:1

    Topics: Aluminum Hydroxide; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Models, Animal; Dose-

2017
Lyn regulates mucus secretion and MUC5AC via the STAT6 signaling pathway during allergic airway inflammation.
    Scientific reports, 2017, 02-16, Volume: 7

    Topics: Animals; Cytokines; Disease Models, Animal; Gene Expression; Humans; Mice; Mice, Knockout; Models, B

2017
Novel triple neurokinin receptor antagonist CS-003 inhibits respiratory disease models in guinea pigs.
    European journal of pharmacology, 2008, Oct-31, Volume: 596, Issue:1-3

    Topics: Administration, Oral; Animals; Asthma; Bronchoconstriction; Capillary Permeability; Capsaicin; Cough

2008
Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration.
    Journal of immunology (Baltimore, Md. : 1950), 2008, Sep-15, Volume: 181, Issue:6

    Topics: Animals; Arginase; Boronic Acids; Bronchi; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Enz

2008
Endothelin A receptor antagonist modulates lymphocyte and eosinophil infiltration, hyperreactivity and mucus in murine asthma.
    International immunopharmacology, 2008, Dec-20, Volume: 8, Issue:13-14

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; En

2008
Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma.
    International immunopharmacology, 2009, Volume: 9, Issue:4

    Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchoalveolar Lav

2009
Expression of survivin in lung eosinophils is associated with pathology in a mouse model of allergic asthma.
    International immunology, 2009, Volume: 21, Issue:6

    Topics: Airway Obstruction; Allergens; Animals; Apoptosis; Asthma; Cell Adhesion; Cytokines; Disease Models,

2009
Gastric antisecretory and antiulcer activities of Cyclea peltata (Lam.) Hook. f. & Thoms. in rats.
    Journal of ethnopharmacology, 2009, Sep-07, Volume: 125, Issue:2

    Topics: Animals; Anti-Ulcer Agents; Catalase; Cyclea; Disease Models, Animal; Ethanol; Gastric Juice; Gastri

2009
Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen.
    American journal of physiology. Lung cellular and molecular physiology, 2009, Volume: 297, Issue:2

    Topics: Adrenal Cortex Hormones; Allergens; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Disease Mod

2009
Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice.
    American journal of respiratory cell and molecular biology, 2010, Volume: 42, Issue:5

    Topics: Adenosine; Allergens; Animals; Bronchi; Bronchoalveolar Lavage Fluid; Chronic Disease; Disease Model

2010
Distinct roles of FOXA2 and FOXA3 in allergic airway disease and asthma.
    American journal of respiratory and critical care medicine, 2009, Oct-01, Volume: 180, Issue:7

    Topics: Animals; Asthma; Disease Models, Animal; Epithelial Cells; Gene Expression; Hepatocyte Nuclear Facto

2009
Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.
    Journal of virology, 2009, Volume: 83, Issue:21

    Topics: Animals; Cell Line; Cervix Uteri; Disease Models, Animal; Female; HIV Infections; HIV-1; Humans; Hyd

2009
Prostaglandin E2 receptor EP2, EP3, and EP4 agonists inhibit antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats.
    The Annals of otology, rhinology, and laryngology, 2009, Volume: 118, Issue:7

    Topics: Alprostadil; Animals; Dinoprostone; Disease Models, Animal; Hypertrophy; Male; Metaplasia; Methyl Et

2009
Petasites extract Ze 339 (PET) inhibits allergen-induced Th2 responses, airway inflammation and airway hyperreactivity in mice.
    Phytotherapy research : PTR, 2010, Volume: 24, Issue:5

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Chemokine CCL5; Disease Mo

2010
Gastroprotective activity of Trichosanthes cucumerina in rats.
    Journal of ethnopharmacology, 2010, Feb-17, Volume: 127, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Cimetidine; Disease Models, Animal; Ethanol; Female; Gastric Juice; Gast

2010
Gastroprotective effect of barbatusin and 3-beta-hydroxy-3-deoxibarbatusin, quinonoid diterpenes isolated from Plectranthus grandis, in ethanol-induced gastric lesions in mice.
    Journal of ethnopharmacology, 2010, Feb-17, Volume: 127, Issue:3

    Topics: Acetylcysteine; Animals; Anti-Ulcer Agents; Antioxidants; Capsaicin; Disease Models, Animal; Diterpe

2010
The plant extract Isatis tinctoria L. extract (ITE) inhibits allergen-induced airway inflammation and hyperreactivity in mice.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2010, Volume: 17, Issue:8-9

    Topics: Allergens; Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lav

2010
Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.
    The American journal of pathology, 2010, Volume: 176, Issue:3

    Topics: Animals; Cell Proliferation; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; D

2010
Anti-ulcerogenic effect of a whey protein isolate and collagen hydrolysates against ethanol ulcerative lesions on oral administration to rats.
    Journal of medicinal food, 2010, Volume: 13, Issue:1

    Topics: Alkylation; Animals; Anti-Ulcer Agents; Carbenoxolone; Cattle; Collagen; Disease Models, Animal; Dru

2010
Lipids control mucus production in cystic fibrosis.
    Nature medicine, 2010, Volume: 16, Issue:3

    Topics: Animals; Carbonic Anhydrase II; Carbonic Anhydrase IV; Cystic Fibrosis; Cystic Fibrosis Transmembran

2010
Gastrointestinal protective effect of dietary spices during ethanol-induced oxidant stress in experimental rats.
    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2010, Volume: 35, Issue:2

    Topics: Alkaloids; Animals; Antioxidants; Benzodioxoles; Capsaicin; Capsicum; Catalase; Cytoprotection; Diet

2010
Ozone increases airway hyperreactivity and mucus hyperproduction in mice previously exposed to allergen.
    Journal of toxicology and environmental health. Part A, 2010, Volume: 73, Issue:11

    Topics: Air Pollutants; Allergens; Animals; Asthma; Biomarkers; Bronchial Hyperreactivity; Bronchoalveolar L

2010
Critical role of cytosolic phospholipase A2{alpha} in bronchial mucus hypersecretion in CFTR-deficient mice.
    The European respiratory journal, 2010, Volume: 36, Issue:5

    Topics: Animals; Arachidonic Acid; Bronchi; Cell Line; Chlorides; Cystic Fibrosis Transmembrane Conductance

2010
Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth.
    Science translational medicine, 2010, Apr-28, Volume: 2, Issue:29

    Topics: Animals; Animals, Newborn; Cystic Fibrosis; Disease Models, Animal; Ileus; Inflammation; Lung; Mecon

2010
Glycyrrhizin attenuates mucus production by inhibition of MUC5AC mRNA expression in vivo and in vitro.
    Journal of pharmacological sciences, 2010, Volume: 113, Issue:1

    Topics: Animals; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regula

2010
The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model.
    Journal of immunology (Baltimore, Md. : 1950), 2010, Jul-15, Volume: 185, Issue:2

    Topics: Adoptive Transfer; Airway Remodeling; Animals; Antibodies, Monoclonal; Asthma; Blotting, Western; Cy

2010
Antiulcer effects of Achyrocline satureoides (Lam.) DC (Asteraceae) (Marcela), a folk medicine plant, in different experimental models.
    Journal of ethnopharmacology, 2010, Jul-20, Volume: 130, Issue:2

    Topics: Achyrocline; Animals; Anti-Ulcer Agents; Brazil; Cimetidine; Cytoprotection; Disease Models, Animal;

2010
Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma.
    American journal of respiratory cell and molecular biology, 2011, Volume: 44, Issue:4

    Topics: Airway Remodeling; Animals; Arginine; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Flui

2011
Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
    Journal of gastroenterology and hepatology, 2010, Volume: 25 Suppl 1

    Topics: Animals; Anti-Ulcer Agents; Cimetidine; Disease Models, Animal; Famotidine; Histamine H2 Antagonists

2010
Anti-asthmatic effect of Sanguisorba officinalis L. and potential role of heme oxygenase-1 in an ovalbumin-induced murine asthma model.
    International journal of molecular medicine, 2010, Volume: 26, Issue:2

    Topics: Analysis of Variance; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokine

2010
Repeated stress reduces mucociliary clearance in animals with chronic allergic airway inflammation.
    Respiratory physiology & neurobiology, 2010, Aug-31, Volume: 173, Issue:1

    Topics: Adrenal Glands; Animals; Bronchial Hyperreactivity; Cilia; Disease Models, Animal; Epithalamus; Guin

2010
Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.
    British journal of pharmacology, 2010, Volume: 160, Issue:8

    Topics: Adrenal Cortex Hormones; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveo

2010
Effects of astragaloside IV on IFN-gamma level and prolonged airway dysfunction in a murine model of chronic asthma.
    Planta medica, 2011, Volume: 77, Issue:4

    Topics: Animals; Asthma; Astragalus Plant; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Chronic

2011
Effects of clarithromycin and dexamethasone on mucus production in isografted rat trachea.
    Pharmacology, 2011, Volume: 87, Issue:1-2

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Dexamethasone; Disease Mod

2011
Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia.
    American journal of respiratory and critical care medicine, 2011, Jun-01, Volume: 183, Issue:11

    Topics: Animals; Blotting, Western; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Epithelial

2011
Gastroprotective and ulcer healing effects of essential oil from Hyptis spicigera Lam. (Lamiaceae).
    Journal of ethnopharmacology, 2011, Apr-26, Volume: 135, Issue:1

    Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Bicyclic Monoterpenes; Brazil; Bridged Bicyclo Compounds; C

2011
Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation.
    Journal of immunology (Baltimore, Md. : 1950), 2011, Apr-15, Volume: 186, Issue:8

    Topics: Animals; Antigens, CD; Blotting, Western; Cell Adhesion Molecules; Cells, Cultured; Cytokines; Disea

2011
Swine models of cystic fibrosis reveal male reproductive tract phenotype at birth.
    Biology of reproduction, 2011, Volume: 85, Issue:3

    Topics: Animals; Animals, Genetically Modified; Animals, Newborn; Anions; Chloride-Bicarbonate Antiporters;

2011
Indigofera suffruticosa Mill as new source of healing agent: involvement of prostaglandin and mucus and heat shock proteins.
    Journal of ethnopharmacology, 2011, Sep-01, Volume: 137, Issue:1

    Topics: Acetates; Animals; Anti-Ulcer Agents; Cytoprotection; Disease Models, Animal; Ethanol; Gastric Mucos

2011
Blockade of human group X secreted phospholipase A2 (GX-sPLA2)-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective GX-sPLA2 inhibitor.
    The Journal of biological chemistry, 2011, Aug-12, Volume: 286, Issue:32

    Topics: Allergens; Animals; Asthma; Disease Models, Animal; Enzyme Inhibitors; Gene Knock-In Techniques; Gro

2011
Gastroprotective effect of standardized leaf extract from Argyreia speciosa on experimental gastric ulcers in rats.
    Journal of ethnopharmacology, 2011, Sep-01, Volume: 137, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Aspirin; Butanols; Catalase; Convolvulaceae; Cytoprotection; Disease Mod

2011
Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway.
    PloS one, 2011, Volume: 6, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Antimalarials; Artemisinins; Artesunate; Asthma; Bronchi; Broncho

2011
IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.
    The American journal of pathology, 2011, Volume: 179, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Blotting, Western; CD8-Positive T-Lymphocytes; Disease Models, Anim

2011
Gastroprotective activity of Zanthoxylum rhoifolium Lam. in animal models.
    Journal of ethnopharmacology, 2011, Sep-01, Volume: 137, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Catalase; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Eth

2011
In vivo antiulcer activity of the aqueous extract of Bauhinia purpurea leaf.
    Journal of ethnopharmacology, 2011, Sep-02, Volume: 137, Issue:2

    Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Bauhinia; Chromatography, High Pressure Liquid; Di

2011
Gastroprotective activity of methanol extract and marrubiin obtained from leaves of Marrubium vulgare L. (Lamiaceae).
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:9

    Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Diterpenes; Ethanol; Gastric Acid; Hydrogen-Ion

2011
Environmental tobacco smoke and progesterone alter lung inflammation and mucous metaplasia in a mouse model of allergic airway disease.
    Clinical reviews in allergy & immunology, 2012, Volume: 43, Issue:1-2

    Topics: Allergens; Animals; Asthma; Disease Models, Animal; Female; Humans; Hypersensitivity, Immediate; Mal

2012
Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:2

    Topics: Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Calcium Channel Blockers; Disease Models, An

2012
Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:2

    Topics: Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Calcium Channel Blockers; Disease Models, An

2012
Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:2

    Topics: Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Calcium Channel Blockers; Disease Models, An

2012
Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:2

    Topics: Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Calcium Channel Blockers; Disease Models, An

2012
Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.
    Gastroenterology, 2012, Volume: 142, Issue:4

    Topics: Administration, Oral; Analgesics; Animals; Chlorides; Chromosomes, Artificial, Bacterial; Colon; Dis

2012
Gastroprotective effect of Senecio candicans DC on experimental ulcer models.
    Journal of ethnopharmacology, 2012, Mar-06, Volume: 140, Issue:1

    Topics: Adenosine Triphosphatases; Alkaloids; Animals; Anti-Ulcer Agents; Antioxidants; Biphenyl Compounds;

2012
Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB.
    European journal of pharmacology, 2012, Mar-15, Volume: 679, Issue:1-3

    Topics: Airway Resistance; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Adhesion Molecules; Cell Coun

2012
Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin.
    Journal of ethnopharmacology, 2012, May-07, Volume: 141, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Antioxidants; Arbutin; Aspirin; Cell Line; Cytoprotection; Disease Model

2012
Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction.
    Physiological genomics, 2012, Apr-15, Volume: 44, Issue:8

    Topics: Airway Obstruction; Animals; Disease Models, Animal; Epithelial Sodium Channels; Lung Diseases, Obst

2012
Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation.
    Mucosal immunology, 2012, Volume: 5, Issue:4

    Topics: Animals; Bacterial Infections; Disease Models, Animal; Epithelial Sodium Channels; Lung; Mice; Mice,

2012
Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation.
    Immunity, 2012, Mar-23, Volume: 36, Issue:3

    Topics: Adoptive Transfer; Allergens; Animals; Asthma; Cytokines; Disease Models, Animal; Gene Expression Pr

2012
Microbiological and mucociliary properties of the ethanol extract of Hymenocardia acida on selected respiratory clinical isolates.
    Journal of dietary supplements, 2011, Volume: 8, Issue:1

    Topics: Ammonium Chloride; Animals; Anti-Bacterial Agents; Bacteria; Cilia; Columbidae; Disease Models, Anim

2011
Multiple peptidoglycan modification networks modulate Helicobacter pylori's cell shape, motility, and colonization potential.
    PLoS pathogens, 2012, Volume: 8, Issue:3

    Topics: Animals; Bacterial Physiological Phenomena; Bacterial Proteins; Cell Wall; Disease Models, Animal; F

2012
Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells.
    Journal of immunology (Baltimore, Md. : 1950), 2012, May-01, Volume: 188, Issue:9

    Topics: Adoptive Transfer; Animals; Asthma; Bacterial Capsules; Bacterial Proteins; Disease Models, Animal;

2012
CD137 deficiency does not affect development of airway inflammation or respiratory tolerance induction in murine models.
    Clinical and experimental immunology, 2012, Volume: 168, Issue:3

    Topics: Allergens; Animals; Asthma; Cytokines; Disease Models, Animal; Eosinophils; Humans; Immune Tolerance

2012
Retinoic acid suppresses intestinal mucus production and exacerbates experimental enterocolitis.
    Disease models & mechanisms, 2012, Volume: 5, Issue:4

    Topics: Animals; Dextran Sulfate; Disease Models, Animal; Enterocolitis; Inflammation; Intestinal Mucosa; In

2012
Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor.
    Chinese medical journal, 2012, Volume: 125, Issue:8

    Topics: Animals; Asthma; Chronic Disease; Disease Models, Animal; Female; Fluorobenzenes; GABA-A Receptor An

2012
Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:5

    Topics: Animals; Bronchi; Disease Models, Animal; ErbB Receptors; Histone Deacetylase 2; Lipopolysaccharides

2012
Gastroprotective activity of carvacrol on experimentally induced gastric lesions in rodents.
    Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Cymenes; Disease

2012
Effects and mechanism of arsenic trioxide on reversing the asthma pathologies including Th17-IL-17 axis in a mouse model.
    Iranian journal of allergy, asthma, and immunology, 2012, Volume: 11, Issue:2

    Topics: Animals; Anti-Asthmatic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Asthma; Bronchial Hyperreac

2012
Antiulcerogenic effect of Croton urucurana Baillon bark.
    Journal of ethnopharmacology, 2012, Aug-30, Volume: 143, Issue:1

    Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Croton; Disease Models, Animal; Ethanol; Female; Gastric Ac

2012
Comparative analysis of gastric bacterial microbiota in Mongolian gerbils after long-term infection with Helicobacter pylori.
    Microbial pathogenesis, 2012, Volume: 53, Issue:1

    Topics: Animals; Biodiversity; Disease Models, Animal; DNA Primers; Gastric Juice; Gerbillinae; Helicobacter

2012
Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma.
    Anesthesiology, 2012, Volume: 117, Issue:3

    Topics: Anesthetics, Local; Animals; Asthma; Bronchi; Disease Models, Animal; Fibrosis; GATA3 Transcription

2012
In vivo determination of mouse olfactory mucus cation concentrations in normal and inflammatory states.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Adult; Allergens; Animals; Cations; Disease Models, Animal; Eosinophil Major Basic Protein; Eosinoph

2012
SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:10

    Topics: 3' Untranslated Regions; Airway Obstruction; Animals; Antiporters; Asthma; Bronchitis; Calcium; Chil

2012
Antiulcer activity of the chloroform extract of Bauhinia purpurea leaf.
    Pharmaceutical biology, 2012, Volume: 50, Issue:12

    Topics: Animals; Anti-Ulcer Agents; Bauhinia; Chloroform; Chromatography, High Pressure Liquid; Cytoprotecti

2012
Possible biochemical effects following inhibition of ethanol-induced gastric mucosa damage by Gymnema sylvestre in male Wistar albino rats.
    Pharmaceutical biology, 2012, Volume: 50, Issue:12

    Topics: Animals; Anti-Ulcer Agents; Cytoprotection; Disease Models, Animal; DNA; Dose-Response Relationship,

2012
Gastroprotective activity of the ethanolic extract and hexane phase of Combretum duarteanum Cambess. (Combretaceae).
    Journal of natural medicines, 2013, Volume: 67, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Combretum; Cytoprotection; Disease Models, Animal; Dose-Response Relatio

2013
Gastroprotective mechanisms of the chloroform and ethyl acetate phases of Praxelis clematidea (Griseb.) R.M.King & H.Robinson (Asteraceae).
    Journal of natural medicines, 2013, Volume: 67, Issue:3

    Topics: Acetates; Animals; Anti-Ulcer Agents; Asteraceae; Biomarkers; Chloroform; Cytoprotection; Disease Mo

2013
IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells.
    Gastroenterology, 2013, Volume: 144, Issue:2

    Topics: Animals; Cells, Cultured; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Stres

2013
The AGC kinase inhibitor H89 attenuates airway inflammation in mouse models of asthma.
    PloS one, 2012, Volume: 7, Issue:11

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Immunoglobulin E;

2012
Alleviating effects of Lactobacillus strains on pathogenic Vibrio parahaemolyticus-induced intestinal fluid accumulation in the mouse model.
    FEMS microbiology letters, 2013, Volume: 339, Issue:1

    Topics: Analysis of Variance; Animals; Bacterial Adhesion; Disease Models, Animal; Female; Histocytochemistr

2013
Lipopolysaccharide inhibits Th2 lung inflammation induced by house dust mite allergens in mice.
    American journal of respiratory cell and molecular biology, 2013, Volume: 48, Issue:3

    Topics: Animals; Antigens, Dermatophagoides; Asthma; Complement Activation; Cytokines; Disease Models, Anima

2013
A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model.
    Journal of immunology (Baltimore, Md. : 1950), 2002, Nov-01, Volume: 169, Issue:9

    Topics: Administration, Intranasal; Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar L

2002
Effect of polysaccharides from Angelica sinensis on gastric ulcer healing.
    Life sciences, 2003, Jan-10, Volume: 72, Issue:8

    Topics: Angelica sinensis; Angiogenesis Inhibitors; Animals; Anti-Ulcer Agents; Disease Models, Animal; Drug

2003
A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse.
    Journal of immunology (Baltimore, Md. : 1950), 2003, Mar-15, Volume: 170, Issue:6

    Topics: Adoptive Transfer; Aerosols; Allergens; Animals; Bronchial Hyperreactivity; CD4-Positive T-Lymphocyt

2003
CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction.
    Journal of immunology (Baltimore, Md. : 1950), 2003, Mar-15, Volume: 170, Issue:6

    Topics: Animals; Bronchial Hyperreactivity; Bronchiolitis, Viral; Disease Models, Animal; Female; Goblet Cel

2003
Spontaneous remission of edema and regranulation of goblet cells in rat tracheae after capsaicin-induced acute inflammation.
    Anatomy and embryology, 2003, Volume: 206, Issue:4

    Topics: Acute Disease; Animals; Capsaicin; Cytoplasmic Granules; Disease Models, Animal; Edema; Goblet Cells

2003
In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells.
    American journal of respiratory and critical care medicine, 2003, Sep-01, Volume: 168, Issue:5

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Clarithromy

2003
[Effect of azithromycin on mucus secretion from nasal epithelium].
    The Japanese journal of antibiotics, 2003, Volume: 56 Suppl A

    Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Depression, Chemical; Disease Models,

2003
A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.
    Nature medicine, 2004, Volume: 10, Issue:2

    Topics: Animals; Asthma; Bronchi; Bronchial Provocation Tests; Cytoplasmic Granules; Disease Models, Animal;

2004
Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA.
    Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol; Cimetidine; Diseas

2004
Complex role of the IL-4 receptor alpha in a murine model of airway inflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Apr-01, Volume: 172, Issue:7

    Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Disease Model

2004
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
    Nature medicine, 2004, Volume: 10, Issue:5

    Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Anima

2004
Breath condensate hydrogen peroxide correlates with both airway cytology and epithelial lining fluid ascorbic acid concentration in the horse.
    Free radical research, 2004, Volume: 38, Issue:2

    Topics: Airway Obstruction; Animals; Ascorbic Acid; Breath Tests; Bronchoalveolar Lavage Fluid; Bronchoscopy

2004
Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Jun-01, Volume: 172, Issue:11

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid;

2004
Expiratory chest compression for atelectasis: No harm, no foul-oops!
    Respiratory care, 2004, Volume: 49, Issue:8

    Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Disease Models, Animal; Intubation, Intratrachea

2004
Effects of expiratory rib cage compression combined with endotracheal suctioning on gas exchange in mechanically ventilated rabbits with induced atelectasis.
    Respiratory care, 2004, Volume: 49, Issue:8

    Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Disease Models, Animal; Female; Intubation, Intr

2004
Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model.
    European journal of immunology, 2005, Volume: 35, Issue:1

    Topics: Animals; Asthma; Cytokines; Disease Models, Animal; Female; Heterozygote; Immunization; Immunoglobul

2005
Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice.
    FEMS immunology and medical microbiology, 2005, Feb-01, Volume: 43, Issue:2

    Topics: Animals; Bacterial Adhesion; Dextran Sulfate; Disease Models, Animal; Feces; Inflammatory Bowel Dise

2005
An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model.
    International immunopharmacology, 2005, Volume: 5, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cell Movement; Chromones; C

2005
[Effects of interleukin-13 on the gob-5 and MUC5AC expression in lungs of a murine asthmatic model].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2004, Volume: 27, Issue:12

    Topics: Animals; Asthma; Chloride Channels; Disease Models, Animal; Immunohistochemistry; Interleukin-13; Ma

2004
[The preventive effect of bacillus Calmette-Guerin vaccination in early life on airway inflammation and mucus production in a murine model of asthma].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2005, Volume: 28, Issue:1

    Topics: Animals; Asthma; BCG Vaccine; Bronchi; Disease Models, Animal; Lung; Mice; Mice, Inbred C57BL; Mucin

2005
Allophylus serratus: a plant with potential anti-ulcerogenic activity.
    Journal of ethnopharmacology, 2005, Jul-14, Volume: 99, Issue:3

    Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Aspirin; Cold Temperature; Disease Models, Animal;

2005
Menadione protects gastric mucosa against ethanol-induced ulcers.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2005, Volume: 56, Issue:6

    Topics: Administration, Oral; Animals; Antifibrinolytic Agents; Disease Models, Animal; Dose-Response Relati

2005
Gob-5 is not essential for mucus overproduction in preclinical murine models of allergic asthma.
    American journal of respiratory cell and molecular biology, 2005, Volume: 33, Issue:3

    Topics: Animals; Asthma; Cells, Cultured; Chloride Channels; Disease Models, Animal; Female; Gastrointestina

2005
Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model.
    The Journal of allergy and clinical immunology, 2005, Volume: 116, Issue:2

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Apoptosis; Asthma; Bronchial Hyperreactivity; Disease

2005
Characteristic features of allergic airway inflammation in a murine model of infantile asthma.
    International archives of allergy and immunology, 2005, Volume: 138, Issue:1

    Topics: Age Factors; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Di

2005
Antibody-antigen interaction in the airway drives early granulocyte recruitment through BLT1.
    American journal of physiology. Lung cellular and molecular physiology, 2006, Volume: 290, Issue:1

    Topics: Animals; Antigen-Antibody Reactions; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid

2006
Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model.
    American journal of physiology. Lung cellular and molecular physiology, 2006, Volume: 290, Issue:2

    Topics: Animals; Animals, Newborn; Cytokines; Disease Models, Animal; Female; Inflammation Mediators; Interl

2006
Culture of murine nasal epithelia: model for cystic fibrosis.
    American journal of physiology. Lung cellular and molecular physiology, 2006, Volume: 290, Issue:2

    Topics: Animals; Cell Culture Techniques; Cell Differentiation; Cystic Fibrosis; Disease Models, Animal; Ele

2006
Effect of disodium cromoglycate on airway mucus secretion during antigen-induced late asthmatic responses in a murine model of asthma.
    International archives of allergy and immunology, 2005, Volume: 138, Issue:3

    Topics: Airway Obstruction; Animals; Anti-Asthmatic Agents; Antigens; Asthma; Bronchoalveolar Lavage Fluid;

2005
Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma.
    The Journal of allergy and clinical immunology, 2005, Volume: 116, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Asthma; Cytokines; Disease Models, Animal; Female; Hepatitis A Viru

2005
Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation.
    Journal of pediatric gastroenterology and nutrition, 2006, Volume: 42, Issue:1

    Topics: Animals; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cystic Fibrosis; Cystic Fibrosis Transmembr

2006
Mucus in chronic airway diseases: sorting out the sticky details.
    The Journal of clinical investigation, 2006, Volume: 116, Issue:2

    Topics: Animals; Disease Models, Animal; Epithelial Cells; ErbB Receptors; Humans; Interleukin-13; Lung Dise

2006
Erratum: name change.
    American journal of respiratory cell and molecular biology, 2006, Volume: 34, Issue:3

    Topics: Animals; Asthma; Chloride Channels; Disease Models, Animal; Mice; Mucoproteins; Mucus; Respiratory M

2006
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.
    The Journal of clinical investigation, 2006, Volume: 116, Issue:3

    Topics: Allergens; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Dendritic Cells; Disease Models, Ani

2006
Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
    International immunology, 2006, Volume: 18, Issue:6

    Topics: Animals; Asthma; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Embryo, Mammalian; Eosinop

2006
Suppressive effect of verproside isolated from Pseudolysimachion longifolium on airway inflammation in a mouse model of allergic asthma.
    International immunopharmacology, 2006, Volume: 6, Issue:6

    Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disea

2006
Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation.
    American journal of respiratory cell and molecular biology, 2006, Volume: 35, Issue:3

    Topics: Airway Resistance; Animals; Antigens; Bronchoalveolar Lavage Fluid; Chemokines; Chloride Channels; D

2006
The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Experimental & molecular medicine, 2006, Apr-30, Volume: 38, Issue:2

    Topics: Acetates; Airway Obstruction; Animals; Anti-Asthmatic Agents; Asthma; Collagen; Cyclopropanes; Cyste

2006
Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice.
    The Journal of infectious diseases, 2006, Jun-15, Volume: 193, Issue:12

    Topics: Animals; Disease Models, Animal; Histocytochemistry; Lung; Lung Diseases, Obstructive; Metapneumovir

2006
Death receptor-6 regulates the development of pulmonary eosinophilia and airway inflammation in a mouse model of asthma.
    Immunology letters, 2006, Jul-15, Volume: 106, Issue:1

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Cytokines; Disease Models, Animal; Interferon-gamma; Mic

2006
Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006, Volume: 36, Issue:7

    Topics: Activins; Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female; Follistatin

2006
The spontaneously hypertensive rat: an experimental model of sulfur dioxide-induced airways disease.
    Toxicological sciences : an official journal of the Society of Toxicology, 2006, Volume: 94, Issue:1

    Topics: Acetylglucosaminidase; Administration, Inhalation; Animals; Bronchitis; Bronchoalveolar Lavage Fluid

2006
A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Oct-31, Volume: 103, Issue:44

    Topics: Allergens; Animals; Bronchial Hyperreactivity; Cell Movement; Chemokine CCL11; Chemokines, CC; Chron

2006
[Effects of glucocorticoid on airway mucus secretion in asthma: experiment with asthmatic mouse model].
    Zhonghua yi xue za zhi, 2006, Sep-19, Volume: 86, Issue:35

    Topics: Aluminum Hydroxide; Animals; Asthma; Bronchoalveolar Lavage Fluid; Dexamethasone; Disease Models, An

2006
Gastroprotective effects of DA-6034, a new flavonoid derivative, in various gastric mucosal damage models.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:11

    Topics: Acetic Acid; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Centra

2007
A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Benzamides; Biological Availability; Bronchitis; Bronchoalveolar

2007
The tick salivary protein, Salp15, inhibits the development of experimental asthma.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Jun-01, Volume: 178, Issue:11

    Topics: Adjuvants, Immunologic; Animals; Asthma; Bronchial Hyperreactivity; CD4-Positive T-Lymphocytes; Dise

2007
Plasminogen is an important regulator in the pathogenesis of a murine model of asthma.
    American journal of respiratory and critical care medicine, 2007, Aug-15, Volume: 176, Issue:4

    Topics: Animals; Antifibrinolytic Agents; Asthma; Bronchoalveolar Lavage Fluid; Collagen; Disease Models, An

2007
Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
    American journal of physiology. Gastrointestinal and liver physiology, 2007, Volume: 293, Issue:3

    Topics: Acetylcysteine; Animals; Bacteria; Body Weight; Cathartics; Cystic Fibrosis; Disease Models, Animal;

2007
Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Aug-15, Volume: 179, Issue:4

    Topics: Acute Disease; Administration, Intranasal; Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Mo

2007
Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model.
    Immunobiology, 2007, Volume: 212, Issue:8

    Topics: Administration, Oral; Animals; Asthma; Bronchial Hyperreactivity; Cultured Milk Products; Cytokines;

2007
The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthma.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2007, Volume: 37, Issue:11

    Topics: Animals; Asthma; Bronchitis; Bronchoalveolar Lavage Fluid; Cell Count; Cell Differentiation; Cytokin

2007
Airway responses to esophageal acidification.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:1

    Topics: Airway Resistance; Animals; Bronchi; Cats; Disease Models, Animal; Esophagus; Female; Gastroesophage

2008
Glutamine preferentially inhibits T-helper type 2 cell-mediated airway inflammation and late airway hyperresponsiveness through the inhibition of cytosolic phospholipase A(2) activity in a murine asthma model.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2008, Volume: 38, Issue:2

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchitis; Cytokines; Disease Models, Animal; Eosinophi

2008
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.
    The Journal of clinical investigation, 2008, Volume: 118, Issue:2

    Topics: Animals; Colitis, Ulcerative; Disease Models, Animal; Gene Transfer Techniques; Genetic Therapy; Gob

2008
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation.
    Nature medicine, 2008, Volume: 14, Issue:2

    Topics: Animals; Antibody Formation; Bronchial Hyperreactivity; Chemokines; Chemotactic Factors; Dendritic C

2008
EP4 agonist inhibits lipopolysaccharide-induced mucus secretion in airway epithelial cells.
    The Annals of otology, rhinology, and laryngology, 2008, Volume: 117, Issue:1

    Topics: Animals; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Dinoprostone; Disease Models, Animal; Gene Exp

2008
Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthma.
    American journal of respiratory cell and molecular biology, 2008, Volume: 39, Issue:1

    Topics: Adenoviridae; Adenoviridae Infections; Airway Obstruction; Animals; Cell Culture Techniques; Cell Di

2008
Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2008, Volume: 38, Issue:5

    Topics: Allergens; Animals; Cytokines; Disease Models, Animal; Inflammation; Isoquinolines; Lung; Mice; Mice

2008
Gastroprotective activity of Eriobotrya japonica seed extract on experimentally induced gastric lesions in rats.
    Journal of natural medicines, 2008, Volume: 62, Issue:1

    Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, D

2008
Successful prevalidation of the slug mucosal irritation test to assess the eye irritation potency of chemicals.
    Toxicology in vitro : an international journal published in association with BIBRA, 2008, Volume: 22, Issue:5

    Topics: Animal Use Alternatives; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Eye; Irr

2008
Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease.
    Journal of immunology (Baltimore, Md. : 1950), 2008, May-01, Volume: 180, Issue:9

    Topics: Aged; Animals; Asthma; Chlorocebus aethiops; COS Cells; Disease Models, Animal; Epithelial Cells; Fe

2008
Mucous obstruction and airway hyperresponsiveness in mice.
    American journal of respiratory and critical care medicine, 2008, May-15, Volume: 177, Issue:10

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Disease Models, Animal; Mic

2008
Symposium: Host defences.
    European journal of respiratory diseases. Supplement, 1983, Volume: 126

    Topics: Acquired Immunodeficiency Syndrome; Airway Resistance; Animals; Antigens; Cilia; Disease Models, Ani

1983
The chronically isoproterenol-treated rat in the study of cystic fibrosis: X-ray microanalysis of the submandibular gland.
    Experimental and molecular pathology, 1984, Volume: 40, Issue:3

    Topics: Animals; Calcium; Cystic Fibrosis; Disease Models, Animal; Drug Interactions; Electron Probe Microan

1984
Hypersecretion of mucus glycoprotein by the gallbladder epithelium in experimental cholelithiasis.
    The Journal of pathology, 1981, Volume: 134, Issue:3

    Topics: Animals; Cholelithiasis; Cholestanol; Cholesterol; Cholic Acids; Disease Models, Animal; Epithelium;

1981
Control and modulation of airway epithelial cells and their secretions.
    Experimental lung research, 1983, Volume: 4, Issue:2

    Topics: Animals; Asthma; Bronchitis; Chronic Disease; Cystic Fibrosis; Disease Models, Animal; Dogs; Epithel

1983
Experimental chronic bronchitis.
    International review of experimental pathology, 1983, Volume: 24

    Topics: Animals; Bronchi; Bronchitis; Chronic Disease; Cricetinae; Disease Models, Animal; Dogs; Epithelium;

1983
Effect of dexamethasone on antigen-induced high molecular weight glycoconjugate secretion in allergic guinea pigs.
    American journal of respiratory cell and molecular biology, 1995, Volume: 13, Issue:2

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Dexamethasone; Disease Models, Animal; Eosinophils; G

1995
Hyperplastic effects of aerosolized sodium metabisulfite on rat airway mucus-secretory epithelial cells.
    Canadian journal of physiology and pharmacology, 1994, Volume: 72, Issue:9

    Topics: Aerosols; Animals; Disease Models, Animal; Epithelium; Glycoproteins; Hyperplasia; Hypertrophy; Lung

1994
Antiulcerogenicity of the flavonoid fraction from Bidens aurea: comparison with ranitidine and omeprazole.
    Journal of ethnopharmacology, 1994, Volume: 42, Issue:3

    Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cold Temperature; Disease Models, Animal; Female; Flavono

1994
Influence of simulated mucus on cough sounds in cats.
    Respiratory medicine, 1993, Volume: 87, Issue:1

    Topics: Animals; Cats; Cough; Disease Models, Animal; Female; Male; Mucus; Sound

1993
MAO-A and -B inhibitors selectively alter Xenopus mucus-induced behaviors of snakes.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 44, Issue:2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Clorgyline; Disease Models, Animal; Movement Disord

1993
The effects of a cysteinyl leukotriene antagonist (ONO-1078) on antigen-induced responses in allergic sheep.
    Prostaglandins, leukotrienes, and essential fatty acids, 1993, Volume: 48, Issue:3

    Topics: Airway Resistance; Animals; Antigens, Helminth; Ascaris; Bronchoalveolar Lavage Fluid; Bronchoconstr

1993
Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats.
    Gastroenterology, 1996, Volume: 110, Issue:4

    Topics: Animals; Cell Division; Colitis; Disease Models, Animal; Fibroblast Growth Factor 10; Fibroblast Gro

1996
Evaluation of cecal ligation as a model of mucoid enteropathy in specific-pathogen-free rabbits.
    Laboratory animal science, 1996, Volume: 46, Issue:2

    Topics: Animals; Cecal Diseases; Cecum; Colon; Disease Models, Animal; Inflammation; Intestinal Diseases; Li

1996
The importance of leukotrienes in airway inflammation in a mouse model of asthma.
    The Journal of experimental medicine, 1996, Oct-01, Volume: 184, Issue:4

    Topics: 5-Lipoxygenase-Activating Proteins; Allergens; Animals; Asthma; Bronchial Provocation Tests; Broncho

1996
Cytoprotective activity in the gastric mucosa of rats exposed to carbon tetrachloride-induced liver injury.
    Inflammation, 1997, Volume: 21, Issue:5

    Topics: Animals; Carbon Tetrachloride; Dinoprostone; Disease Models, Animal; Drug Resistance; Ethanol; Gastr

1997
Studies on the antisecretory, gastric anti-ulcer and cytoprotective properties of glycine.
    Research communications in molecular pathology and pharmacology, 1997, Volume: 97, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Caustics; Disease Models, Anima

1997
Early stages in the development of goblet cells in the paranasal sinuses: a multimethodological study in the rabbit.
    Acta oto-laryngologica, 1998, Volume: 118, Issue:1

    Topics: Administration, Topical; Animals; Capsaicin; Cell Count; Cell Differentiation; Cytoplasmic Granules;

1998
Inflammation and a thickened mucus layer in mice with cholesterol gallstones.
    The Journal of surgical research, 1998, Volume: 74, Issue:1

    Topics: Animals; Cholecystitis; Cholelithiasis; Cholesterol; Cholesterol, Dietary; Cholic Acid; Cholic Acids

1998
Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model.
    Molecular genetics and metabolism, 1998, Volume: 64, Issue:2

    Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Anima

1998
Mucus transportability: the bovine trachea and frog palate models compared.
    The European respiratory journal, 1998, Volume: 12, Issue:4

    Topics: Animals; Anura; Cattle; Cystic Fibrosis; Disease Models, Animal; Humans; Mucociliary Clearance; Mucu

1998
[Protective effects of teprenone and gefarnate against taurocholate/hydrochloric acid-induced acute gastric mucosal lesions in rats].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1998, Volume: 112, Issue:5

    Topics: Acute Disease; Animals; Anti-Ulcer Agents; Disease Models, Animal; Diterpenes; Dose-Response Relatio

1998
T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production.
    The Journal of experimental medicine, 1999, Nov-01, Volume: 190, Issue:9

    Topics: Animals; Asthma; Disease Models, Animal; Eosinophilia; Flow Cytometry; Hypersensitivity; Inflammatio

1999
Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma.
    Journal of immunology (Baltimore, Md. : 1950), 2000, Jan-15, Volume: 164, Issue:2

    Topics: Administration, Intranasal; Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar L

2000
Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model.
    Journal of immunology (Baltimore, Md. : 1950), 2000, Mar-15, Volume: 164, Issue:6

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Allergens; Animals; Anti-Inflammatory Agents, Non-St

2000
Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment.
    American journal of physiology. Lung cellular and molecular physiology, 2000, Volume: 279, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid;

2000
Evaluation of the gastroprotective activity of cordatin, a diterpene isolated from Aparisthmium cordatum (Euphorbiaceae).
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Disease Models, Animal; Diterpe

2000
Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Apr-24, Volume: 98, Issue:9

    Topics: Animals; Asthma; Cell Line; Chloride Channels; Cloning, Molecular; Disease Models, Animal; Epitheliu

2001
Synergy of histone-derived peptides of coho salmon with lysozyme and flounder pleurocidin.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:5

    Topics: Aeromonas; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fish Diseases

2001
Suppression of asthma-like responses in different mouse strains by oral tolerance.
    American journal of respiratory cell and molecular biology, 2001, Volume: 24, Issue:5

    Topics: Administration, Inhalation; Administration, Oral; Animals; Antibodies; Antigens; Asthma; Bronchial P

2001
Sulfated polysaccharides, but not cellulose, increase colonic mucus in rats with loperamide-induced constipation.
    Digestive diseases and sciences, 2001, Volume: 46, Issue:7

    Topics: Alginates; Animals; Carrageenan; Cellulose; Chondroitin Sulfates; Colon; Constipation; Dietary Fiber

2001
Murine cytomegalovirus infection alters Th1/Th2 cytokine expression, decreases airway eosinophilia, and enhances mucus production in allergic airway disease.
    Journal of immunology (Baltimore, Md. : 1950), 2001, Sep-01, Volume: 167, Issue:5

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Cytomegalovirus Infections; Disease Models

2001
The CF salt controversy: in vivo observations and therapeutic approaches.
    Molecular cell, 2001, Volume: 8, Issue:1

    Topics: Aerosols; Amiloride; Animals; Cells, Cultured; Cystic Fibrosis; Disease Models, Animal; Diuretics; G

2001
Exposure to diesel exhaust exacerbates allergen-induced airway responses in guinea pigs.
    American journal of respiratory and critical care medicine, 2001, Nov-15, Volume: 164, Issue:10 Pt 1

    Topics: Allergens; Analysis of Variance; Animals; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavag

2001
In vivo microdialysis for determination of nasal liquid ion composition.
    American journal of physiology. Cell physiology, 2002, Volume: 282, Issue:6

    Topics: Animals; Chlorides; Cystic Fibrosis; Disease Models, Animal; Electrodes; Female; Ions; Male; Membran

2002
Inflammatory responses and mucus secretion in rats with acute bronchiolitis induced by nickel chloride.
    Inhalation toxicology, 2002, Volume: 14, Issue:4

    Topics: Animals; Bronchiolitis; Disease Models, Animal; Inflammation; Inhalation Exposure; Male; Mucus; Nick

2002
Studies on the pathogenesis of diet-induced dog gallstones.
    The American journal of digestive diseases, 1977, Volume: 22, Issue:4

    Topics: Amino Acids; Animals; Bile; Bile Pigments; Bilirubin; Cholelithiasis; Cholesterol, Dietary; Diet; Di

1977
Modification of mucus in animal models of disease.
    Advances in experimental medicine and biology, 1977, Volume: 89

    Topics: Animals; Bronchi; Disease Models, Animal; Epithelium; Glycoproteins; Hydrogen-Ion Concentration; Hyp

1977
Animal models in clinical disease.
    Ciba Foundation symposium, 1978, Issue:54

    Topics: Animals; Cytoplasmic Granules; Disease Models, Animal; Exocrine Glands; Glycoproteins; Mucus; Rats;

1978
The parasympathetic nervous system in airways disease.
    Scandinavian journal of respiratory diseases. Supplementum, 1979, Volume: 103

    Topics: Animals; Asthma; Bronchial Spasm; Disease Models, Animal; Dogs; Humans; Lung; Mucus; Parasympathetic

1979
An animal model for cystic fibrosis made by gene targeting.
    Science (New York, N.Y.), 1992, Aug-21, Volume: 257, Issue:5073

    Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Digestive System; Dis

1992
Experimental sinusitis in rabbits induced by aerobic and anaerobic bacteria: models for research in sinusitis.
    The Journal of otolaryngology, 1991, Volume: 20, Issue:6

    Topics: Animals; Bacteroides fragilis; Bacteroides Infections; Blood Flow Velocity; Disease Models, Animal;

1991
The oral mucosa of the MRL/I mouse: a synoptic picture of systemic autoimmune disorders.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1991, Volume: 20, Issue:6

    Topics: Animals; Autoimmune Diseases; Capillaries; Connective Tissue; Disease Models, Animal; Epithelium; Ex

1991
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.
    Infection and immunity, 1990, Volume: 58, Issue:8

    Topics: Animals; Bacterial Outer Membrane Proteins; Disease Models, Animal; Escherichia coli; Escherichia co

1990
A nasal allergy model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate.
    International archives of allergy and applied immunology, 1988, Volume: 85, Issue:4

    Topics: Administration, Intranasal; Animals; Cyanates; Disease Models, Animal; Guinea Pigs; Histamine; Male;

1988
Common bile duct ligation in rabbit: a new model of acute cholecystitis description of histology and bile analysis.
    The Journal of surgical research, 1988, Volume: 45, Issue:6

    Topics: Acute Disease; Animals; Bile; Bile Acids and Salts; Cholecystitis; Common Bile Duct; Disease Models,

1988
Changes in glycoconjugates in rat submandibular gland after chronic treatment with reserpine and isoproterenol.
    Histochemistry, 1988, Volume: 90, Issue:4

    Topics: Animals; Cystic Fibrosis; Cytoplasmic Granules; Disease Models, Animal; Glycoconjugates; Isoproteren

1988
Transition from normal to hypersecretory bronchial mucus in a canine model of bronchitis: changes in yield and composition.
    Experimental lung research, 1988, Volume: 14, Issue:1

    Topics: Animals; Bronchi; Bronchitis; Disease Models, Animal; Dogs; Glycoproteins; Glycosaminoglycans; Mucus

1988
Pharmacodynamic mechanism and therapeutic activity of ambroxol in animal experiments.
    Respiration; international review of thoracic diseases, 1987, Volume: 51 Suppl 1

    Topics: Albuterol; Ambroxol; Animals; Bromhexine; Cilia; Disease Models, Animal; Guinea Pigs; In Vitro Techn

1987
Simian model for the evaluation of immunity to influenza.
    Infection and immunity, 1974, Volume: 9, Issue:1

    Topics: Aerosols; Animals; Disease Models, Animal; Erythrocytes; Guinea Pigs; Haplorhini; Hemagglutination I

1974
Ingestion of asbestos.
    Environmental health perspectives, 1974, Volume: 9

    Topics: Animals; Asbestos; Diet; Disease Models, Animal; Dogs; Guinea Pigs; Haplorhini; Mucus; Rabbits; Rats

1974
An interpretive summary of the Bermuda workshop.
    Archives of internal medicine, 1970, Volume: 126, Issue:3

    Topics: Animals; Basement Membrane; Cell Division; Congresses as Topic; Disease Models, Animal; Environmenta

1970
Experimental chronic bronchitis. Pathology in the dog.
    Laboratory investigation; a journal of technical methods and pathology, 1974, Volume: 30, Issue:2

    Topics: Air; Animals; Bronchi; Bronchitis; Chronic Disease; Cilia; Disease Models, Animal; Dogs; Environment

1974
Evaluation of model systems for study of airway epithelium, cilia, and mucus.
    Archives of internal medicine, 1970, Volume: 126, Issue:3

    Topics: Animals; Bronchi; Bronchitis; Cilia; Disease Models, Animal; Dogs; Epithelium; Glycoproteins; Haplor

1970
Experimental requirements for the toxicological evaluation of tobacco smoke in the respiratory system.
    Scandinavian journal of respiratory diseases, 1969, Volume: 50, Issue:4

    Topics: Air Pollution; Animals; Cats; Cilia; Disease Models, Animal; Environmental Exposure; Humans; Macroph

1969
The canine tracheal pouch. A model for use in respiratory mucus research.
    The American review of respiratory disease, 1970, Volume: 101, Issue:5

    Topics: Animals; Disease Models, Animal; Dogs; Methods; Models, Biological; Mucus; Muscle Contraction; Muscl

1970
Studies of lung defense to infections in inhalation toxicology.
    Archives of internal medicine, 1970, Volume: 126, Issue:3

    Topics: Aerosols; Bacteria; Bacteriolysis; Cilia; Disease Models, Animal; Environmental Exposure; Epithelium

1970
Integrated defense mechanisms in models of chronic pulmonary disease.
    Archives of internal medicine, 1970, Volume: 126, Issue:3

    Topics: Aerosols; Animals; Antibodies; Bronchi; Chronic Disease; Cilia; Disease Models, Animal; Infections;

1970
Experimental bronchitis in animals due to sulphur dioxide and cigarette smoke. An automated quantitative study.
    Inhaled particles, 1970, Volume: 1

    Topics: Animals; Bronchitis; Disease Models, Animal; Germ-Free Life; Lung; Methods; Models, Biological; Mucu

1970